Biotech & Healthcare
Merck To Pay First-Quarter Dividend On Jan 9 – $MRK $DIA $ATOS $INVO
Reportedly, Merck & Co., Inc. (MRK) is to pay the first quarterly, 2023 dividend of $0.73 per share of the company’s common stock on January 9, 2023. The dividend will be payable to shareholders as of December 15, 2022. Merck & Co., Inc. (MRK) is a global healthcare solutions provider tha...
Dec 04, 2022
View Article
Alaska Airlines To Expand & Modernize Its Fleet With 52 Boeing 737 MAX Jets – $BA $DIA $ATOS $INVO
Reportedly, Alaska Airlines has placed an order for 52 Boeing (BA) airplanes expanding its Boeing's 737 MAX fleet along with an option for an additional 42 737-10 and 10 737-9 jets. The airline is focussing to build one of the most sustainable and efficient fleets in the industry, with the addition....
Dec 04, 2022
View Article
Apple’s Quarterly Earnings Exceeded Estimates – Forecasted Weak Holiday Quarter – $AAPL $DIA $ATOS $INVO
Reportedly, Apple's (AAPL) quarterly revenue and profit exceeded market estimates, however, the forecast for the holiday quarter was bleak. The iPhone expects revenue growth to fall below 8% in the December quarter. For the quarter, iPhone sales were not as strong as expected, however, Mac sales of...
Dec 03, 2022
View Article
Fed Chair Empowers Weekly Stock Market Continuation – $ADT $AMC $FATE $HL $KDNY $TSLA $XBI Rise!
Quote of the Day: "No man was ever wise by chance." - Lucius Annaeus Seneca Happy Saturday All! I hope you ll had a great week and enjoyed the balance of the group stage of the 2022 World Cup. Congratulations to Team USA that is now scheduled to play Netherlands in the knock out stage ...
Dec 03, 2022
View Article
Amgen To Webcast Investor Call On Dec 5 At #WCIRDC2022 – $AMGN $DIA $ATOS $INVO
As per reports, Amgen (AMGN) is to host a webcast call for the investment community at 8:00 a.m. ET on Monday, Dec. 5, 2022, in conjunction with the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC). The webcast can be reached at www.amgen.com, under Investors. ...
Dec 02, 2022
View Article
UnitedHealth To Pay Quarterly Dividend On Dec 13 – $UNH $DIA $ATOS $INVO
As per reports, the board of UnitedHealth Group (UNH) has authorized the payment of a cash dividend of $1.65 per share to common stock shareholders as of December 5, 2022. The dividend is payable on December 13, 2022. Dow 30 component UnitedHealth Group Incorporated (UNH) operates as a diversified ...
Dec 02, 2022
View Article
World’s Chief Manufacturer of Natural Gas Engines Caterpillar Waives Retirement Policy – Jim Umpleby To Continue As CEO – $CAT $DIA $ATOS $INVO
As per reports, Caterpillar, Inc.s (CAT) board have waived the policy requiring Chairman and CEO Jim Umpleby to retire at age of 65. The heavy machinery maker follows Target Corp, which last month waived its retirement policy allowing CEO Brian Cornell to lead. Umpleby, 64, assumed Caterpillar's ch...
Dec 01, 2022
View Article
JPMorgan Chase Merchants To Include ‘Meta Pay’ As A Payment Method – $JPM $DIA $ATOS $INVO
As per reports, JPMorgan Chase & Co's (JPM) merchants' network customers can now make payments through Meta Pay. In 2019, Facebook Pay (now knowns as Meta Pay) was launched as a unified payments service allowing users across Meta's platforms including Instagram and WhatsApp to make payments wi...
Dec 01, 2022
View Article
Amgen Reports Stronger Quarter Profits Recording Volume Growth – $AMGN $DIA $ATOS $INVO
Reportedly, Biotechnology company and Dow 30 component Amgen Inc's (AMGN) third-quarter revenue rose 1% as higher volume growth for its cancer, rheumatology, and cardiovascular products were offset by lower prices and foreign exchange losses. Revenue for the quarter totaled $6.7 billion, exceeding W...
Dec 01, 2022
View Article
Visa Recently Beat Quarterly Estimates As Consumers Spent ‘Huge’ On Travel – $V $DIA $ATOS $INVO
Reportedly, Visa Inc (V) had better-than-expected quarterly earnings as more Americans took advantage of a stronger dollar and flew to international destinations, and splurged on shopping and entertainment. Transactions increased 12% on a constant dollar basis to 50.9 billion in the fourth quarter t...
Dec 01, 2022
View Article
Japan’s Skymark To Acquire Boeing 737 MAX Airplanes – $BA $DIA $INVO
Reportedly, Japan's Skymark Airlines announced plans to add up to 12 Boeing (BA) 737 MAX airplanes as part of its fleet modernization efforts. The carrier intends to order four airplanes including the 737-8 and 737-10 variants with options for two additional jets. "As Skymark Airlines looks to su...
Dec 01, 2022
View Article
Boeing’s Q3 Earnings Disappointed – $BA $DIA $ATOS $INVO
As per reports, Boeing (BA) released third-quarter earnings reporting a wide miss on its earnings line, as defense unit losses weighed against a strong quarter on its commercial side. Boeing reported an adjusted loss of $6.18 per share, due to charges in its Air Force One and KC-46 air tanker projec...
Nov 30, 2022
View Article
Travelers Partnering With Wysa To Promote Holistic Recovery For Mental Health – $TRV $DIA $INVO
As per reports, The Travelers Companies, Inc. (TRV) has launched an app designed to promote the mental health of injured employees to facilitate a more holistic recovery. The app was created in partnership with Wysa, a provider of mental health support solutions powered by artificial intelligence. ...
Nov 30, 2022
View Article
Goldman Sachs Appointed Former Starbucks CEO Kevin R. Johnson To The Board – $GS $SBUX $DIA $ATOS $INVO
As per reports, Kevin R. Johnson is to join as an independent director of the Goldman Sachs Group, Inc. (GS), effective October 26, 2022. The Board announced Mr. Johnson will also join as a member of each of the firm’s Compensation, Governance, and Risk Committees. Mr. Johnson retired in April 20...
Nov 30, 2022
View Article
Travelers Quarterly Profits Hit By Hurricane, But Strong Premiums Surfaced- $TRV $DIA $ATOS $INVO
Reportedly, Property and casualty insurer The Travelers Companies, Inc. (TRV) reported a 20% fall in quarterly profit majorly hurt by hurricane-related claims and lower returns on its investments. Hurricanes Ian and Fiona, as well as severe storms in many U.S. regions, pushed the insurer's pretax ca...
Nov 30, 2022
View Article
Merck & Veeva Extend Their 12-Year Partnership – $MRK $VEEV $ATOS $INVO
Reportedly, Merck & Co., Inc. has recently announced a ten-year strategic partnership agreement with Veeva Systems (VEEV), building on the existing 12-year partnership between the companies. As per the agreement, Merck will take a Veeva-first approach to new industry-specific software and data, ...
Nov 30, 2022
View Article
Bottler Coca-Cola HBC Remains Confident On 2022 Profit Outlook – $KO $DIA $INVO
As per reports, Soft drinks bottler Coca-Cola Company (KO) HBC AG raised its full-year profit forecast as increasing prices helped the soft drinks bottler to keep sales steady. Sky-high inflation has pinched household budgets and forced consumers to cut down spending, but packaged food makers are ex...
Nov 30, 2022
View Article
Coca-Cola Raises Outlook Remains Confident Amid Price Raise – $KO $DIA $ATOS $INVO
Reportedly, Coca-Cola Company (KO) has raised its annual forecast as the soda giant gains from multiple price increases that have so far failed to bring the demand down. On an adjusted basis, Coca-Cola earned 69 cents per share on net revenue of $11.1 billion. Analysts were expecting 64 cents per s...
Nov 30, 2022
View Article
Goldman Sachs Approves Promotion Of 80 Bankers To Elite Rank – $GS $DIA $INVO
Reportedly, Wall Street Giant Goldman Sachs Group (GS) recently approved 80 bankers as partners including 21 in Europe, the Middle East, and Africa region, 53 employees in the Americas, and 6 in Asia. The promotions are up from 60 people in 2020. The racial breakdown for the 2022 class is 24% Asian,...
Nov 30, 2022
View Article
3M Cuts Full-Year Forecast Amid Tight Consumer Spending – $MMM $DIA $ATOS $INVO
Recently, 3M Co (MMM) lowered its full-year forecasts over an uncertain economic environment. The post-it maker, which gets 60 percent of its revenue from outside the United States, cut its full-year revenue and profit forecasts. The company now expects full-year revenue to drop between 3.5% and 3%,...
Nov 29, 2022
View Article
Walgreens Renews 5-yr-Agreement With Western Union Offering Easy Money Transfers – $WBA $DIA $ATOS $INVO
Reportedly, Western Union and Walgreen Boots Alliance (WBA) have renewed a five-year agreement to their long-standing relationship. The collaboration will allow consumers to have access to Western Union Money Transfer and bill payment services at nearly 9,000 Walgreens locations across the United S...
Nov 29, 2022
View Article
Disney Attracts U.S. Disney+ Customers With Early Merchandise Access $DIS $DIA $ATOS $INVO
As per reports, U.S. subscribers to the Disney+ streaming service will be able to purchase new Star Wars lightsabers, Black Panther masks, and other merchandise, as an offering as a limited test of an additional benefit for streaming customers looking to grab products created for the holiday shoppin...
Nov 29, 2022
View Article
Energy Giant Chevron To Pay Quarterly Dividend On December 12 – $CVX $DIA $ATOS $INVO
Reportedly, the Board of Directors of Chevron Corporation (CVX) declared a quarterly dividend of one dollar and forty-two cents ($1.42) per share, payable on December 12, 2022. The dividend is payable to all holders of common stock as of November 18, 2022. Dow 30 component Chevron Corpo...
Nov 29, 2022
View Article
Boeing Expects Higher Cash Flow In 2023 – $BA $DIA $ATOS $INVO
As per reports, Aerospace giant Boeing Co (BA) expects higher free cash flow as it expects to ramp up deliveries of 737 MAX and 787 jets, informed Chief Financial Officer Brian West. Boeing estimates it will generate $3 billion-$5 billion in free cash flow next year, way higher than the $1.5 billion...
Nov 29, 2022
View Article
Caterpillar Foundation Raises Record $13.8M To Serve Communities – $CAT $DIA $INVO
Reportedly, Caterpillar Inc. (CAT) retirees and employees together with the philanthropic organization, Caterpillar Foundation, have raised more than $13.8 million to the United Way chapters across Mexico, the United States, Canada, and Panama as part of its 2022-2023 campaign, to serve communitie...
Nov 29, 2022
View Article
Caterpillar Completes Successful Demonstration Of First Battery Electric Truck On 7-kilometer Course – $CAT $DIA $ATOS $INVO
Reportedly, Caterpillar, Inc. (CAT) announced a successful showing of 793 large mining trucks, their first battery electric powered mining trucks, and additionally announced a significant investment to transform its Arizona-based proving ground into a sustainable testing and validation hub of the fu...
Nov 29, 2022
View Article
AmEx Lifts COVID Vaccine Requirements For Working From Office – $AXP $DIA $INVO
As per reports, American Express Co. (AXP) has lifted COVID-19 vaccine requirements at its offices effective November 1, as the credit card giant prepares to remove pandemic-era protocols. According to the memo, the new guidelines will apply to offices in the United States, Canada, Australia, and Ne...
Nov 29, 2022
View Article
IBM Pushes The Limits With Its Most Powerful Quantum Computer To Date – $IBM $DIA $INVO
Reportedly, International Business Machines Corporation (IBM) announced a 433-qubit, Osprey machine, the most powerful and impressive quantum computer, built with three times the number of qubits than its earlier Eagle machine. Quantum computers are much faster than the fastest supercomputers today....
Nov 29, 2022
View Article
Disney’s Media & Entertainment Distribution Chairman Kareem Daniel Elected To McDonald’s Board – $MCD $DIS $DIA $INVO
As per reports, McDonald’s Corporation (MCD) announced the appointment of Kareem Daniel as an independent Director of the Board, effective October 1, 2022. Mr. Daniel currently serves as Chairman, of Disney Media and Entertainment Distribution at The Walt Disney Company, leading the organizatio...
Nov 29, 2022
View Article
Chevron Commits $500k Contribution For Ian Hurricane Relief – $CVX $DIA $INVO
Reportedly, Chevron Corporation (CVX) has committed $500k to support relief efforts in Florida after Hurricane Ian left devastation across the state, causing catastrophic floods and damage. "Our thoughts are with all the people whose lives have been impacted by Hurricane Ian. With deep ties in Flor...
Nov 29, 2022
View Article
Walt Disney Appoints Veteran Carolyn Everson To Its Board – $DIS $DIA $INVO
As per reports, the Walt Disney Company (DIS) announced the appointment of Carolyn Everson, a veteran media and technology executive, to its Board of Directors, effective November 21. Ms. Everson will be included in the Company’s slate of director nominees in the proxy statement for Disney’s 202...
Nov 28, 2022
View Article
Apple Hires Timothy Campos From Facebook To Lead Its Information Systems Group – $AAPL $META $DIA $INVO
As per reports, Apple Inc. has hired Timothy Campo, a startup founder, and former Facebook (META) executive, to run its information systems group after a series of departures in that department. Campion will lead the Information Systems and Technology department, responsible for the infrastructure b...
Nov 28, 2022
View Article
UnitedHealth Unit Acquires Change Healthcare – $UNH $DIA $INVO
As per reports, the UnitedHealth Group (UNH) health services unit has completed the acquisition of Change Healthcare, following more than a year of uncertainty due to anti-competitive concerns. The deal's completion follows last month a U.S. judge denying the U.S. Justice Department's appeal to sto...
Nov 28, 2022
View Article
Emirates To Add 5 Boeing 777 Freighters To Its Cargo Fleet – $BA $DIA $INVO
As per reports, Emirates has placed an order for five 777 Freighters, valued at more than $1.7 billion at list prices, expanding its all-Boeing (BA) dedicated freighter fleet. The airline was a launch customer for the 777 Freighter and is currently the world’s largest operator of the 777 families,...
Nov 28, 2022
View Article
Merck Agrees On Distribution Rights For Its COVID-19 Drug With China’s Sinopharm – $MRK $DIA $INVO
As per reports, Merck & Co., Inc. (MRK) has agreed to allow China's Sinopharm to distribute and import its COVID-19 antiviral molnupiravir in China if the drug is approved for use there. The drugmaker has reached a cooperation framework agreement with Sinopharm allowing the Chinese company to di...
Nov 28, 2022
View Article
Salesforce To Release Q3 Earnings On November 30 – $CRM $DIA $INVO
Reportedly, global CRM leader Salesforce (CRM) has scheduled to release its third-quarter fiscal year 2023 results on November 30, 2022, after trading closes, followed by a conference call at 5:00 p.m. ET to discuss and review financial results with the investment community. Interested parties can ...
Nov 28, 2022
View Article
Apple Seeking To Expand Live TV Advertising Around MLS Games Next Year – $AAPL $DIA $INVO
Reportedly, Apple (AAPL) is gearing up to expand its advertising network for live television in an attempt to stream Major League Soccer (MLS) games next year. The company is in talks with advertising partners and MLS sponsors in advance of the launch next February about airing advertisements during...
Nov 27, 2022
View Article
Microsoft Charged With EU Antitrust Complaint On Cloud Computing Practices – $MSFT $DIA $INVO
Reportedly, Microsoft (MSFT) faces a new antitrust complaint over its cloud computing practices as trade group CISPE, whose members include Amazon, took its grievance to European Union antitrust regulators. The trading body alleged that Microsoft's new contractual terms imposed on Oct. 1 together wi...
Nov 27, 2022
View Article
Nike To Host Q2 Earnings Call On Dec 20 – $NKK $DIA $INVO
Reportedly, NIKE, Inc. is to announce its second quarter fiscal 2023 earnings on December 20, 2022, at approximately 1:15 p.m. PT, followed by a conference call beginning at 2:00 p.m. PT to review the results with the management team. The call can be reached at http://investors.nike.com. NIKE, Inc....
Nov 27, 2022
View Article
JP Morgan To Expand Business In Latin America – $JPM $DIA $INVO
As per reports, JPMorgan Chase & Co (JPM) is to expand in Latin America over the coming years as it expects the region's geopolitical outlook to improve, informed the bank's chief executive for Latin America and Canada, Alfonso Eyzaguirre. JP Morgan has been adding employees and services for cor...
Nov 27, 2022
View Article
Tesla Offers Beta Version Of It Full Self-Driving Feature For Test – $TSLA $SPY $INVO
As per reports, Tesla (TSLA) is making its driver-assistance system available to customers behind the wheel to test, a feature that was previously deemed not safe enough. CEO, Elon Musk tweeted that the system which Tesla calls Full Self-Driving Beta will be now available to anyone in North Americ...
Nov 27, 2022
View Article
UnitedHealth To Discuss Growth & Strategic Plans On Investor’s Day In #NYC Nov. 29 – $UNH $DIA $ATOS $INVO
Reportedly, UnitedHealth Group Incorporated (UNH) announced that its annual Investor Conference will be held in New York City on Tuesday, November 29, 2022, starting at 8:00 a.m. ET. A team of UnitedHealth Group leaders will offer perspectives on the company’s performance, and its long-term strat...
Nov 27, 2022
View Article
Disney Reported Disappointing Quarter Earnings – $DIS $DIA $INVO
Reportedly, the Walt Disney Company (DIS) added 12.1 million Disney+ subscribers and 14.6 million total direct-to-consumer customers in its fiscal fourth quarter, exceeding estimates. Total quarterly Disney revenue of $20.1 billion missed the average analyst estimate by nearly $1 billion. Net operat...
Nov 26, 2022
View Article
3M Schedules Fourth-Quarterly Dividend For December – $MMM $DIA $INVO
As per reports, the board of 3M (MMM) announced a fourth-quarter common stock dividend of $1.49 per share payable on December 12, 2022. The dividend is payable to shareholders as of November 18, 2022. 3M (MMM) is a global science company that seems to never stop inventing. Using 46 technology...
Nov 26, 2022
View Article
Europe Strengthens Grip On Global Chip Industry 2030 Initiative As Design Center Opening In Barcelona – $CSCO $DIA $INVO
Reportedly, Cisco Systems, Inc. (CSCO) is set to open a new semiconductor chip design center in the northeastern Spanish city of Barcelona. The initiative is a part of government subsidies, PERTE plan for semiconductor research and development using the European Union's pandemic relief funds, alloca...
Nov 26, 2022
View Article
Thanksgiving Holiday-Shortened World Cup Filled Week Produces Positive Returns – $ADT $ATOS $BBY $DIS $JPM $SHIP Rise!
Quote of the Day: "Progress is man's ability to complicate simplicity." - Thor Heyerdahl Happy Saturday All! I hope that you are enjoying the long Thanksgiving holiday weekend and that you are taking in your favorite festivities and games including those from 2022 World Cup that are bei...
Nov 26, 2022
View Article
IBM & Bosch Connect To Find Alternatives To Critical Minerals For EV’s – $IBM
As per reports, International Business Machines Corporation (IBM) and Germany's Bosch have formed a partnership to use quantum computing and simulation technology to find alternatives to the rare earth and metals needed for electric vehicles. The minerals used in membranes in fuel cells for hydrog...
Nov 23, 2022
View Article
Apple Launched Emergency SOS Service – $AAPL $DIA $SPY $INVO
Reportedly, the iPhone giant Apple (AAPL) has launched its Emergency SOS service, which allows iPhones to communicate using satellites when they have no signal. The feature allows people to contact emergency services when they are outside of cellular or WiFi coverage. The feature will also allow the...
Nov 23, 2022
View Article
Intel Elects BlackRock Co-Founder To Its Board – $INTC $BLK $DIA $INVO
As per reports, Intel Corporation (INTC) has elected co-founder and senior advisor at BlackRock Inc. (BLK) Barbara G. Novick, to its board of directors effective Dec. 1, 2022. Barbara will serve as an independent director and join the board’s Audit & Finance and Compensation committees. &nbs...
Nov 22, 2022
View Article
Nike Announces Quarterly Dividend Raise – $NKE $DIA $INVO
Reportedly, Nike's board announced a quarterly cash dividend of $0.340 per share on the company’s outstanding Common Stock payable on December 28, 2022, the dividend represents an increase of 11 percent. The dividend is payable to shareholders as of December 5, 2022. NIKE, Inc. (NKE) is t...
Nov 22, 2022
View Article
Cisco Announces Quarterly Earnings, Raises Full-Year Outlook – $CSCO $DIA $INVO
As per reports, Cisco Systems, Inc. (CSCO) recently raised its full-year profit and revenue forecast amid easing supply chain hurdles and announced $600 million in analysis and restructuring charges, impacting 5% of its workforce roughly. In the first quarter, Cisco's revenue exceeded analysts' esti...
Nov 22, 2022
View Article
Disney’s “Disenchanted” To Begin Streaming On Disney+ Starting November 18 – $DIS $DIA $INVO
Reportedly, The Walt Disney Company (DIS) sequel film “Disenchanted” premiered in Hollywood following its predecessor, “Enchanted,” by flipping the narrative of typical Disney fairytales. “Enchanted,” the tale of a cartoon princess being transported to modern-day New York, was released i...
Nov 22, 2022
View Article
Honeywell Agrees To Pay $1.3B To Handle Asbestos-Related Claims – $HON $DIA $INVO
Reportedly, Honeywell International Inc. (HON) is to pay $1.3B to end asbestos-related claims stemming from its former unit. As part of a deal with the North American Refractories Asbestos Personal Injury Settlement Trust, the settlement will help Honeywell eliminate its funding obligations. Honeywe...
Nov 21, 2022
View Article
Bob Iger ReAppointed As Disney CEO! – $DIS $DIA $INVO
Reportedly, The Walt Disney Company (DIS) has re-appointed Disney veteran Bob Iger as its chief executive officer after he retired last year, in an attempt to revive investor confidence and profits at its streaming media unit amid the economic turmoil. Iger stayed at Disney through 2021 to ease the ...
Nov 21, 2022
View Article
Visa Appoints President Ryan McInerney As Its New CEO – $V $DIA $INVIO
Reportedly, Visa (V) has named its president, Ryan McInerney, as its new CEO to help the company come through a challenging period for the payments industry as consumers shrink and tighten their expenses. Starting in February, McInerney will lead replacing Alfred Kelly Jr, who has been CEO since 201...
Nov 21, 2022
View Article
Air India To Order New Aircrafts, In Talks With Airbus & Boeing – $BA $DIA $INVO
Reportedly, Tata Group-owned Air India is in talks with Boeing (BA) and Airbus about ordering new aircraft and is meeting its immediate needs by leasing planes and repairing grounded aircraft, the airline's chief executive informed. Tata Group-owned Air India is in talks with Boeing and Airbus about...
Nov 21, 2022
View Article
Merck To Acquire Cancer Drug Developer Imago BioSciences For $1.35B – $MRK $DIA $IMGO $ATOS $INVO
Reportedly, Merck & Co., Inc. (MRK) announced the acquisition of Imago BioSciences (IMGO), a cancer drug developer for a total equity value of $1.35B. The company's offer of $36 per share in cash for Imago is nearly a 107% premium to its last closing price. The transaction is expected to close i...
Nov 21, 2022
View Article
Nvidia Teaming With Microsoft To Build ‘Massive’ Cloud AI Computer -$NVDA $MSFT $DIA $INM
Reportedly, Nvidia Corp (NVDA) is partnering with Microsoft Corp (MSFT) to build a “massive” computer to handle high artificial intelligence computing work in the cloud. The AI computer will operate on Microsoft’s Azure cloud, with tens of thousands of graphics processing units, Nvidia’s mos...
Nov 17, 2022
View Article
Home Depot Releases Quarterly Earnings, Stays Strong On Fiscal Outlook – $HD $DIA $INM
Reportedly, The Home Depot, Inc. (HD) quarterly earnings beat estimates as price increases helped the company post an 8.8% jump in average ticket, or the average amount of sales per customer assisting offset a 4.3% fall in customer transactions in the quarter. Comparable sales at the home improvem...
Nov 17, 2022
View Article
American Express To Create First Credit Card For Square Sellers Empowering Small Businesses – $AXP $SQ $DIA $INM
Reportedly, American Express (AXP) and Square (SQ) are expanding their relationship and plan to launch a new credit card built specifically for Square sellers on the American Express network. The card will be issued by Celtic Bank and powered by i2c Inc. "Small businesses can struggle to find fair ...
Nov 17, 2022
View Article
Walmart Raises Annual Sales Forecast As Consumer Demand Remain Strong – $WMT $DIA $INM
Reportedly, Walmart Stores, Inc. (WMT) raised its annual sales and profit forecast as demand for groceries continued to remain strong despite higher prices. The retailer also raised its full-year net sales expectations ahead of the holiday season, announcing a new $20-billion share buyback plan. Wa...
Nov 17, 2022
View Article
P&G Announced Webcast Of Investor Day 2022 – $PG $DIA $INVO
As per reports, The Procter & Gamble Company (PG) to webcast the presentation from the P&G Investor Day 2022 in Cincinnati, Ohio on Thursday, November 17, 2022, beginning at 2:00 p.m. ET. The live audio webcast at www.pginvestor.com starting 2:00 P.M. ET. Chairman of the Board, President...
Nov 16, 2022
View Article
Recently Disney Froze Hiring As Economic Uncertainty Continues – $DIS $DIA $INVO
As per reports recently, Walt Disney (DIS) is set to freeze hiring and cut some jobs as it struggles to move the Disney+ streaming service to profitability amid economic uncertainty. The move came after Disney missed estimates for quarterly earnings as the entertainment giant racked up more losses f...
Nov 15, 2022
View Article
Cisco To Release Q1 Results – CSCO $DIA $INVO
As per reports, Cisco Systems, Inc. (CSCO) has scheduled a conference call for Wednesday, November 16, 2022, at 1:30 PM (PT) / 4:30 PM (ET) to announce its first quarter fiscal year 2023 financial results for the period ending Saturday, October 29, 2022. Web & Dial-Dial-In : The webcast can...
Nov 15, 2022
View Article
Disney To Host Fiscal Full Year & Q4 2022 Financial Results – $DIS $DIA $INVO
As per reports, the Walt Disney Company announced the release of the fourth quarter of 2022 and fiscal full year and earnings on Tuesday, November 8, 2022, after the close of regular trading. The release will be followed by a live audio webcast beginning at 4:30 p.m. ET / 1:30 p.m. PT and can be rea...
Nov 07, 2022
View Article
Tesla’s Semi Truck Deliveries Expected In December 2022 For PepsiCo – $TSLA $PEP $SPY $INVO
Reportedly, PepsiCo Inc (PEP) is to become the first company to receive its orders for Tesla's (TSLA) much-delayed Semi truck EVs in December. The beverage giant informed that the trucks would be used at its Frito-Lay plant in Modesto, California, and its PepsiCo beverages factory in Sacramento. The...
Nov 03, 2022
View Article
Amgen To Webcast Third-Quarter Earnings – $AMGN $DIA $INVIO
Reportedly, healthcare giant Amgen (AMGN) is to release its third-quarter earnings on November 3, 2022, after the market closes. The release will be followed by a conference call with the investment community to discuss the results at 1:30 p.m. PT. The call will be hosted by the chairman and CEO Rob...
Nov 02, 2022
View Article
Caterpillar To Pay Quarterly Dividend On Nov 18 – $CAT $DIA $INVO
As per reports, the Board of Caterpillar, Inc. (CAT) announced a quarterly common stock dividend of $1.20 per share payable to stockholders as of October 24, 2022. The dividend is payable on November 18, 2022. Dow 30 Component Caterpillar, Inc. (CAT) is the world’s chief manufacturer ...
Oct 27, 2022
View Article
Microsoft & Mercedes Benz Partner On Supply Chain Data Platform – $MSFT $DIA $INVO
Reportedly, Mercedes-Benz has entered a partnership with Microsoft (MSFT) using its Cloud for a data platform, MO360 intended to improve production efficiency at over 30 passenger car plants globally. The collaboration is aimed at a 20% increase in vehicle production efficiency by 2025 from 2022 lev...
Oct 26, 2022
View Article
Biotech Giant Amgen Completes The Acquisition Of ChemoCentryx – $AMGN $JNJ $DIA $ATOS
As per reports, Amgen (AMGN) has successfully acquired ChemoCentryx, Inc. (CCXI), for $52 per share in cash, representing aggregate merger consideration of approximately $3.7 billion. A biopharmaceutical company, ChemoCentryx, Inc is focused on orally-administered methods to treat cancer, inflammato...
Oct 26, 2022
View Article
Aviation Giant Boeing Reports Q3 2022 Commercial & Defense Deliveries & Results- $BA $DA $INVO
Dow 30 comments and aviation giant Boeing (BA) reported major program deliveries across its commercial and defense operations for the third quarter of 2022 earlier in October, as listed below: Major Programs - 3rd Quarter 2022 Commercial Airplanes Programs 3rd Quarter 2022 Year-to-date ...
Oct 26, 2022
View Article
Vista Partners Progress Report: Atossa Receives FDA Authorization & Adds Former $JNJ Director Richard Grayson – $ATOS $XBI
Breast cancer is the most frequently diagnosed cancer in premenopausal women worldwide. It is estimated that almost half of the cancers that occur in women aged 15-49 is breast cancer. An overwhelming majority (75%) of premenopausal breast cancer falls under luminal A (ER+/HER2-) or B (ER+...
Oct 26, 2022
View Article
Boeing Schedules Third-Quarter Release – $BA $DIA $INVO
As per reports, the Boeing Company (BA) is to release its third-quarter 2022 financial results on Wednesday, October 26. President & CEO David Calhoun and Executive Vice President and Chief Financial Officer Brian West will host a conference call that day at 10:30 a.m. ET to discuss the results ...
Oct 25, 2022
View Article
Honeywell Announces Dividend Increase – INVO Bioscience Progresses At #ASRM2022 – $HON $DIA $INVO
Reportedly, the board of Dow 30 component Honeywell (HON), a Fortune 500 technology company that delivers industry specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally, has increased the company's regul...
Oct 25, 2022
View Article
Intel Ties With Google Cloud Introducing Secure & Improved Chip For Data Centre – $INTC $GOOG $DIA $BRQS $INVO
Reportedly, Intel Corporation (INTC) and Alphabet Inc's Google Cloud have launched a co-designed chip to make data centers more secure and efficient. The E2000 chip, code-named Mount Evans, takes over from the expensive central processing units (CPU) that do the main computing, for the work of packa...
Oct 18, 2022
View Article
Merck Schedules Release Of Third-Quarter Earnings – $MRK $DIA $INVO
Reportedly, Merck & Co., Inc. (MRK) is to hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, October 27. Investors, journalists, and the general public may access a live audio webcast of the call via this link. Me...
Oct 15, 2022
View Article
Nike Partners With Britain’s JD Sports – $NKE $DIA $INVO
Reportedly, JD Sports Fashion, Britain's biggest sportswear retailer has extended its deal with sportswear giant Nike Inc. (NKE) giving its customers access to more of the U.S. brand's footwear and apparel. The partnership would be Nike's first European retail partner for its Connected Partnership l...
Oct 10, 2022
View Article
Honeywell To Work On Lower-Carbon Aviation Fuel Amid Increasing SAF Demand – $HON $DIA $INVO
As per reports, Honeywell International Inc. (HON) is expecting to roll out technology that could increase supplies of lower-carbon aviation fuel produced from ethanol. The company's technology can increase the production efficiency of sustainable aviation fuel (SAF) to lower costs. The airline indu...
Oct 10, 2022
View Article
Boeing Announces Deal With UPS For Eight Additional 767s Freighters – $BA $DIA $INVO
As per reports, Boeing (BA) announced that it has received an order from UPS for eight more 767 Freighters. The additional orders will increase UPS's 767 Freighter fleet to 108 airplanes, enabling Boeing to further modernize and sustainably grow its fleet. Air cargo continues to play a significant ...
Oct 07, 2022
View Article
Boeing Gains Orders For 42 MAX 10 Jets From Canada’s WestJet Group – $BA $DIA $INVO
Reportedly, Canada's WestJet Group has placed an order with Boeing Co (BA) for 42 MAX 10 jets in a deal valued at $5.67 billion at list prices. The Calgary-based carrier now has more than 60 firm orders for the 737 MAX jets, Boeing's best-selling single-aisle airplane family. Owned by private equity...
Oct 06, 2022
View Article
Honeywell Announces Release Date Of Q3 Earnings – $HON $DIA $INVO
As per reports, Honeywell is to release its third quarter financial results on Thursday, October 27, before the market opens, followed by a conference call at 8:30 a.m. EDT. A real-time audio webcast of the presentation can be reached at http://www.honeywell.com/investor. Vista Partners LLC (”Vis...
Oct 06, 2022
View Article
Jacqueline Arthur Succeeds Bentley de Beyer To Lead Goldman Sachs HR Unit – $GS $DIA $INVO
Reportedly, Goldman Sachs Group, Inc. (GS) has appointed Jacqueline Arthur, a 15-year veteran of the bank, to run human resources starting Jan. 1. Arthur, 45, will take over from Bentley de Beyer, who has been the bank's global head of human capital management since early 2020. Jacqueline Arthur,...
Oct 06, 2022
View Article
VISTA UPDATE REPORT: Peer Reviewed Study Published Regarding Conventional IVF vs. INVO Bioscience’s INVOcell System – $INVO $IYH
Today, the global fertility market is a multi-million dollar market that is predicted to hit around US$47.9 billion by 2030, yet remains severely underserved with experts’ estimates suggesting that more than 90% of couples in need of infertility treatment are going without care. On Sept...
Oct 06, 2022
View Article
American Express Announces Quarterly Dividend Payable November 10, 2022 – $AXP $DIA $INVO
As per reports, the Board of American Express Company (AXP) declared a regular quarterly dividend of $0.52 per common share to stockholders as of October 14, 2022. The dividend is payable on November 10, 2022. Dow 30 component American Express Company (AXP) and its subsidiaries provide cu...
Oct 05, 2022
View Article
Walmart’s Starts Testing Its Electric Delivery Vehicles In Dallas – $WMT $DIA $INVO
Reportedly, Walmart Stores, Inc. (WMT) has begun deploying the Canoo vans in the Dallas-Fort Worth metroplex area for deliveries to Walmart+ in-home service customers to test their configuration before an anticipated nationwide rollout in 2023. In mid-July, Walmart entered an agreement with Canoo to...
Oct 05, 2022
View Article
Cisco’s Board Increases To 12 Members With The Appointment Of Sarah Rae Murphy – $CSCO $DIA $INVO
As per reports, Cisco Systems, Inc. (CSCO) has appointed Sarah Rae Murphy to its board of directors effective immediately, with Cisco's board size increasing to 12 members. Murphy's broad executive leadership experience in finance, operations, innovation, and transformation is expected to bring an a...
Oct 04, 2022
View Article
Boeing To Expand Investments In India – $BA $DIA $INVO
As per reports, Boeing (BA) plans to build on its existing investments in India in defense supply chains and manufacturing areas. The company was offering its F/A-18 fighter jet for sale to India's armed forces and informed the selection of the plane would help boost investments in the country's def...
Oct 03, 2022
View Article
JP Morgan To Release Q3 Earnings On October 14 – $JPM $DIA $INVO
Reportedly, JPMorgan Chase & Co. (JPM) is to host a conference call at 8:30 a.m. (EDT) on Friday, October 14, 2022, to review third-quarter 2022 financial results, following the release at approximately 7:00 a.m. (EDT). Web: Live webcast can be reached at the link. Dial-IN: The conference ...
Oct 03, 2022
View Article
Intel Offers Customers To Try Out New Chips With Expanded Developer Cloud Base – $INTC $DIA $INVO
Reportedly, Intel Corporation (INTC) is planning to expand the Intel Developer Cloud, allowing customers to try a range of new chips before they hit the market, as it hopes it will pull more application developers to use its processors. Chip companies are working to enable software and hardware deve...
Oct 03, 2022
View Article
Salesforce Lowers Annual Forecast, Announces Share Buyback – $CRM $DIA $INVO
Salesforce (CRM) reported its quarterly earnings, cutting its annual revenue and profit forecasts over "measured" spending from clients and a hit from a stronger dollar, pushing its shares down. The company announced a stock repurchase of up to $10 billion, its first-ever buyback. Salesforce's seco...
Oct 01, 2022
View Article
Netflix Rolling Out $7-$9 Per Month Ad-Supported Subscription – $NFLX $INVO
As per reports, Netflix Inc. (NFLX) is planning to charge about $7 to $9 per month for its new advertising-supported subscription plan. The budget-friendly option is to be introduced in the year's final three months across at least half a dozen geographies. However, the full rollout may have to wait...
Sep 30, 2022
View Article
Apple Eyeing Latest Chip Technology By Taiwan’s TSMC For Upcoming iPhones, Macs – $AAPL $DIA $INVO
Reportedly, Apple Inc (AAPL) is planning to use an updated version of Taiwanese chipmaker TSMC's latest chip-producing technology in iPhones and Macbooks next year. The A17 mobile processor, which is currently under development and is expected to be available in the second half of next year, will be...
Sep 30, 2022
View Article
Microsoft’s & Activision Blizzard Deal Faces Scrutiny By British Regulators – $MSFT $ATVI $DIA $INVO
As per reports, Microsoft Corp.’s (MSFT) deal to buy Activision Blizzard Inc. is facing intense scrutiny by British antitrust regulators who are concerned the $69 billion acquisition could harm competition. The U.K.’s Competition and Markets Authority is concerned that Microsoft’s dominant pro...
Sep 29, 2022
View Article
Amgen’s Lumakras Pill Reduces Risk Of Lung Cancer Progression By 34% In Clinical Trial -$AMGN $DIA $ATOS
Reportedly, Amgen Inc.'s (AMGN) Lumakras pill reduced the risk of disease progression in patients with advanced lung cancer by 34% compared with chemotherapy in a clinical trial. Amgen is also testing whether the drug could be effective against lung cancer earlier in the disease, and informed that a...
Sep 29, 2022
View Article
Jennifer Mann To Succeed As The President For North America Operating Unit Of Coca-Cola – $KO $DIA $INVO
As per reports, Jennifer Mann is to succeed Alfredo Riveraas as the Coca-Cola Company (KO) president for North America operating unit effective Jan. 1, 2023. Alfredo Rivera, 61 who will step down on Dec. 31 has led the North America operating unit since August 2020 and will continue with the beverag...
Sep 29, 2022
View Article
Boeing’s August Deliveries Improved – $BA $DIA $INVO
Reportedly, Boeing (BA) jetliner deliveries increased in August to 35 airplanes as the U.S. planemaker resumed handovers of its 787 Dreamliner after a 15-month delay. The monthly deliveries included 27 737 MAX jets, two 787s, and five freighters raising the total MAX deliveries this year to 240 jets...
Sep 29, 2022
View Article
Walmart & UnitedHealth Offering Seniors Focused Preventive Healthcare Program – $WMT $UNH $DIA $INVO
Reportedly, Walmart and healthcare giant UnitedHealth Group are collaborating to offer preventive care for people aged 65 and up, and virtual healthcare services for all age groups. The 10-year partnership represents Walmart's latest investment into healthcare that could help the retail giant better...
Sep 29, 2022
View Article
Is Apple Shifting iPhone 14 Production To India Away From China? -$AAPL $DIA $INVO
Reportedly, Apple (AAPL) has begun producing its iPhone 14 model in southern India less than a month after it was launched, as the iPhone giant is looking for ways to diversify its supply chains out of China and expand production in India, as geopolitical tension rises between Washington and Beijing...
Sep 29, 2022
View Article
Disney Star Bags Right To Broadcast ICC Events In India For Next Five Years – $DIS $DIA $INVO
Reportedly, Disney Star will broadcast International Cricket Council (ICC) events in India after bagging the digital rights to both men's and women's global competitions through to the end of 2027. The tender, bidding, and evaluation process began in June. "We are delighted to continue to partner w...
Sep 29, 2022
View Article
Apple’s iPhone 14 Records Better Sales Than Its Predecessor – $AAPL $DIA $INVO
Reportedly, Apple Inc.'s (AAPL) iPhone 14 is reportedly recording better sales than last year's iPhone 13 models. Apple started taking preorders for its latest handsets last week. U.S. delivery times for the iPhone 14 Pro and Pro Max have extended to 29 to 36 days, however, delivery times for the re...
Sep 28, 2022
View Article
JP Morgan To Buy California-Based Renovite Technologies Boosting Global Payments Platform – $JPM $DIA $INVO
As per reports, JPMorgan Chase & Co announced buying California-based Renovite Technologies to expand its payments processing business, occupying market share in a lucrative industry where big banks face tough competition from fintech disrupters. Renovate with a presence both in India and Britai...
Sep 28, 2022
View Article
Zoom Enhances Chat Features Competing With Rivals Including Microsoft’s Teams & Slack – $ZM $MSFT $DIA $INVO
As per reports, Zoom Video Communications Inc. (ZM) has renamed its chat product and added some features, including third-party integration, as it gears to compete with rivals including Microsoft's Teams and Slack. Zoom's app, now known as Zoom Team Chat, will offer features such as the ability to ...
Sep 28, 2022
View Article
Merck’s Fiona Marshall To Join Novartis As Research Head – $MRK $DIA $INVO
As per reports, Merck & Co., Inc. (MRK) executive Fiona Marshall has been appointed as president of the Novartis Institutes for Biomedical Research, effective November 1. Marshall will replace Jay Bradner, who is stepping down after seven years as research head. Marshall is currently serving as...
Sep 28, 2022
View Article
Honeywell Appoints Former CEO Of John Wood Group PLC To Its Board – $HON $DIA $INVO
As per reports, Honeywell (HON) has elected Robin Watson, 55, former Chief Executive Officer of John Wood Group PLC, as an independent director to its board. Prior to joining Wood, Watson was a director and senior manager at Petrofac, working in a variety of service roles and investment delivery. He...
Sep 28, 2022
View Article
Is Goldman Sachs Cutting Jobs Amid Economic Slowdown? – $GS $DIA $INVO
As per reports, Goldman Sachs Group, Inc. (GS) is to cut jobs this month after two years of the pandemic. The bank typically lays about 1% to 5% of its staff each year, and this year it plans to cuts in the lower end of that range. In July, the investment bank had warned it might slow hiring and cu...
Sep 27, 2022
View Article
Cisco Secures Second Position For Best Workplaces in Asia™, 2022 – $CSCO $DIA $INVO
Reportedly, Cisco Systems, Inc. (CSCO) has secured the number two position in the Asia list for 2022 Best Workplaces. The result is based on over 1 million survey responses across Asia and the Middle East, including the feedback of more than 4.7 million employees in the region. The results are base...
Sep 27, 2022
View Article
Disney In Talks To Launch Membership Program For Its Customers – $DIS $DIA $INVO
As per reports, Walt Disney Company (DIS) is exploring a membership program that could offer discounts or perks to encourage customers to spend more on its streaming services, theme parks, resorts, and merchandise. The discussions at Disney are in the early stages and much was not known about how th...
Sep 27, 2022
View Article
Musk’s SpaceX To Launch More Astronaut Missions To International Space Station For NASA – $TSLA $SPY $INVO
Reportedly, Elon Musk's SpaceX will launch five more astronaut missions to the International Space Station for NASA at the end of the decade under a $1.4 billion contract order taking the company's total contracted missions for its Crew Dragon astronaut capsule to 14. SpaceX's NASA contract is part ...
Sep 26, 2022
View Article
Walgreens Acquires Majority Share Of CareCentrix – $WBA $DIA $INVO
Reportedly, Walgreen Boots Alliance (WBA) announced the complete acquisition of the majority share of CareCentrix, Inc., a leading independent home-centered platform that coordinates care to the home for health plans, patients, and providers. The partnership enhances Walgreens trusted health servi...
Sep 26, 2022
View Article
Disney Turns Down Activist Loeb’s Call For ESPN Spin-Off – $DIS $DIA $INVO
Reportedly, Walt Disney Company (DIS) chief executive Bob Chapek has rejected Daniel Loeb, a billionaire activist investor offer to sell or spin off the ESPN sports television network. In August, Loeb disclosed a stake of roughly $1 billion in Disney and announced plans to push the entertainment gi...
Sep 26, 2022
View Article
Visa To Include New Code Identifying Sales At U.S. Gun Stores – $V $DIA $INVO
As per reports, Visa Inc. (V) announced the implementation of a new merchant category code for U.S. gun retailers, that will identify transactions at firearms stores. Recently, the International Organization for Standardization (ISO) approved the creation of the merchant code after gun-control activ...
Sep 25, 2022
View Article
Walmart Recently Beat Wall Street’s Quarterly Estimates – $WMT $DIA $INVO
Reportedly, Walmart Stores, Inc. (WMT) exceeded second-quarter earnings reporting adjusted earnings of $1.77 per share versus $1.78 a year earlier. Revenue grew 8.4% to $152.9 billion. Analysts predicted Walmart's earnings to drop 9% to $1.62 per share. "The actions we've taken to improve inventory...
Sep 24, 2022
View Article
Reportedly JP Morgan In Talks To Invest In Fintech Startup Yapily – $JPM $DIA $INVO
Reportedly, JPMorgan Chase & Co (JPM) is considering buying a stake in London-based Yapily, a financial technology startup that is looking to raise fresh funds. The banking giant is in early-stage talks with Yapily about the possibility of making an investment. Yapily is seeking to bring in the ...
Sep 22, 2022
View Article
Coca Cola’s Platform Services Unit To Undergo Restructuring, Chief Barry Simpson Steps Down – $KO $DIA $INVO
The Coca-Cola Company (KO) announced that Barry Simpson will step down from his role as the chief Platform Services officer on September 30 and will remain with the company as a senior advisor through February 2023. The company’s Platform Services was created in 2021, and since then Simpson, 62, h...
Sep 20, 2022
View Article
Salesforce Schedules Annual Investor Day – $CRM $DIA $INVO
Reportedly, the global leader in CRM, Salesforce (CRM) announced that it will hold its annual Investor Day on Wednesday, Sept. 21 beginning at 1:00 p.m. (PT) / 4:00 p.m. (ET). The live broadcast and on-demand replay can be reached at http://www.salesforce.com/investorday2022 and at www.salesforce....
Sep 19, 2022
View Article
Sanjiv Gossain To Lead Verizon’s EMEA Succeeding Scott Lawrence – $VZ $DIA $INVO
Reportedly, Verizon Business (VZ) has named Sanjiv Gossain as Group Vice President and Head of EMEA. Sanjiv succeeds Scott Lawrence, who continues to serve in the role of Senior Vice President, Global Solutions. In his new role, Sanjiv will have overall responsibility for the company's global enter...
Sep 19, 2022
View Article
Will The iPhone 14 To Cost More In Asian Countries? – $AAPL $DIA $INVO
Reportedly, Apple (AAPL) has kept prices for its latest iPhone stable in the United States, but raised prices in some Asian countries where currencies have dropped against the dollar in the past year. Buyers of the primary iPhone 14 in Japan, where the yen dropped 24% since September will have to pa...
Sep 16, 2022
View Article
3M & Vomela Collaborating To Reuse Plastic Endcaps Supporting The Environment $MMM $DIA $INVO
Reportedly, 3M (MMM) and Vomela, a graphics and printing company have collaborated on an amazing sustainability initiative to reuse plastic endcaps which are crucial for transit because they protect 3M’s commercial graphics film from damage during shipping. Since the endcaps are strong and stu...
Sep 15, 2022
View Article
Goldman Hires Elizabeth Burton As Its New Adviser For Asset Management Unit – $GS $DIA $INVO
As per reports, Goldman Sachs Group, Inc's (GS) asset management arm has hired Elizabeth Burton to advise its institutional clients. Burton will be a managing director and client investment strategist at the Wall Street bank's client solutions and capital markets business in New York. Burton will ...
Sep 15, 2022
View Article
McDonald’s Increasing Support To The Chicago Community Impact Grants Program For Youth – $MCD $DIA $INVO
As per reports, McDonald’s Corporation (MCD) is set to invest in 40 Chicago-based nonprofit organizations addressing some of the city's most pressing needs for Opportunity Youth through its Chicago Community Impact Grants Program, developed in partnership with The Chicago Community Trust (the Trus...
Sep 15, 2022
View Article
Paul Halpern Joins As Chief Marketing Officer For JP Morgan U.S. Wealth Management – $JPM DIA $INVO
As per reports, JPMorgan Chase & Co (JPM) announced that Paul Halpern has joined as Chief Marketing Officer for U.S. Wealth Management, one of the firm’s major areas of focus for customer growth. Halpern will lead an extensive team at an important time when the business is set to launch multip...
Sep 14, 2022
View Article
Apple Planning To Appeal Brazil’s Ban On The Sale Of iPhones Sans Chargers – $AAPL $INVO $DIA
As per reports, Apple (AAPL) is planning an appeal against the move by Brazil to ban the sale of iPhones without battery chargers, arguing that the company has helped reduce environmental waste by not including the accessory with new devices. In 2020, Apple announced it would discontinue putting ch...
Sep 14, 2022
View Article
Alethia Jackson Named Senior VP, ESG & Chief DEI Officer For Walgreens – $WBA $DIA $INVO
Reportedly, Alethia Jackson has been named senior vice president, environmental, social, and governance (ESG), and chief diversity, equity, and inclusion (DEI) officer for the U.S. Jackson will report to the executive vice president, and global chief human resources officer, Holly May, Walgreens Boo...
Sep 07, 2022
View Article
India’s Serum Institute & Aspen Enter Deal Utilizing Latter’s Idle COVID-19 Vaccine Unit – $JNJ $DIA
As per reports, Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa, as it seeks to utilize its near-idle COVID-19 vaccine production lines in eastern South Africa. Aspen was under a contract with Johnson & Johnson ...
Sep 07, 2022
View Article
Walgreens Offering Flu Shots Nationwide For Ages 3 & Above – $WBA $INVO $DIA
As per reports, Walgreen Boots Alliance (WBA) is now offering flu shots for people aged 3 years and up at nearly 9,000 store locations nationwide to help reduce the spread of vaccine-preventable illnesses in communities. A recent rise in flu cases in the Southern Hemisphere is an alarming sign that ...
Sep 01, 2022
View Article
Diversified Health & Well-Being Co. UnitedHealth Group Announces Quarterly Dividend – $UNH $ATOS $INVO $DIA
Reportedly, the board of the UnitedHealth Group Incorporated (UNH) announced a cash dividend of $1.65 per share, payable on September 20, 2022. The dividend is payable to common stock shareholders as of September 12, 2022. Dow 30 component UnitedHealth Group Incorporated (UNH) operates as a div...
Sep 01, 2022
View Article
J&J To Discontinue Selling Its Talc-Based Baby Powder Globally – $JNJ $INVO $ATOS $DIA
As per reports, Johnson & Johnson (JNJ) announced that it plans to globally discontinue selling its talc-based baby powder in 2023, almost more than two years after it ended U.S. sales of the product amid thousands of consumer safety lawsuits. "As part of a worldwide portfolio assessment, we ha...
Aug 31, 2022
View Article
Low J&J Vaccine Demand Forces Production Halt At S.Africa’s Aspen Unit – $JNJ $DIA
Reportedly, South Africa's Aspen Pharmacare will stop making COVID-19 vaccines from the end of this month due to a lack of orders. Aspen currently produces vaccines for Johnson & Johnson. In March, it struck a deal to produce, price, and sell its own-brand version of the shot for African market...
Aug 30, 2022
View Article
Mathai Mammen Exits As Executive VP, Pharmaceuticals, R&D, Johnson & Johnson – $JNJ $DIA $IBB
As per reports, Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson (JNJ) and pursue other opportunities outside of the Company. Dr. Mammen joined Johnson & Johnson in 2017 as Global Head of Janssen R&D. W...
Aug 30, 2022
View Article
Amgen’s Acquisition Of ChemoCentryx To Add Potential Blockbuster Drug To Its List – $AMGN $CCXI $ATOS $DIA
As per reports, Amgen Inc is to acquire ChemoCentryx Inc for $3.7 billion to gain access to a potential blockbuster treatment, Tavneos for inflammatory disorders. The U.S drug maker is to pay $52 in cash for each share of ChemoCentryx. Approved last year, Tavneos is used to treat patients with vasc...
Aug 29, 2022
View Article
Global Tech Leader Cisco Approves Quarterly Cash Dividend Payable October 26- $CSCO $INVO $DIA
Reportedly, the board of Cisco Systems, Inc. (CSCO) announced a quarterly cash dividend of $.38 per common share, payable on October 26, 2022, to all stockholders as of October 5, 2022. Cisco Systems, Inc. (CSCO) is a global technology leader that designs, manufactures, and sells Internet Protoco...
Aug 29, 2022
View Article
Did Merck Stalls Seagen Acquisition Over Price Agreement? – $MRK $DIA $INVO
Reportedly, Merck & Co., Inc.(MRK) talks to buy cancer-drug maker Seagen Inc. has been put on hold for now as the companies have failed to agree on a price, as per sources. In 2020, Merck invested in Seagen as part of a drug partnership and has already tested some of Seagen’s drugs in combinat...
Aug 26, 2022
View Article
Michael V. Drake Appointed To The Board Of Amgen – $AMGN $ATOS $IBB $XBI
Reportedly, Amgen (AMGN) announced the appointment of Michael V. Drake, M.D., to its Board of Directors, effective immediately. Dr. Drake will also serve as a member of the Board's Corporate Responsibility and Compliance Committee and its Governance and Nominating Committee. Following the appointm...
Aug 23, 2022
View Article
VISTA UPDATE REPORT: INVO Bioscience Q2 Progress, Insiders Buying, & Accretive Acquisition Strategy Added – $INVO
Today, the global fertility market is a multi-million dollar market that is predicted to hit around US$47.9 billion by 2030, yet remains severely underserved with experts' estimates suggesting that more than 90% of couples in need of infertility treatment are going without care. INVO Bioscience, I...
Aug 17, 2022
View Article
Amgen Releases Earnings For June Quarter – Reduces 2022 Revenue Projections – $AMGN $DIA
Amgen (AMGN) reported quarterly earnings this week, reporting adjusted earnings at 163% higher to $4.65 a share, and exceeding expectations for $4.39. Overall sales inched 1% ahead during the June quarter, to $6.59 billion. Sales of Amgen's medicines increased 3% versus the same three months last...
Aug 12, 2022
View Article
Dow 30 Component Amgen To Pay Q3 Dividend On Sep 8th – $AMGN $DIA
As per reports, the board of Dow 30 component Amgen (AMGN) declared a $1.94 per share dividend for Q3 2022, payable on September 8, 2022. The dividend is payable to all shareholders as of August 18, 2022. Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Fr...
Aug 12, 2022
View Article
Amgen To Report Second Quarter Earnings On Aug 4 – $AMGN $DIA
As per reports, Amgen (AMGN) announced that it will report its second quarter financial results on Thursday, August 4, 2022, after trading closes. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PT. Participating in the call from Amgen will be Robe...
Aug 03, 2022
View Article
Merck’s Quarterly Earnings Beat Estimates Riding Blockbuster Cancer Drug Keytruda Revenues – $MRK $DIA $ATOS
Merck & Co., Inc. (MRK) reported higher-than-expected Q2 earnings and revenue on strong sales of its blockbuster cancer drug Keytruda. Merck reported earnings of $4.74B in the quarter, or $1.87 a share, compared with $1.55 billion, or 61 cents a share, a year earlier. Analysts on average were ex...
Aug 03, 2022
View Article
Atossa Therapeutics Completed Part C Dosing In Phase 1/2a Study of AT-H201 in Healthy Volunteers – $ATOS $XBI $IBB
RADIATION INDUCED LUNG INJURY (RILI) is damage to the lungs caused by ionizing radiation administered to treat cancer. RILI is a significant issue for patients undergoing radiation treatment for various forms of cancer and is often irreversible. For instance, RILI affects 30-40% of lung cancer pati...
Jul 29, 2022
View Article
Johnson & Johnson’s Executive VP, General Counsel Michael Ullmann To Retire – $JNJ $DIA
Reportedly, Johnson & Johnson (JNJ) announced the retirement of Michael Ullman, Executive VP, General Counsel at the end of this year with 33 years of leadership and service to the Company. Effective October 17, 2022, Ullmann will be succeeded by Elizabeth (Liz) Forminard having an exceptional e...
Jul 25, 2022
View Article
J&J Lowers Annual Profit Forecast As Dollar Strengthens – $JNJ $DIA
As per reports, Johnson & Johnson (JNJ) cut its full-year adjusted profit and sales forecast due to a hit from a stronger dollar, even though the company's pharmaceuticals unit boosted its second-quarter profit. The company's largest unit, pharmaceuticals have helped the company offset the blow...
Jul 22, 2022
View Article
UnitedHealth Beats Quarterly Estimates Building On 5 ‘Growth Pillars’ – $UNH $DIA
Reportedly, UnitedHealth Group Incorporated's (UNH) quarterly earnings exceeded estimates with adjusted earnings increasing 18.5% versus a year earlier to $5.57 per share, and 36 cents ahead of estimates. Revenue grew 12.6% to $80.33 billion, clearing estimates of $79.68 billion. "Customers are res...
Jul 22, 2022
View Article
Amgen’s Lumakras/Immunotherapy Combo Data Results Decision Due Aug 7 – $AMGN $DIA
Reportedly, early trial data on Amgen Inc's (AMGN) Lumakras was released by the World Conference on Lung Cancer (WCLC), but it has been decided that it will hold until Aug. 7 by the meeting organizers from a highly anticipated study in combination with drugs that help the immune system attack cancer...
Jul 19, 2022
View Article
Merck Seeking To Close Buyout Of Biotech Company Seagen Inc. – $MRK $SGEN $DIA $ATOS
Reportedly, Merck & Co., Inc. (MRK) is in advanced talks to buy cancer-focused biotech company Seagen Inc. (SGEN) for roughly $40 billion or more. The companies are discussing a price above $200 a share for Seagen. Both the parties are seeking to seal a deal on or before the announcement of Merc...
Jul 14, 2022
View Article
Merck Schedules Release Of Q2 Earnings On July 28 – $MRK $DIA $ATOS
Reportedly, Merck & Co., Inc. (MRK) to host its second-quarter 2022 sales and earnings conference call with the investment community and analysts at 8:00 a.m. ET on Thursday, July 28, discussing Merck’s performance for the quarter and outlook. Web & Call Details: Journalists, Investors, ...
Jul 08, 2022
View Article
J&J To Soon Terminate Emergent Manufacturing Deal For COVID Vaccine Production – $JNJ $DIA
As per reports, Johnson & Johnson (JNJ) had formally informed Emergent BioSolutions Inc. of its decision to terminate the agreement with the contract manufacturer to make the COVID-19 vaccine for the drugmaker. Earlier, Emergent informed that J&J breached an agreement by failing to buy the m...
Jun 23, 2022
View Article
Merck Appoints Chirfi Guindo To Lead The Marketing For Merck Human Health – $MRK $DIA
As per reports, Merck & Co., Inc. (MRK) has appointed Chirfi Guindo to lead Human Health Marketing as chief marketing officer for Merck Human Health. Guindo will lead Merck’s Executive Team, effective July 1, 2022, and will report directly to Robert M. Davis, CEO, and president, of Merck. Jann...
Jun 22, 2022
View Article
Updates From UnitedHealth’s 2022 Annual Shareholder Meeting – $UNH $DIA
UnitedHealth Group (UNH) released updates on its 2022 annual shareholder meeting and actions by its Board of Directors. The Shareholders elected all those nominated to the Board; Timothy P. Flynn, Paul R. Garcia, Stephen J. Hemsley, Michele J. Hooper, F. William McNabb III, Valerie C. Montgomery Ric...
Jun 22, 2022
View Article
Walgreens Diversifying Into Clinical Trials Business- $WBA $DIA
As per reports, Walgreen Boots Alliance (WBA) launched a clinical trials business that aims to use patient data from its pharmacies to help boost recruitment in studies conducted by drugmakers. Last year, Walgreens invested $5.5 billion to take majority stakes in two health care providers, VillageMD...
Jun 21, 2022
View Article
Are Chemicals In Hair Products A Possible Risk Of Breast Cancer In Black Women?
Reportedly, parabens, a class of endocrine-disrupting chemicals found in hair and personal care products, have been found to promote viability and gene expression of a breast cancer cell line in Black women, as per the data presented at ENDO 2022. The researchers evaluated the effects of three ty...
Jun 21, 2022
View Article
Multi-Specialty National Telehealth Provider MeMD Announces Official Transition To Walmart Health Family – $WMT $DIA
Reportedly, MeMD, a multi-specialty national telehealth provider, announced its name change to Walmart Health Virtual Care marking its official transition to the Walmart Health (WMT) family. The name change marks the final stages of MeMD’s acquisition by Walmart Health, which was initially announc...
May 26, 2022
View Article
UnitedHealth Group Schedules Q2 July Earnings Date – $UNH $DIA
Reportedly, UnitedHealth Group Incorporated (UNH) is to release its second-quarter 2022 financial results on Friday, July 15, 2022, before trading opens followed by a teleconference call at 8:45 a.m. ET with analysts and investors to discuss and review the results. The webcast can be reached on th...
May 25, 2022
View Article
State of Missouri Names UnitedHealthcare As One Of Three Organizations To Serve Medicaid Beneficiaries – $UNH $DIA
As per reports, the state of Missouri has selected UnitedHealthcare Community Plan of Missouri as one of three managed care organizations to administer its MO HealthNet Managed Care Program for Medicaid members in the Children’s Health Insurance Program (CHIP) and Temporary Assistance for Needy Fa...
May 13, 2022
View Article
J&J Appoints Thibaut Mongon As CEO Of Its Soon To Be Spun Off Consumer Health Unit – $JNJ $DIA
Reportedly, Johnson & Johnson (JNJ) has appointed Thibaut Mongon as the chief executive officer of the consumer health division, the division which the pharmaceutical giant plans to spin off into a listed company by the end of next year. Mongon joined the company in 2000, and currently serves as...
May 12, 2022
View Article
US Health Regulators Limit The Use Of J&J’s COVID Vaccine Over Blood Clot Risks – $JNJ $DIA
Reportedly, the U.S. health regulator has issued notice to limit the use of the Johnson & Johnson (JNJ) COVID-19 vaccine for adults due to the high risk of a rare blood clotting syndrome. The Food and Drug Administration informed, that the J&J vaccine can be administered in cases where autho...
May 11, 2022
View Article
Merck’s Keytruda & COVID Pill Push Quarterly Beat- $MRK $DIA
Reportedly, Merck & Co., Inc.'s (MRK) quarterly earnings beat estimates reporting a 50% increase in revenue to $15.9 billion with the majority of the growth coming from sales of molnupiravir (approved in November). The drugmaker also raised its full-year forecasts on strong demand for top-sellin...
Apr 29, 2022
View Article
Amgen Due To Release Q1 Earnings Wednesday, April 27, 2022 – $AMGN $DIA
Reportedly, Amgen (AMGN) is to release its first-quarter earnings on Wednesday, April 27, 2022, after the market closes, followed by a conference call with the chairman and CEO Robert A. Bradway, the investment community, and other members of the company's senior management team at 2:00 p.m. PT. Liv...
Apr 26, 2022
View Article
Joseph Romanelli Returns To Merck To Lead Human Health International – $MRK $DIA
Reportedly, Merck & Co., Inc. (MRK) announced that Joseph Romanelli will lead Human Health International, and join Merck’s Executive Team, effective August 1, 2022, and will directly report to Robert M. Davis, chief executive officer, and president, of Merck. In this role, Romanelli will have ...
Apr 20, 2022
View Article
J&J Trims Annual Profit Forecast Due To Vaccine Performance – $JNJ DIA
Johnson & Johnson (JNJ) released quarterly earnings, refusing to provide a forecast for sales of its COVID-19 vaccine, as vaccine hesitancy in low-income countries and low demand in higher-income nations, lead to a surplus. J&J also cut both ends of its full-year profit forecast by 25 cents ...
Apr 20, 2022
View Article
India’s Reliance Industries Studying A Bid For Walgreens’s Boots Chain – $WBA $DIA
Reportedly, Indian Billionaire Mukesh Ambani’s Reliance Industries Ltd is exploring a bid for drug retailer Walgreens Boots Alliance's (WBA) UK-based Boots business. The Boots business spans 2,200 stores in the UK, including pharmacies, and health and beauty stores, according to the chain's websit...
Apr 19, 2022
View Article
UnitedHealth’s Raises Full-Year Earnings Guidance – $UNH $DIA
UnitedHealth Group Incorporated's (UNH) Q1 earnings exceeded market estimates, reporting an adjusted profit of $5.49, up 3.4% from a strong year-ago quarter and 11 cents ahead of estimates. Revenue increased 14.2% to $80.149 billion, above estimates of $79 billion. The medical cost ratio, paid benef...
Apr 14, 2022
View Article
VillageMD Adds Walgreens CEO Roz Brewer To Board Of Directors – $WMT $DIA
As per reports, Walgreen Boots Alliance (WBA) chief executive officer Roz Brewer has joined the board of VillageMD, a company focused on developing hundreds of doctor-staffed clinics & connected to Walgreens drugstores across the U.S. Brewer, as well as another Walgreens board member, Dr. David ...
Apr 13, 2022
View Article
Merck’s Q1 Earnings To Be Released On April 28 – $MRK $DIA
Reportedly, Merck & Co., Inc. (MRK) is scheduled to hold its Q1 2022 earnings conference call with investors and analysts at 8:00 a.m. EDT on Thursday, April 28, discussing the company's performance for the quarter and outlook. Interested parties may access the live audio webcast of the call on ...
Apr 13, 2022
View Article
Floridians Can Now Enjoy Affordable & Convenient Health Care Services At 5 New Walmart Health Centers – $WMT $DIA
Reportedly, Walmart Stores, Inc. (WMT) announced the opening of 5 new Walmart Health centers across North and Central Florida, marking its expansion into Florida. Situated adjacent to Walmart Supercenters, these convenient state-of-the-art Walmart Health centers provide diverse services, including p...
Apr 12, 2022
View Article
Amgen Contemplates Further Issuance of Green Bonds- $AMGN $DIA
Reportedly, Pharmaceutical giant Amgen Inc. (AMGN) is planning to sell more bonds to benefit the environment and society after its debut green bond was received well by investors. Amgen raised $4 billion in February in a four-part transaction including a $750 million green-bond tranche, a first for ...
Apr 08, 2022
View Article
UnitedHealth To Acquire Home Healthcare Services Co. LHC Group For $5.4B In Cash
As per reports, UnitedHealth Group (UNH) is to acquire providers of healthcare services at home, LHC Group for $5.4 billion in cash, expanding its home health services. The deal will combine the LHC Group with UnitedHealth's Optum unit, primarily for older patients dealing with chronic illness and i...
Apr 05, 2022
View Article
J&J & Legend Biotech’s Multiple Myeloma CAR-T Therapy Receives Recommendation From European Medicines Agency – $JNJ $LEGN $DIA
Reportedly, the European Medicines Agency has recommended the use of CAR-T therapy to treat multiple myeloma by Johnson & Johnson (JNJ) and its partner Legend Biotech Corp. (LEGN) nearly a month after the treatment was cleared in the United States. The drug now needs the approval of the European...
Mar 25, 2022
View Article
Merck’s Head Of Global Clinical Development & Chief Medical Officer Dr. Roy D. Baynes Announces Retirement – $MRK $DIA
As per reports, the head of Global Clinical Development (GCD), and Chief Medical Officer, Merck Research Laboratories (MRL) (MRK) , Dr. Roy D. Baynes announces retirement from the position in July. He will be succeeded by Dr. Eliav Barr, effective April 1, 2022. Dr. Baynes will continue to report to...
Mar 24, 2022
View Article
UnitedHealth Schedules Q1 2022 Release On April 14 – $UNH $DIA
As per reports, UnitedHealth Group (UNH) is to release its Q1 2022 financial results on Thursday, April 14, 2022, before the market opens, followed by a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. The call will be a webcast on the Investor Relations page of the...
Mar 23, 2022
View Article
AstraZeneca-Merck’s Lynparza Early-Stage Breast Cancer Drug Gains U.S. FDA Approval – $AZN $MRK $DIA $ATOS
As per reports, the U.S. Food and Drug Administration has approved the cancer drug, jointly developed by Merck & Co., Inc. (MRK) and AstraZeneca Plc. (AZN) as a treatment for patients with early-stage breast cancer with certain mutations. The drug, Lynparza, was approved for patients suffering f...
Mar 15, 2022
View Article
United Health Foundation Donate $1M To Support Relief Efforts In Ukraine – $UNH $DIA
As per reports, the philanthropic foundation of UnitedHealth Group (UNH), the United Health Foundation, is to donate $1 million in support of relief efforts in Ukraine. The donation includes $500,000 to Save the Children, the U.S. affiliate of Save the Children International, supporting Ukraine Cris...
Mar 09, 2022
View Article
Merck’s COVID-19 Antiviral Pill Receives WHO Recommendation For High-Risk Patients – $MRK $DIA
Reportedly, the World Health Organization (WHO) expert panel has backed the use of Merck & Co Inc's (MRK) COVID-19 antiviral pill for high-risk patients. The expert panel conditionally recommended the pill, molnupiravir, for patients with the non-severe disease with a high risk of hospitalizatio...
Mar 06, 2022
View Article
Amgen To Pay Q2 2022 Dividend On June 8 – $AMGN $DIA
Reportedly, the board of Amgen (AMGN) has announced a $1.94 per share dividend for the second quarter of 2022, payable June 8, 2022, to all shareholders of record as of May 17, 2022. If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners...
Mar 06, 2022
View Article
Merck Announces Exit Of Dr. Julie L. Gerberding, Chief Patient Officer & Executive VP Population Health & Sustainability – $MRK $DIA
Reportedly, Merck & Co., Inc. (MRK) chief patient officer and executive vice president, population health and sustainability, Dr. Julie L. Gerberding, to retire from the company in May 2022. Dr. Gerberding to join as CEO of the Foundation for the National Institutes of Health (FNIH) on May 16. ...
Mar 03, 2022
View Article
New Data To Be Presented By Neubase Therapeutics On Myotonic Dystrophy Type 1 Program At #MDA2022 In Nashville- $NBSE $XBI
Patients with myotonic dystrophy type 1 (DM1) suffer from cognitive deficits and muscle pathology caused by a trinucleotide expansion in the DMPK gene. NeuBase’s DM1 investigational genetic therapy targets DMPK pre-mRNA with a novel peptide-nucleic acid (PNA) pharmacophore and is designed to sele...
Mar 01, 2022
View Article
UnitedHealth Care Faces Lawsuit By U.S. Justice Department Over $7.8B Acquisition Of Change Healthcare – $UNH $DIA
As per reports, the U.S. Justice Department has filed a lawsuit to stop UnitedHealth Group Incorporated (UNH) from acquiring Change Healthcare, stating that the $7.84B deal would give UnitedHealth access to its competitors' sensitive information. The largest U.S. health insurer informed that it woul...
Feb 28, 2022
View Article
J&J In Close Talks With S.Africa’s Aspen Over Vaccine Licensing Deal – $JNJ $DIA
Reportedly, Johnson & Johnson (JNJ) is close to a vaccine licensing deal with South African group Aspen Pharmacare, informed a senior executive at the company. In November, Aspen signed non-binding terms with subsidiaries of J&J, marking a step towards a licensing deal for Aspen to package a...
Feb 23, 2022
View Article
Merck Announces 3 New Leadership Appointments For Its Human Health Business – $MRK $DIA
As per reports, Merck & Co., Inc. (MRK) announced three new leadership for its Human Health business, effective Feb. 28, 2022. Arpa Garay will lead Human Health Global Marketing, Jannie Oosthuizen will lead Human Health U.S., and the company is recruiting externally to fill the Human Health Inte...
Feb 23, 2022
View Article
UnitedHealth Announces Cash Dividend On Common Stock- $UNH $DIA
Reportedly, the board of UnitedHealth Group Incorporated (UNH) declared a cash dividend of $1.45 per share, payable to all shareholders of record of UnitedHealth Group common stock as of March 14, 2022. The dividend is to be paid on March 22, 2022. Dow 30 component UnitedHealth Group ...
Feb 22, 2022
View Article
Merck To Discuss Its ESG Priorities On Feb 23
As per reports, Merck & Co., Inc. (MRK) is scheduled to hold a virtual Investor Event where its senior management team will discuss Environmental, Social & Governance (ESG) priorities on Wednesday, February 23 at 10:00 a.m. EST. The webcast can be reached by analysts, investors, members of t...
Feb 17, 2022
View Article
EU Countries Donate 2M Doses Of J&J COVID Vaccine To Nigeria As A Part Of COVAX Initiative
Reportedly, Nigeria has received 2 million doses of the Johnson & Johnson (JNJ) COVID-19 vaccine from Finland, Greece, and Slovenia. More EU donations are expected to arrive in the coming weeks, as part of a donation pledge by the European Union to African countries via the COVAX initiative laun...
Feb 10, 2022
View Article
INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment ‘INVO Centers’ – $INVO
Today, the global fertility market is a multi-billion industry, yet remains severely underserved, with estimates suggesting more than 90% of couples in need of infertility treatment going without care. INVO Bioscience (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access t...
Feb 09, 2022
View Article
Amgen’s Q4 Earnings Report Confirms Increase in Revenues – $AMGN $DIA
Reportedly, Amgen (AMGN) released Q4 revenue reporting a 3% increase driven by the sales of a COVID-19 antibody treatment it has partnered with Eli Lilly and Co. (LLY). However, sales its of own legacy drugs dropped 1%, amid pricing pressure from lower-cost competition. The Dow 30 component reporte...
Feb 08, 2022
View Article
Walgreens Announces Appointment Of HealthCare Tech Co. Expert Steven J. Shulman As 11th Board Member – $WBA $DIA
Reportedly, Walgreen Boots Alliance (WBA) announced the appointment of Steven J. Shulman to the company’s board of directors becoming the board’s 11th member, effective Jan. 27, 2022. Shulman appointment will offer expertise in healthcare management, as well as an extensive leadership background...
Feb 08, 2022
View Article
JOIN US TODAY FOR Tribe Public’s FREE Webinar Feb 3 (8AM PT / 11AM ET) Event “Drugging The Genome” – $NBSE $IBB $XBI
You are cordially invited to join Vista Partners' sister organization, Tribe Public, for a FREE Webinar Presentation and Q&A Event which will be held today, Thursday, February 3rd (8:00 am PT/ 11:00 am ET). Tribe Public's (www.tribepublic.com) complimentary worldwide webinars are efficient 30-m...
Feb 03, 2022
View Article
J&J Reports Mixed Quarterly Report & 24.8B Sales – $JNJ $DIA
As per reports, Johnson & Johnson (JNJ) reported mixed quarter results with $28.4 billion in sales. Adjusted profit of $2.13 per share was reported a little higher than $2.12 expected and driven by high Covid vaccine sales. On a year-over-year basis, sales grew more than 10% and earnings advance...
Jan 27, 2022
View Article
Merck Announces Exit Of Executive VP & President For Human Health, Frank Clyburn – $MRK $DIA
Reportedly, Frank Clyburn, executive vice president, and president, Human Health, to leave Merck & Co., Inc. (MRK) on Feb. 1, 2022, and continue with leadership opportunity in another company. Clyburn joined Merck in 2008 and held several leadership positions with increasing responsibility throu...
Jan 25, 2022
View Article
U.N.-backed Medicines Patent Pool (MPP) Enterd Deal To Produce Low-Cost Versions Of Merck’s COVID-19 Pill- $MRK $DIA
As per reports, the U.N.-backed Medicines Patent Pool (MPP) has entered a deal with nearly 30 generic drugmakers to make low-cost versions of Merck & Co's., Inc. (MRK) COVID-19 pill molnupiravir for poorer nations, allowing access to the drug globally. As per the clinical trial results, the anti...
Jan 24, 2022
View Article
Diversified Health & Well-Being Company UnitedHealth Group Releases Q4 Earnings – $UNM $DIA
As per reports, UnitedHealth Group Incorporated (UNH) reported Q4 earnings & exceeded Wall Street's quarterly profit estimates. The beat was powered in part by lower medical costs due to fewer elective surgeries. Health insurers also gained as people who were afraid of contracting the virus and ...
Jan 20, 2022
View Article
Merck To Supply 3M Courses Of COVID-19 Antiviral Pill To UNICEF – $MRK $DIA
As per reports, Merck & Co., Inc. (MRK) and partner Ridgeback Biotherapeutics have entered an agreement with the United Nations Children's Fund (UNICEF) to supply up to 3 million courses of their COVID-19 antiviral pill. Merck would supply the pill, molnupiravir, to UNICEF through the first hal...
Jan 20, 2022
View Article
UnitedHealthcare Introduces Eye Care Program For Children As Exposure To Digital Devices Surge In Pandemic – $UNH $DIA
As per reports, UnitedHealthcare is building ways to help children and adults across the country reduce their exposure to blue light and support the overall wellness of their eye health as the use of screens during the pandemic has increased remarkably. UnitedHealthcare, a UnitedHealth Group Incorpo...
Jan 19, 2022
View Article
3M Committed To Making Sure Everyone Who Needs An N95 Has Access – $MMM $DIA
Amid the rapidly spreading Omicron variant, 3M (MMM) has been providing information about 3M N95 respirators, including where to buy them, ensuring a proper fit, and why they are considered the standard for protection. "As we have throughout the pandemic, 3M is committed to making sure everyone w...
Jan 14, 2022
View Article
Walgreens & CVS Update Paid COVID -19 Sick Leave Policy For Employees In Alignment With CDC Guidance – $WBA $CVS
Reportedly, Walgreen Boots Alliance (WBA) and CVS Health Corp (CVS) have cut paid sick leave for workers who test positive for COVID-19 in line with a change in U.S. health guidance. Recently, the board of U.S. Centers for Disease Control and Prevention updated guidelines that Covid infected people ...
Jan 14, 2022
View Article
Merck Schedules Fourth-Quarter & Full-Year 2021 Earnings Call On February 3 – $MRK $IBB
Reportedly, Merck & Co., Inc. (MRK) to host its fourth-quarter and full-year 2021 sales and earnings conference call with institutional investors and analysts on Thursday, Feb. 3. at 8:00 a.m. EST. Link & Call Details: Interested parties can reach a live audio webcast of the call on Merck...
Jan 11, 2022
View Article
INVITATION: Tribe Public’s FREE Webinar Jan. 6 Event Titled “InMed Pharmaceuticals (INM): Addressing The Increasing Demand For Rare Cannabinoids”
You are cordially invited to join Vista Partners sister organization, Tribe Public for a FREE Webinar Presentation and Q&A Event which will be held tomorrow, Thursday, January 6 (8:00 am PT/ 11:00 am ET). Tribe Public's (www.tribepublic.com) complimentary worldwide webinars are efficient 30-min...
Jan 05, 2022
View Article
J&J’s Booster Shot Effective In Preventing Hospitalization Caused By Omicron Variant In S. Africa -Study
Reportedly, a booster dose of Johnson & Johnson (JNJ) Inc's single-dose COVID-19 vaccine has proven to be 84% effective at preventing hospitalization in South African healthcare workers who became infected with the fast-spreading Omicron variant. The real-world study was based on a second dose o...
Jan 02, 2022
View Article
Merck’s Antiviral Covid-19 Pill Gets Approval In Japan
As per reports, the Japanese health ministry panel has approved the use of the COVID-19 antiviral pill, molnupiravir developed by Merck & Co., Inc. (MRK) as a part of Prime Minister Fumio Kishida's plan to roll out new treatments by year-end amid growing concerns for the rising Omnicron variant....
Dec 29, 2021
View Article
U.S. Pharmacy Chains Reportedly Limiting Home COVID-19 Test Sales Amid Omicron..?
Reportedly, Walmart (WMT), Walgreens Boots Alliance (WBA), and CVS Health Corp (CVS) have limited sales of at-home COVID-19 testing kits as testing demand surges due to the increasing spread of the Omicron variant of the coronavirus. The variant has become a cause of concern, ruining hopes for a mo...
Dec 28, 2021
View Article
AstraZeneca-Amgen Drug For Severe Asthma Gains U.S. FDA Approval
As per reports, the U.S. Food and Drug Administration has approved AstraZeneca (AZN) and Amgen's (AMGN) asthma drug, Tezspire, to treat severe asthma for those aged 12 years and above. The approval comes based on late-stage trial data that shows the drug cut the rate of asthma attacks by 56% among p...
Dec 23, 2021
View Article
United Health Announces Q4 & Full-Year 2021 Earnings Release On Jan 19
As per reports, UnitedHealth Group Incorporated (UNH) announced to release fourth-quarter and full-year 2021 financial results before the market opens on Wednesday, January 19, 2022. The release will be followed by a teleconference at 8:45 a.m. ET with investors and analysts to discuss the results. ...
Dec 22, 2021
View Article
INVO Bioscience Expands Ovoclinic Relationship To Accelerate Adoption of INVOcell in Spain & European Union – $INVO
INVO Bioscience, Inc. (NASDAQ: INVO) is a medical device and fertility clinic development company focused on creating simplified, affordable treatments for patients diagnosed with infertility. Their solution, the INVO® Procedure, is a revolutionary in-vivo method of vaginal incubation that offers p...
Dec 16, 2021
View Article
INmune Bio’s CEO Publishes Article “Alzheimer’s disease should be approached as white matter disease, not gray” – $INMB
VP Watchlist company, INmune Bio (NASDAQ: INMB), is a publicly-traded, clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms that are both in clinical trials. The DN-TNF product platform uti...
Dec 09, 2021
View Article
Walgreens Enters Deal To Fully Acquire German GEHE-Alliance Healthcare JV
Reportedly, Walgreen Boots Alliance (WBA) and McKesson Corporation have reached an agreement for WBA to acquire the remaining 30% share of the joint venture of GEHE Pharma Handel (GEHE) and Alliance Healthcare Deutschland (AHD). The deal will allow WBA to become the 100% owner of the combined GEHE a...
Dec 03, 2021
View Article
Wall Street, Goldman Sachs, BofA Finance Epidermolysis Bullosa (EB) Research – $KRYS $INM
What is epidermolysis bullosa (EB)? Epidermolysis bullosa, or EB, is a rare genetic skin disease characterized by fragile skin that can lead to extensive blistering and wounding. It is a painful and often debilitating disease that affects skin and mucous membranes, particularly of the gas...
Dec 03, 2021
View Article
EU’s Regulator Expected To Reveal ‘Opinion’ On Merck’s COVID Pill ‘Within Weeks’
Reportedly, the European Union's drug regulator has started reviewing U.S. drugmaker Merck & Co Inc's (MRK) experimental COVID-19 antiviral pill for adults following an application and is expected to issue an opinion "within weeks." In October, the European Medicines Agency has already evaluated...
Dec 01, 2021
View Article
S. Africa’s Aspen Pharmacare Enters Agreement To Acquire License Of J&J’s COVID Vaccine
Reportedly, South Africa's Aspen Pharmacare has signed a non-binding agreement with subsidiary firms of U.S. company Johnson & Johnson (JNJ) for a licensing deal to package, market and sell the J&J’s COVID-19 vaccine in Africa. Currently, Aspen packages J&J's COVID-19 vaccine at its S...
Dec 01, 2021
View Article
Canada Allows Import Of J&J’s COVID-19 Vaccine From The Troubled Emergent Facility
As per reports, the Canadian health regulator has approved Johnson & Johnson (JNJ) to import its COVID-19 vaccine manufactured at Emergent BioSolutions Inc's plant in Baltimore, Maryland. The decision came after Health Canada completed an inspection of the facility, along with the European Medic...
Nov 30, 2021
View Article
Join Today’s Tribe Public FREE Webinar “A Town Hall Q&A Event With Atossa Therapeutics Management Team”
Please join our sister organization, which is hosting a Tribe Public FREE Q&A Webinar Event today, Tuesday, November 30 (8 am PT/ 11 am ET). The events are approximately 30 minutes in duration. Tribe Public LLC is a San Francisco, CA based organization that hosts complimentary worldwide webina...
Nov 30, 2021
View Article
UnitedHealth Group To Host 2021 Investor Conference On Nov 30
Reportedly, UnitedHealth Group (UNH) to conduct its annual Investor Conference in New York City beginning at 8:00 a.m. ET, on Tuesday, November 30, 2021, with analysts and institutional investors. In addition, to the Investor Conference, an updated view of financial performance for 2021 and the init...
Nov 29, 2021
View Article
Merck’s Acquisition Of Acceleron Pharma Inc. Finalized
Reportedly, Merck & Co., Inc. (MRK) has completed the acquisition of Acceleron Pharma Inc, a public American "clinical stage biopharmaceutical company" building on mobilizing the power of the transforming growth factor (TGF)-beta superfamily of proteins that plays a key role in the regulation of...
Nov 24, 2021
View Article
Walgreens To Administer Covid-19 Booster Shots For U.S. Individuals Aged 18+
As per reports, Walgreen Boots Alliance (WBA) recent announced that all individuals over the age of 18 can now receive a Moderna, Pfizer, or Johnson & Johnson COVID-19 vaccine booster in stores nationwide. The Food and Drug Administration’s recently authorized the Emergency Use of Pfizer and M...
Nov 23, 2021
View Article
J&J Targeting The Launch Of Multibillion-Dollar Drugs By 2025
As per reports, Johnson & Johnson (JNJ) is looking forward to filing for approval of 14 new drugs by 2025, projecting average peak sales of $4 billion a year for each. The global head of research for J&J's Janssen pharmaceutical unit, Mathai Mammen is reportedly confident about its top upcom...
Nov 19, 2021
View Article
Australian Scientists Discover Possible Causes In Alzheimer’s disease
Reportedly, researchers in Australia have identified one of the likely causes of neurodegenerative condition, Alzheimer’s disease. The findings may suggest potential treatment and prevention options for the neurodegenerative condition. Alzheimer’s disease which is one of the most common forms o...
Nov 17, 2021
View Article
J&J Dividing To Create 2 Public Co’s In Consumer & Healthcare
As per reports, Johnson & Johnson (JNJ) is to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded companies. The move will separate its household/consumer products unit, maker of Band-Aid bandages, Aveeno and Neutrogena skincar...
Nov 14, 2021
View Article
J&J’s Chairman & CEO Alex Gorsky Added To Apple’s BOD
As per reports, Alex Gorsky, Chairman & CEO of Johnson & Johnson (JNJ) to join Apple’s (AAPL) board of directors. Gorsky joined Johnson & Johnson in 1988, accumulating a broad range of experience in sales, management, and marketing before becoming CEO in 2012. Gorky’s inclusion will ...
Nov 11, 2021
View Article
Merck Reportedly Advancing Talks With European Union With Regard To Covid-19 Pills
Reportedly, the European Union is negotiating with Merck & Co., Inc. (MRK) and Pfizer over possible contracts to supply their experimental COVID-19 drugs. Both the healthcare giants have developed antiviral pills that have shown promising efficacy in adults displaying Merck's efficacy result of ...
Nov 10, 2021
View Article
Boeing Employee Vaccine Exemption Requests Reaching Approx. 9% Of U.S. Workforce
Reportedly, the number of Boeing Co. (BA) employees seeking a vaccine exemption on religious or medical grounds has reached more than 11,000 - or nearly 9% of its U.S. workforce. Recently, the White House pushed back its vaccination deadline, to Jan. 4 for employees at federal contractors or to be ...
Nov 10, 2021
View Article
FDA Authorizes Batches Of J&J COVID-19 Vaccine From Emergent’s Baltimore Plant
As per reports, the U.S. Food and Drug Administration had authorized the use of two more batches of Johnson & Johnson (JNJ) one-dose COVID-19 vaccine manufactured at the problem-plagued Baltimore factory of Emergent BioSolutions Inc, based on a thorough review of facility records and quality tes...
Nov 10, 2021
View Article
UnitedHealth Group To Pay Quarterly Dividend On December 14
As per reports, the board of UnitedHealth Group Incorporated (UNH) board of directors has authorized payment of a cash dividend of $1.45 per share, to be paid on December 14, 2021. The dividend is payable to all shareholders as of December 6, 2021. Dow 30 component UnitedHealth Group In...
Nov 10, 2021
View Article
Walmart & Sam’s Club To Administer The Latest Approved Pfizer $PFE Vaccine For Children Aged 5 – 11 Years
As per reports, the U.S. Food and Drug Administration and Centers for Disease Control and Prevention have authorized the Pfizer (PFE) vaccine for children aged 5 to 11. Walmart Stores, Inc. (WMT) and Sam’s Club will administer the Pfizer vaccine to eligible children aged 5 to 11 across more than 5...
Nov 09, 2021
View Article
$INVO Bioscience ‘Freed’ To Roll Out Affordable Infertility Treatment Clinics (INVO Centers) Across The US
INVO Bioscience, Inc. (NASDAQ: INVO) is a medical device and fertility clinic development company focused on creating simplified, affordable treatments for patients diagnosed with infertility. Their solution, the INVO® Procedure, is a revolutionary in-vivo method of vaginal incubation that offers p...
Nov 09, 2021
View Article
Biotech Giant Amgen Releases Q3 Earnings
Amgen (AMGN) reported a 4% rise in quarterly revenue, as pandemic restrictions eased reporting adjusted earnings per share for the quarter of $4.69, beating the average analyst forecast of $4.27. Amgen's net earnings dropped 3% to $3.31 per share with a $400 million licensing-related expense from a ...
Nov 05, 2021
View Article
Merck Reports Quarterly Earnings Beat- Raises Outlook Point Toward Covid-19 Antiviral Molnupiravir Pill Sales
As per reports, Merck & Co., Inc. (MRK) is riding high on its Covid-19 antiviral molnupiravir that is expected to bring in as much as $7 billion in global sales through 2022, the figure includes up to $1 billion in revenue this year if the experimental drug is authorized in December. Merck’s M...
Nov 01, 2021
View Article
Johnson & Johnson & Moderna Booster Shots Now Available At US Walmart & Walgreens
Reportedly, Walmart Inc. (WMT) and Walgreens Boots Alliance Inc. (WBA) have started to administer COVID-19 booster shots from Johnson & Johnson and Moderna Inc., in addition to the previously authorized Pfizer-BioNTech booster. The Centers for Disease Control and Prevention said citizens can cho...
Oct 26, 2021
View Article
Walgreens Schedules Quarterly Dividend Payable On Dec 10
Reportedly, the board of Walgreen Boots Alliance (WBA) declared a quarterly dividend of 47.75 cents per share, the same as the previous quarter. The dividend is payable to stockholders of record as of Nov. 15, 2021, and is payable on Dec. 10, 2021. Walgreen Boots Alliance (WBA) is a pharmacy-led,...
Oct 26, 2021
View Article
Apple Mandates Daily Covid-19 Testing For Unvaccinated Employees
As per reports, Apple (AAPL) is requiring unvaccinated corporate employees to test for Covid-19 each time they want to enter an office, a crucial step in tightening its virus protocols while still stopping short of a vaccine mandate. The above requirement will also apply to employees who do not repo...
Oct 25, 2021
View Article
J&J’s Q3 Profits Increased With Higher Sales In Consumer, Pharmaceutical & Medical Devices Units
Reportedly, Johnson & Johnson (JNJ) sold $502 million of its Covid-19 vaccine in the third quarter. The Pharma giant reported adjusted EPS of $2.60 per share versus $2.35 expected. Revenue stood at $23.34 billion versus $23.72 billion expected. The company maintained its Covid vaccine sales outl...
Oct 20, 2021
View Article
$INVO Bioscience Presents Exciting Conclusions For Affordable Infertility Treatment INVOcell At #ASRM2021
The American Society for Reproductive Medicine (ASRM) is dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in evidence-based, life-long education and learning, through the advancement and support ...
Oct 20, 2021
View Article
Boeing Faces Protest From Employees Amid Vaccination Mandate
Reportedly, some 200 Boeing Co (BA) employees and others have staged a protest over the planemaker's COVID-19 vaccine mandate for U.S. workers. Waving signs like "coercion is not consent," and "stop the mandate," was witnessed outside Boeing's factory in Everett, north of Seattle. "It's my choice...
Oct 19, 2021
View Article
Verizon Joins The List Of Federal Contractors Issuing Vaccine Mandate For Its U.S Workforce
As per reports, VVerizon Communications, Inc. (VZ) has issued a vaccination mandate for its U.S. workforce, under President Joe Biden's federal contractor executive order. Verizon, a federal contractor said that thousands of non-union U.S. employees must be fully vaccinated by Dec. 8 under the execu...
Oct 18, 2021
View Article
INVO Bioscience Schedules Opening Of 3rd INVO Center “Positib Fertility” – Advanced Fertility Care Utilizing The Efficient, Effective, & Affordable INVOcell Solution – $INVO
Infertility is a condition of the reproductive system that prevents the conception of children. It is estimated to affect between 8 and 12% of reproductive-aged couples worldwide. Today, INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only i...
Oct 14, 2021
View Article
World’s Largest Aerospace Co. Boeing Requiring U.S. Employees To Be Vaccinated By Dec. 8 Following Executive Order Issued By The White House
Reportedly, Boeing Co. (BA) announced that it will require its 125,000 U.S. employees to be vaccinated by Dec. 8 under an executive order issued by President Joe Biden for federal contractors. "Boeing is requiring its U.S.-based employees to either show proof of vaccination or have an approved re...
Oct 14, 2021
View Article
InMed Pharma ($INM) Acquires BayMedica Seeking To Accelerate The Commercialization of Rare Cannabinoids!
There are over 2,000 years of documented history of the health benefits of Cannabis in humans which stems primarily from the fact that the human body produces 2 cannabinoids naturally called endocannabinoids and therefore have natural affinity to interact with these compounds on a biologic...
Oct 14, 2021
View Article
Biotech Giant Amgen Makes Investment In Precision Medicines for Brain Diseases Focused Neumora Therapeutics
As per reports, U.S. biotech giant, Amgen In. (AMGN), has made a $100-million equity investment in Neumora Therapeutics, and simultaneously is allowing Neumora to obtain the global rights to develop and sell certain of Amgen's experimental drugs for neurodegenerative diseases. Neumora Therapeutics, ...
Oct 08, 2021
View Article
J&J Seeking FDA Approval For Authorization Of Its COVID-19 Vaccine Booster
As per reports, Johnson & Johnson has submitted data to the U.S. Food and Drug Administration for emergency use authorization of a booster shot of its COVID-19 vaccine in people aged 18 and above. The submission includes data from a late-stage study reporting a booster given 56 days after the fi...
Oct 06, 2021
View Article
Walgreens Considering Deal With Arlington, Virginia-Based Evolent Health?
As per reports, Walgreen Boots Alliance (WBA) is considering a deal to acquire Arlington, Virginia-based, Evolent Health Inc., the healthcare group. Evolent has a platform that helps providers like hospitals and doctors manage their costs. It also works on behalf of health insurers and assists to ge...
Oct 04, 2021
View Article
Merck’s Oral COVID-19 Antiviral Drug Showing To Be Efficacious Against Variants
Reportedly, Merck & Co., Inc.'s (MRK) experimental oral COVID-19 antiviral drug, molnupiravir is expected to produce promising results against variants of the coronavirus, including the dominant, highly transmissible Delta. Molnupiravir does not target the spike protein of the virus, which all ...
Oct 01, 2021
View Article
Merck Appoints Board Member Thomas H. Glocer As Independent Lead Director Effective Immediately
Reportedly, the board of Merck & Co., Inc. (MRK) announced the appointment of Thomas H. Glocer as independent lead director effective immediately. Mr. Glocer has served on the Merck Board of Directors since 2007 and has extensive management, technology, operational, and international business ex...
Sep 30, 2021
View Article
JOIN TRIBE PUBLIC’s WEBINAR IN ~1-Hour – “Improving White Matter Integrity In Alzheimer’s Disease” -With INmune Bio’s CEO
Alzheimer’s Disease is an immunologic disease with the neurological symptoms of dementia and psychiatric dysfunction. Unfortunately, the onset of Alzheimer’s is all to common as we advance in age and it is estimated that by mid‐century, the number of Americans age 65 and older with Alzheimer's...
Sep 30, 2021
View Article
JOIN TOMORROW’S TRIBE PUBLIC WEBINAR (Sept. 30 at 8:30am PT) “Improving White Matter Integrity In Alzheimer’s Disease” – INmune Bio $INMB
Alzheimer’s Disease is an immunologic disease with the neurological symptoms of dementia and psychiatric dysfunction. Unfortunately, the onset of Alzheimer’s is all to common as we advance in age and it is estimated that by mid‐century, the number of Americans age 65 and older with Alzheimer's...
Sep 29, 2021
View Article
Reportedly, Merck Expected To Close $11B Deal With Blood-Related Disorder Therapeutics Firm Acceleron Pharma
Reportedly, Merck & Co., Inc. (MRK) is in advanced talks to acquire drugmaker Cambridge, Massachusetts-based, Acceleron Pharma Inc (XLRN) . Acceleron is focused on the discovery, development, and commercialization of therapeutics to treat blood-related disorders. As per a Bloomberg report, ...
Sep 28, 2021
View Article
UnitedHealth Group To Release Q3 Results On Oct 14
As per reports, UnitedHealth Group Incorporated (UNH) is to release its third-quarter 2021 financial results on Thursday, October 14, 2021, before the market opens, followed by a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. The webcast of the call can be reach...
Sep 25, 2021
View Article
Rare Cannabinoid Leader InMed Pharmaceuticals (INM) Reports Fiscal 2021 Progress – Strengthened Balance Sheet, BayMedica Acquisition, & Pharmaceutical Drug Developments
InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”) and is developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids. The Company...
Sep 24, 2021
View Article
Study Reveals Neuroinflammation As A Possible Cause For Alzheimer’s
As per reports, Doctors are studying the possibility of amyloid plaque lodged between the brain’s nerve cells and tangled tau protein fibers forming within the cells as the hallmark of Alzheimer’s disease. The study suggests combination therapies addressing both amyloid plaque buildup and neuroi...
Sep 23, 2021
View Article
Invitation To Today’s FREE Presentation: “InMed Pharmaceuticals (INM): Accelerating The Commercialization of Rare Cannabinoids”
You are cordially invited to join me at Vista Partners' sister organization FREE Tribe Public Webinar Presentation and Q&A Event which will be held today, Tuesday, September 21 (8:30 am PT/ 11:30 am ET). Tribe Public's (www.tribepublic.com) complimentary worldwide webinars are efficient 30-minu...
Sep 21, 2021
View Article
J&J’s Ebola Vaccine Demonstrated Promising Antibody Immune Responses In Adults & Children
As per reports, Johnson & Johnson (JNJ) Ebola vaccine regimen has demonstrated promising antibody immune responses in adults and children, as published in Lancet Infectious Diseases journal. J&J informed that the two-dose regimen was well-accepted and released antibody responses to the Zaire...
Sep 15, 2021
View Article
BayMedica Acquisition Propels InMed (NASDAQ: INM) Into Leadership Role In Manufacturing & Commercialization of Rare Cannabinoids
Beyond the well-known cannabinoids of THC and CBD, there’s a whole world of rare cannabinoids. Indeed, there are more than 100 rare cannabinoids that have been found in the Cannabis plant, including CBG, CBN, CBC and THCV with unique properties that are believed to have a wide range of health ben...
Sep 14, 2021
View Article
PROGRESS REPORT: INVO Bioscience’s Acquisition Provides Platform To Leverage The Existing INVOcell Product Registration In Canada
The INVOcell procedure is the first in-vivo culture (IVC) system in the world used for the incubation of eggs and sperm during fertilization and early embryo development within the body, as an alternative to conventional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Through its i...
Sep 10, 2021
View Article
Alzheimer’s Experts Raise Concern Over Link Between Covid-19 & Dementia
Reportedly, the ongoing Covid-19 pandemic could cause a significant rise in the number of dementia patients in the long term, raised Alzheimer's Disease International. The organization is urging the World Health Organization and governments around the world to "urgently fast track research on the po...
Sep 07, 2021
View Article
VISTA UPDATE: INVO Bioscience (NASDAQ: INVO) Successfully Opens Its 2nd Advanced & Affordable Fertility Care INVO Center In The U.S.
“The global fertility market size is predicted to hit around US$ 47.9 billion by 2030 with a CAGR of 4.7%”, according to new report study by Precedence Research. According to the data published by the National Center for Biotechnology Information (NCBI), “over 15% of couples are affected by fe...
Sep 07, 2021
View Article
VISTA UPDATE: INVO Bioscience (INVO) Completes Nigerian Distribution Registration – To Speak At Association for Fertility & Reproductive Health (AFRH) Conference In September
INVO Bioscience, Inc. (NASDAQ: INVO) is a medical device company focused on creating simplified, lower-cost treatments for patients diagnosed with infertility. Their solution, the INVO® Procedure, is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and inti...
Sep 06, 2021
View Article
PROGRESS REPORT: Atossa Therapeutics Pushes Karisma-Endoxifen Study Forward With Swedish Ethics Review Authority Approval For Reduction of MBD
Endoxifen is the most active metabolite of tamoxifen, which is an FDA-approved drug to treat breast cancer. Tamoxifen itself must be broken down by the liver into active compounds (metabolites). In third party preclinical studies, endocrine-sensitive and letrozole-resistant breast tumors, Z-endoxife...
Sep 03, 2021
View Article
Merck Begins Enrolling Patients In A Late-Stage Trial Of Its COVID-19 Experimental Drug Molnupiravir
Reportedly, Merck & Co., Inc. (MRK) and partner Ridgeback Biotherapeutics have begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for the prevention of COVID-19 infection. The drug will be administered and studied in over 1,300 volunteers to determine if it ca...
Sep 02, 2021
View Article
Data from INmune Bio’s XPro™ Trial Shows ‘Decreases In Biomarkers of Neuroinflammation & Nerve Cell Death & Improvement In Biomarkers of Neurorepair In Alzheimer’s Patients’
Boca Raton, FL based INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative techno...
Sep 02, 2021
View Article
Johnson & Johnson’s HIV Vaccine Fails To Show Promising Results In Mid-Stage Africa Study
As per reports, Johnson & Johnson (JNJ) experimental vaccine failed to provide sufficient protection against HIV in sub-Saharan Africa to young women who accounted for a large number of infections last year. Results from the mid-stage study are the latest setback to efforts to develop a vaccine ...
Aug 31, 2021
View Article
Walgreens Announces 3 Significant Executive Leadership Positions
As per reports, Walgreen Boots Alliance (WBA) announced the appointment of three significant executive leadership positions, Jeff Gruener has been Appointed as SVP and Chief Financial Officer, Walgreens. Danielle Gray to lead as EVP and Global Chief Legal Officer, Walgreens Boots Alliance. T...
Aug 30, 2021
View Article
INmune Bio (NASDAQ: INMB) Confirms Belief That They Are The First To Successfully Generate mlNK cells In Patients
The innate immune system is one of two basic arms of the human immune system; the other being the adaptive arm. Like adaptive immunity, the innate immune system consists of a variety of cells and soluble factors and the principal cytotoxic cell is the natural killer (NK cell). These cells are essent...
Aug 26, 2021
View Article
Merck Ranks First On The List Of 60 Best Large Workplaces In New York By Fortune
As per reports, Merck (MRK) has ranked first of 60 companies on the 2021 list of the 60 Best Large Workplaces in New York compiled by Great Place to Work, Fortune's research partner. Merck has been appreciated for supportive cultures, where employees find opportunities for growth and help from their...
Aug 22, 2021
View Article
INVO Bioscience (NASDAQ: INVO) Confirms That They Are ‘Well Positioned For Success’
Over the past 40+ years, since the first IVF baby was born, the fertility market has grown into a $20+ billion global industry. Here in the U.S., according to the most recent 2019 CDC data, approximately 330,000 IVF cycles were performed across 448 clinics, which implies a roughly $5 billion domesti...
Aug 17, 2021
View Article
PROGRESS REPORT: Atossa Therapeutics’ Announces Key Developments During Q2 2021
Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, announced their financial results on Friday, August 13th for the fiscal qua...
Aug 16, 2021
View Article
UnitedHealth Group To Pay Quarterly Dividend On Sep 21
The board of UnitedHealth Group Incorporated (UNH) declared a quarterly cash dividend of $1.45 per share, payable to all shareholders as of September 13, 2021. The dividend is scheduled to be paid on September 21, 2021. Dow 30 component UnitedHealth Group Incorporated (UNH) operates as ...
Aug 13, 2021
View Article
UnitedHealth Agrees To Settle Federal & New York Charges Over Mental Health/Substance Abuse Coverage
Reportedly, UnitedHealth Group Incorporated (UNH) has agreed to settle federal and New York state charges that it illegally denied coverage to thousands of patients suffering from mental health problems and substance abuse. The U.S. Department of Labor said that UnitedHealth will pay about $15.7 mil...
Aug 12, 2021
View Article
Walgreens & VillageMD Expand Partnership With 3 New Village Medical At Walgreens In Orlando Area
As per reports, Walgreen Boots Alliance (WBA) and VillageMD announced the opening of three new Village Medical at Walgreens locations in the Orlando area with a target to open seven additional locations by end of this year. Walgreens and VillageMD’s integrated care model offers patients convenient...
Aug 12, 2021
View Article
A Recent Discussion With The CEO of InMed Pharmaceuticals (NASDAQ: INM) Regarding Development Of IntegraSyn™, A Proprietary Manufacturing Approach To Economically Produce Pharmaceutical-Grade Cannabinoids
Recently, I had the distinct pleasure of having a discussion with a long term friend of mine, Eric A. Adams, CEO of InMed Pharmaceuticals (NASDAQ: INM). InMed is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic b...
Aug 09, 2021
View Article
Amgen Adds S. Omar Ishrak, Former Chairman & CEO of Medtronic, To Board Of Directors
Reportedly, Amgen (AMGN) has appointed S. Omar Ishrak to its Board of Directors, effective July 30, 2021. Dr. Ishrak will also serve as a member of the Board's Corporate Responsibility and Compliance Committee and its Compensation and Management Development Committee. The Board now consists of 12 di...
Aug 08, 2021
View Article
Walgreens Sees Rise In Vaccinations As COVID-19 Cases Jump In Recent Weeks
Reportedly, Walgreen Boots Alliance (WBA) has overseen more than 29 million COVID-19 vaccines at its stores so far, driven by a surge in parts of the United States that had been low in vaccinations, reporting an increase of more than 30% in states such as Florida, Alabama, Georgia, Kentucky, and Tex...
Aug 05, 2021
View Article
Merck Ranked #1 In Forbes’ 2021 List of ‘Best Employers For New Graduates’
Reportedly, Merck & Co., Inc. (MRK) has been named #1 'Best Employers For New Graduates' as identified by the Forbes team along with market research company Statista. The survey was conducted to identify the companies most liked by new workforce entrants in their annual ranking. The list surv...
Aug 05, 2021
View Article
Q2 PROGRESS REPORT: INmune Bio, Inc. (NASDAQ: INMB) Management Reports Financial Results & Business Update
About XPro™ XPro1595 is a next-generation inhibitor of tumor necrosis factor (TNF) that is currently in clinical trial and acts differently than currently existing TNF inhibitors in that it neutralizes soluble TNF (sTNF), without affecting trans-membrane TNF (tmTNF) or TNF receptors. XP...
Aug 05, 2021
View Article
Amgen Beats Q2 Estimates – Adjusts Outlook
Reportedly, Amgen exceeded Q2 estimates reporting $4.38 per share, minus some items, on $6.53 billion in sales. Earnings increased 4% year over year and exceeded analysts' estimate for $4.09 per share. Sales topped expectations for $6.46 billion and increased 5%. Across all medicines, volumes grew 8...
Aug 04, 2021
View Article
INVO Bioscience (NASDAQ: INVO) Schedules To Open Its FIRST U.S. ‘INVO Center’ To Provide ‘Advanced Affordable Fertility Services’
According to the data published by National Center for Biotechnology Information (NCBI), "over 15% of couples are affected by fertility problems across the globe." INVO Bioscience's (NASDAQ:INVO) FDA cleared INVOcell procedure is the first in-vivo culture (IVC) system in the world used fo...
Aug 03, 2021
View Article
Merck’s Keytruda Approved By U.S. FDA To Treat Early Breast Cancer In Combo With Chemotherapy
Reportedly, U.S FDA has granted approval to Merck & Co Inc.’s (MRK) immunotherapy Keytruda for the treatment of an early form of breast cancer, used in combination with chemotherapy. The U.S. Food and Drug Administration's approval is for the treatment of triple-negative breast cancer (TNBC),...
Aug 02, 2021
View Article
Merck Appoints Cristal N. Downing To Newly Created Role Of Chief Communications & Public Affairs Officer
As per reports, Merck & Co., Inc. (MRK) has appointed Cristal N. Downing as the chief communications & public affairs officer, a newly created role, effective August 16, 2021. Downing will lead the advancement, development, and execution of the company’s communications and public affairs s...
Jul 31, 2021
View Article
Merck Beats Q2 Estimates – Keytruda Growth Remains Strong
Merck & Co., Inc. (MRK) reported quarterly revenue beating Wall Street's estimates, as sales for its blockbuster cancer drug Keytruda remained strong and demand for its Gardasil vaccine also rebounded. The company's second-quarter sales increased 22% to $11.40 billion, beating estimates of $11.1...
Jul 30, 2021
View Article
Aspen Pharmacare To Supply First Batch Of J&J COVID-19 Vaccine To South Africa
Reportedly, South Africa's Aspen Pharmacare is to supply the first batch of Johnson & Johnson (JNJ) COVID-19 vaccines to the country from July 26. It is going to be the first set of vaccines to be manufactured in the country from active pharmaceutical ingredients (API), substances that are used ...
Jul 26, 2021
View Article
INmune Bio Confirms Exciting AD Data At AAIC – Introduces Design of Upcoming 6-Month Phase 2 Study of XProTM In Mild Alzheimer’s Disease
Alzheimer's is the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60-80% of dementia cases. Alzheimer's has no cure. Today, INmune Bio, Inc. (NASDAQ: INMB), a clinica...
Jul 26, 2021
View Article
INmune Bio Employs LUMICKS’ z-Movi Cell Avidity Analysis Platform To Demonstrate That The MOA of The Tumor-Priming Is The Increase In NK cell: Tumor Cell Avidity
LUMICKS is a leading life science tools company that develops equipment for Dynamic Single-Molecule and Cell Avidity analysis, two rapidly emerging areas in biology research and immuno-oncology. Built upon innovative technologies, such as optical tweezers (Nobel Prize for Physics 2018) and STED supe...
Jul 22, 2021
View Article
Fate Therapeutics to Host Virtual Event Highlighting Interim Phase 1 Clinical Data from its Off-the-Shelf, iPSC-derived NK Cell Franchise for B-cell Lymphoma
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, announced this week that management will host a virtual event to highlight interim Phase 1 clinical data from its FT596 and FT516 program...
Jul 21, 2021
View Article
Johnson & Johnson Releases A Q2 Earnings Beat – Medical Device Unit Reported 62.7% Increase
Johnson & Johnson (JNJ) reported earnings exceeding analyst estimates reporting an adjusted EPS of $2.48 per share vs $2.27 expected. Revenue of $23.31 billion was reported, versus $22.21 billion expected. Johnson expects to sell $2.5 billion of its Covid-19 vaccine this year, even as its effect...
Jul 21, 2021
View Article
Insurer UnitedHealth Group Announces Strong Quarter Earnings- Raises Full-Year Earnings Target
UnitedHealth Group Incorporated (UNH) reported strong quarterly profit and also raised its full-year earnings, boosted by strong growth in its Optum unit that manages drug benefits. Spending on medical services at the company’s health insurance business, UnitedHealthcare, regained in the latter pa...
Jul 20, 2021
View Article
INmune Bio (INMB) Will Deliver A Talk Titled “Therapeutic Approaches Targeting Innate Immunity in AD” At The Upcoming Alzheimer’s Association International Congress #AAIC2021
INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively ne...
Jul 19, 2021
View Article
Immunology Co. INmune Bio, Inc. (NASDAQ: INMB) Enters Definitive Agreement With Healthcare Focused Institutional Investor & A Family Office To Raise ~$40M
On June 14th, VP Watchlist stock, INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, announced that it has entered into a definitive agreement with one healthcare focused institutional inve...
Jul 15, 2021
View Article
INVO Bioscience Appoints World Renowned Women’s Health Expert Dr. Barbara Levy To Accelerate Affordable Infertility Treatment INVOcell’s Global OB/GYN Clinical Integration Strategy
INVO Bioscience's INVOcell (IVC) system, an effective and affordable treatment for patients diagnosed with infertility, is positioned to serve a vastly underserved global market. Today, approximately 90% of infertile couples go untreated primarily due to effective care is not available at an ...
Jul 14, 2021
View Article
INmune Bio (INMB) Treats First Patient In High-Risk MDS With NK Cell Platform INKmune
MDS is a serious hematopoietic stem cell disorder in which patients have functionally defective NK cells and the level of dysfunction is predictive of overall survival. Approximately one-third of MDS cases progress to acute myelogenous leukemia (AML). Current treatments, including chemotherapy and b...
Jul 12, 2021
View Article
Amgen – AstraZeneca Asthma Drug Granted Speedy FDA Review
Reportedly, Amgen (AMGN) and AstraZeneca's (AZN) experimental asthma drug tezepelumab has been granted a speedy review by the U.S. Food and Drug Administration for potential approval. The drug displayed promising results to reduce asthma attacks in patients with uncontrolled and severe forms of th...
Jul 12, 2021
View Article
Walgreens & VillageMD Partner To Open 29 Full-Service Primary Care Practices In Austin, Houston, El Paso
Reportedly, Walgreen Boots Alliance (WBA) has announced plans to include 29 new Village Medical at Walgreens practices in Austin, Houston, and El Paso this year with VillageMD, in line with its goal to open at least 600 Village Medical at Walgreens in more than 30 U.S. markets over the next four yea...
Jul 09, 2021
View Article
PROGRESS REPORT: ATOSSA THERAPEUTICS MOVES FORWARD WITH DEVELOPMENT OF NEBULIZED FORMULATION TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS & “LONG HAUL” PATIENTS WITH POST-INFECTION PULMONARY DISEASE
According to the CDC, long-haul Covid is “a range of symptoms that can last weeks or months…[which] can happen to anyone who has had Covid-19.” According to the New England Journal of Medicine long-haul Covid "symptoms are reported to be affecting a wide number of organ systems, occur in div...
Jul 07, 2021
View Article
Researchers At Michigan State University To Use AI To Detect Early Signs Of Alzheimer’s Disease
Approximately 5.8 million people in the United States age 65 and older live with Alzheimer’s disease. Of those, 80% are 75 years old and older. Out of the approximately 50 million people worldwide with dementia, between 60% and 70% are estimated to have Alzheimer’s disease. Reportedly, research...
Jul 07, 2021
View Article
InMed Pharmaceuticals (NASDAQ: INM) Closes Net Proceeds of Approx. $11M With An Institutional Investor
InMed Pharmaceuticals Inc. (Nasdaq: INM), a leading clinical-stage pharmaceutical company developing cannabinoid-based drug candidates for high unmet medical needs and IntegraSyn, a proprietary and cost effective manufacturing approach for synthesized rare cannabinoids, has been very busy lately! &...
Jul 06, 2021
View Article
Lightning Seemingly Strikes Twice This Week For InMed Pharmaceuticals (NASDAQ: INM)
Indeed, I truly believe that it has been a very large week for newly added VP Watchlist company InMed Pharmaceuticals Inc. (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabin...
Jul 01, 2021
View Article
INVO Bioscience Expands INVOcell Clinic North American Footprint With Atlanta-based Bloom Fertility
Depending on what statistics that you review today, Industry forecasts suggest that no more than 10% of the estimated 150 million infertile couples worldwide are currently being treated. After further research, this severely underserved market has been created and left unaddressed primaril...
Jul 01, 2021
View Article
Walmart Announces Its Low-Priced Private Label Analog Insulin With Novo Nordisk
Reportedly, Walmart Stores, Inc. (WMT) has launched its private-label analog insulin at a huge discount to branded insulin vials and pens, driving growth in its healthcare business. The product, ReliOn NovoLog, is rapid-acting analog insulin used to control high blood sugar in adults and children wi...
Jul 01, 2021
View Article
UnitedHealth Group Schedules Q2 Earnings On July 15
Reportedly, UnitedHealth Group has scheduled to release its Q2 2021 earnings on Thursday, July 15, 2021, before the market opens, followed by a conference call at 8:45 a.m. ET to discuss and review results with analysts and investors. The webcast of the call can be reached at the company’s website...
Jul 01, 2021
View Article
InMed’s IntegraSyn™ Produces Cannabinoid Yield (5 g/L) That Significantly Exceeds Currently Reported Industry Yields
InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”), and is developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids. The Compan...
Jun 21, 2021
View Article
Cytovia Therapeutics Takes Another Step Towards An IPO – Hires Experienced Public Co. CFO, William Sullivan, CPA, MBA
Cytovia Therapeutics (www.cytoviatherapeutics.com) aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer. Cytovia focuses on Natural Killer (NK) cell biology and applies precision engin...
Jun 16, 2021
View Article
PROGRESS REPORT: INVO Bioscience Appoints Andrea Goren As CFO – An Exec With Strong Ties To Ben-Gurion University of the Negev
INVO Bioscience (NASDAQ: INVO) operates within the ~$15-$18 Billion global infertility industry growing ~8-10% annually and is commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell® (pictured below), an accessible, inclusive, and affordable treatment for patients ...
Jun 16, 2021
View Article
INmune Bio (INMB) Purchases Xencor’s Option Potentially Eliminating Approx. 2.1M Shares of Future Dilution
INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively ne...
Jun 14, 2021
View Article
Johnson & Johnson’s Single-Shot COVID-19 Vaccine Receives Shell Life Extension Via FDA
As per reports, the U.S. Food and Drug Administration has extended the shelf life of the Johnson & Johnson (JNJ) single-shot COVID-19 vaccine from three months to four-and-a-half months, as millions of unused doses nationwide near expiry amid safety concerns and flagging demand for vaccinations....
Jun 14, 2021
View Article
Merck Enters Supply Agreement With U.S. Government For Investigational Oral Antiviral Candidate For COVID-19
Reportedly, Merck & Co., Inc. (MRK) has entered into a procurement agreement with the United States government for molnupiravir (MK-4482). Molnupiravir is under Phase 3 clinical trial, the MOVe-OUT study for the treatment of non-hospitalized patients with laboratory-confirmed COVID-19 and at lea...
Jun 13, 2021
View Article
Swedish Medical Product Agency (MPA) Confirms Atossa Therapeutics Approval to Initiate Phase 2 Of Oral Endoxifen For Reduction of MBD
MBD is an emerging public health issue affecting more than 10 million women in the United States and many more worldwide. Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious dise...
Jun 11, 2021
View Article
Atossa Therapeutics Phase 2 Endoxifen Breast Cancer Study Hits Primary Endpoint – Management Conducts Webinar Discussion (View Event Video!)
The American Cancer Society (ACS) estimates that in 2021, 281,550 women will be diagnosed with breast cancer in the U.S. and 43,600 will die. ER+ breast cancer makes up approximately 78% of all women diagnosed with breast cancer. Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage bio...
Jun 09, 2021
View Article
Million Of J&J Vaccine Remain Unused In U.S, States Asked To Seek To Lengthen Shell Life
Reportedly, state governors to work with the U.S. Food and Drug Administration will be extending the shelf life of Johnson & Johnson's (JNJ) COVID-19 vaccine after White House orders, as millions of doses remain unused nationwide and are near to expiry. "I would encourage every governor who...
Jun 09, 2021
View Article
YOU ARE INVITED! To The Tribe Public Atossa Therapeutics (NASDAQ: ATOS) FREE Webinar Event – June 9 – 8am PT
You are invited to join me on Wednesday June 9th at 8am PT/ 11am ET at the Tribe Public Presentation & Q&A Event with Atossa Therapeutics’s (NASDAQ: ATOS) CEO Dr. Steven C. Quay, M.D., Ph.D., CFO Kyle Guse, & B. Heather Fraser, Ph.D. VP Clinical, Regulatory & CMC...
Jun 08, 2021
View Article
Biogen’s Historic FDA Nod For Alzheimer’s Treatment Is Boosting Hopes & Values
Approximately 5.8 million people in the United States age 65 and older live with Alzheimer’s disease. Of those, 80% are 75 years old and older. Out of the approximately 50 million people worldwide with dementia, between 60% and 70% are estimated to have Alzheimer’s disease. On Monday, June 07, ...
Jun 08, 2021
View Article
Mexico To Administer J&J’s COVID-19 US Supplied Vaccine To 18-40 Year Olds Along Mexico-U.S. Border
Reportedly, Mexico will seek to administer Johnson & Johnson's (JNJ) COVID-19 vaccine to 18 to 40-year-olds along the Mexico-U.S. border region with the aim of reopening the shared border by late June, informed Foreign Minister Marcelo Ebrard. After a conversation with U.S. Vice President Kamal...
Jun 07, 2021
View Article
Will Biogen’s Highly Anticipated Alzheimer’s Drug Receive FDA Approval Today?
According to the Alzheimer's Association, around 6.2 million Americans are currently living with Alzheimer's but the number is expected to hit 13 million by 2050. The winning approval for Alzheimer's treatment could generate billions in sales and would also open the door for other biotech stocks wor...
Jun 07, 2021
View Article
Merck Completes Spinoff Of Organon & Co. Aiming To Create 2 patient-focused Companies
Reportedly, Merck & Co., Inc. (MRK) has completed the spinoff of Organon & Co. The spinoff aims to create two patient-focused companies with an enhanced strategic and operational focus, simplified operating models, improved agility, improved financial profiles, and optimized capital struct...
Jun 04, 2021
View Article
Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma at 2021 ASCO Annual Meeting
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today highlighted positive interim Phase 1 data from the Company’s FT516 program for patients with relapsed / refractory B-cell lymphom...
Jun 04, 2021
View Article
3M Partners Working With Pandemic Action Network To Prepare For Future Pandemics
Reportedly, 3M (MMM) and Pandemic Action Network have collaborated on programs to help curb the spread of COVID-19 and also announced a commitment to work together to help prepare for any future pandemics. 3M will combine its learnings and insights from the Pandemic Action Network (a coalition of m...
Jun 04, 2021
View Article
INmune Bio (NASDAQ: INMB) Confirms USAN Has Adopted “Pegipanermin” For XPro1595 – A Potential Treatment For Alzheimer’s
VP Watchlist Stock, INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, confirmed today via announcement that the United States Adopted Name Council (USAN) has adopted the name “Pe...
Jun 03, 2021
View Article
Merck & Sanofi Has Developed First Hexavalent Combination Vaccine Vaxelis™ In US
Reportedly, Merck & Co., Inc. (MRK) has developed a hexavalent combination vaccine Vaxelis™ in partnership with Sanofi Pasteur, the global vaccines business unit of Sanofi. Vaxelis will be widely available in the U.S. via traditional private and public channels, including directly from Sanof...
Jun 01, 2021
View Article
Amgen Lung Cancer Drug Sotorasib With Specific Mutation Gains FDA Approval
Reportedly, Amgen Inc.'s (AMGN) drug sotorasib for non-small cell lung cancer with a specific mutation in a gene known as KRAS in patients whose disease has worsened after treatment with chemotherapy or other medicines gained approval from the U.S. Food and Drug Administration. Sotorasib, to be sol...
May 31, 2021
View Article
Britain Authorizes Johnson & Johnson’s COVID-19 Vaccine For Use
Reportedly, Britain's medicine regulator has approved Johnson & Johnson's (JNJ) Janssen COVID-19 vaccine for use, making it the fourth COVID-19 vaccine to be approved in Britain. Britain had earlier approved vaccines made by Pfizer, AstraZeneca, and Moderna. The country reduced its order to 20 m...
May 29, 2021
View Article
GAVI Vaccine Alliance To Purchase 200M Doses Of Johnson & Johnson’s COVID-19 Vaccine
Reportedly, the GAVI Vaccine Alliance to buy 200 million doses of Johnson & Johnson's COVID-19 vaccine, as a major shortfall in the COVAX vaccine-sharing program is caused as India suspends vaccine exports. The country is fighting vaccine shortage and fails to fulfill its home demand as it fight...
May 26, 2021
View Article
Walgreens Boots Alliance Included 3BL Media’s Annual 100 Best Corporate Citizens
Reportedly, Walgreen Boots Alliance has been placed to 3BL Media’s annual 100 Best Corporate Citizens ranking, with outstanding ESG transparency (environmental, social, and governance) and strong performance among the 1,000 largest, publicly listed companies in the U.S. "Being a good corporate ...
May 26, 2021
View Article
Walgreens Reaches 20M COVID-19 Vaccinations- Expects Possible Rise In “More Normal” Cough & Cold Season
As per reports, Walgreen Boots Alliance (WBA) has administered more than 20 million COVID-19 vaccinations as of May 24 closer to the target of about 30 million shots this year. The company has also done more than 8 million COVID-19 tests, informed Walgreens senior vice president Rick Gates. On Marc...
May 25, 2021
View Article
JPMorgan Morgan Health In Washington DC With Deploying Up To $250M
As per reports, JPMorgan Chase & Co (JPM) announced details about Morgan Health, a new business venture focused on improving the efficiency, quality, and equity of employer-sponsored healthcare. The unit will be led by Dan Mendelson, CEO of Morgan Health. Mendelson will report to the Vice-Chair...
May 24, 2021
View Article
Walmart Health Enters Agreement To Acquire With Telehealth Provider MeMD
As per reports, Walmart Health has entered an agreement with MeMD, a multi-specialty telehealth provider. The agreement strengthens Walmart's commitment to integrated, omnichannel health delivery spread across data and technology to enhance engagement and outcomes. The partnership will allow Walmart...
May 09, 2021
View Article
3M Reports Strong Q12021 Earnings – Sees Higher Costs
Reportedly, 3M (MMM) posted strong profit and revenue estimates in the first quarter, as more and more people bought products to prevent potential coronavirus infections i.e. 3M's N95 masks and general cleaning equipment. Sales for the safety and industrial unit increased 13.7% to $3.3 billion for t...
May 03, 2021
View Article
Former Bristol-Myers Squibb (BMS) Cellular Therapy Development VP Appointed As Chief Medical Officer of NKcell Focused Cytovia Therapeutics
Cytovia Therapeutics aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer. Cytovia focuses on Natural Killer (NK) cell biology and applies precision engineering to induced pluripotent stem c...
Apr 29, 2021
View Article
Merck Reports Disappointing Profits In Q1
Merck & Co. Inc. (MRK) reports disappointing Q1 profit figures, hurt by the low demand for drugs that need to be administered at a doctor's office, as the pandemic fear continued. The company informed that two-thirds of its treatments and vaccines need to be administered by a doctor, usage of...
Apr 29, 2021
View Article
Amgen Reports Disappointing Q1 Earnings
Amgen (AMGN) reports disappointing q1 earnings, with earnings declining 12% to $3.70 per share. Sales dropped 4% to $5.9 billion. Amgen's highest selling, an inflammatory treatment called Enbrel reported $924 million, a 20% decline and missed forecasts for nearly $1.1 billion. The company noted sea...
Apr 29, 2021
View Article
Former Coca Cola & Uber Global Chief Marketing Officer Rebecca Messina Joins INVO Bioscience’s Board
It’s estimated that nearly 90% of couples in need of infertility treatment go without care! INVO Bioscience's (NASDAQ: INVO) mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase the availability ...
Apr 27, 2021
View Article
Merck Partners With Indian Generic Drugmakers For COVID-19 Drug Production & Access To Molnupiravi
Reportedly, Merck & Co., Inc. (MRK) has partnered with five Indian generic drugmakers, including Sun Pharmaceutical Industries Ltd & Cipla Ltd, to expand production and access to its experimental COVID-19 drug, molnupiravir. The partnership will allow the companies with licenses to supply...
Apr 27, 2021
View Article
Amgen Schedules To Report Q1 Financials Tuesday, April 27
As per reports, Amgen (AMGN) will announce its first-quarter financial results tomorrow, Tuesday, April 27, 2021, after the market closes. A conference call will be held with the investment community at 2:00 p.m. PT following the results. Robert A. Bradway, chairman, & CEO, along with the member...
Apr 26, 2021
View Article
Apple Launching COVID-19 Shots Program For Its Workers At Its Offices
Reportedly, Apple Inc. (AAPL) plans to launch a program to help its employees get voluntary COVID-19 vaccinations at its offices, along with collaboration with drugstore chain Walgreens Boots Alliance Inc as its vendor. The company to open a website for its workers to sign up for appointments, an Ap...
Apr 26, 2021
View Article
Cytovia Therapeutics Files New Provisional Composition of Matter Patent Applications for Natural Killer Cell Engager Multifunctional Antibodies (FLEX-NK®)
"Precision NK therapies have the potential to revolutionize cancer treatment with unsurpassed safety and efficacy. We are excited to bring NK Cell Engager antibodies and CAR-NK cell therapies to initial clinical trials starting in 2021, moving towards broad patient access to cancer-defeating cures...
Apr 23, 2021
View Article
Walgreens Boots Alliance Schedules Quarterly Dividend On June 11
As per reports, the Board of Walgreen Boots Alliance (WBA) has announced a quarterly dividend of 46.75 cents per share payable on June 11, 2021, to stockholders of record as of May 21, 2021. Walgreen Boots Alliance (WBA) is a pharmacy-led, health and well-being enterprise with a long history of tru...
Apr 23, 2021
View Article
RESOLVE: The National Infertility Association Gains Support From INVO Bioscience – The Providers of The Affordable Treatment Option- INVOcell
It’s estimated that nearly 90% of couples in need of infertility treatment go without care! Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure...
Apr 22, 2021
View Article
Greece To Start Johnson & Johnson Coronavirus Vaccinations Next Month
Reportedly, Greece starts the rollout of the Johnson & Johnson (JNJ) COVID-19 vaccine on May 5 after Europe's drug regulator backed its use, informed health authorities. “We expect decisions by the CDC and FDA on Friday and then by our national committee on vaccinations in the following day...
Apr 22, 2021
View Article
Johnson & Johnson Reports Strong Quarter Earnings- Increases Quarterly Dividend By 5 Cents
As per reports, Johnson & Johnson (JNJ) released its first-quarter earnings this week, reporting adjusted earnings of $2.59 per share and revenue of $22.32 billion, beating estimates of $21.98 billion. The company reported $100 million in sales for its COVID-19 vaccine, which was put on hold by ...
Apr 21, 2021
View Article
Amgen Completes Acquisition Of Five Prime Therapeutics
Reportedly, Amgen (AMGN) has successful completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics for $38 per share in cash. Five Prime Therapeutics is a clinical-stage biotechnology company working on developing immuno-oncology and...
Apr 20, 2021
View Article
INVO Bioscience & Lyfe Medical Partnering To Establish An INVOcell Clinic In The San Francisco Bay Area – (Affordable Infertility Treatment Option)
INVOcell is the first Intravaginal Culture (IVC) system granted FDA clearance in the United States, providing millions of infertile couples across the country access to this revolutionary infertility treatment. This novel device and procedure provides a more natural, safe, effectiv...
Apr 19, 2021
View Article
Kidney Disease Focused Precision Medicine Firm Chinook Therapeutics Presents 6 Posters At ISN World Congress of Nephrology
Chronic kidney diseases are a severe and growing worldwide problem with a lack of effective treatments often leading to dialysis, transplantation, and high costs to health care systems. In the U.S. alone, kidney diseases affect an estimated 37 million people and account for over $120 billion in an...
Apr 16, 2021
View Article
UnitedHealth Reports Q1 Earnings – Raises 2021 Earnings Guidance
UnitedHealth Group Incorporated (UNH) reported strong Q1 earnings, raising prior earning guidance for full-year 2021. The adjusted earnings per share increased 42.7% to $5.31. Revenue increased 9% to $70.2 billion, driven by 11% growth in revenue for the Optum health services division to $36.4 billi...
Apr 16, 2021
View Article
FDA Halts Usage Of Johnson & Johnson COVID-19 Vaccine, As Blood-Clot Reports Appear
Reportedly, the Food and Drug Administration has halted the use of the Johnson & Johnson (JNJ) coronavirus vaccine, after reports of blood clots in six recipients were reported, pushing Johnson & Johnson's stock down. All six cases occurred in women between the ages of 18 and 48 with sympto...
Apr 13, 2021
View Article
Johnson’s Covid Vaccine Under Review By EU Regulator After Blood Clots Reports Surface
As per reports, Johnson & Johnson’s (JNJ) Covid-19 vaccine is under review by the European Union’s drug regulator after four critical cases of unusual clots accompanied by low blood platelets were reported after taking the immunization with the J&J shot. The regulator is now investigatin...
Apr 12, 2021
View Article
UnitedHealth Group Appoints Brian Thompson As CEO For Its UnitedHealthcare Unit
Brian Thompson has been named as the Chief Executive Officer of UnitedHealthcare, the health benefit unit of UnitedHealth Group (UNH), as per reports. Thompson joined UnitedHealth Group in 2004 and recently served as CEO of UnitedHealthcare's government programs including the Medicare & Retireme...
Apr 09, 2021
View Article
Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway
Sometimes called “compassionate use,” expanded access is a potential pathway for a patient with serious disease or condition, or an immediately life-threatening condition, to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical t...
Apr 08, 2021
View Article
Walgreens-Backed Primary Healthcare Provider, VillageMD Prepares For IPO
As per reports, VillageMD, backed by Walgreen Boots Alliance (WBA) is preparing to go public in the U.S. in an IPO. Founded in 2013, VillageMD, a primary healthcare provider plans to raise more than $500 million in a listing that is expected to happen in the third quarter. The IPO could raise as muc...
Apr 08, 2021
View Article
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today provided a business update and reported financial results for the full year ended December 31, 2020. “We are executi...
Apr 07, 2021
View Article
Merck Acquires Pandion Therapeutics
As per reports, Merck & Co., Inc. (MRK) has completed the acquisition of Pandion Therapeutics, Inc, for all of the outstanding shares of the common stock of Pandion Therapeutics, Inc at $60 per share through a subsidiary after successful completion of the cash tender offer. Pandion is set to bec...
Apr 07, 2021
View Article
Johnson & Johnson Now In-Charge Of COVID-19 Vaccine Production At Baltimore Plant After 15 Million Doses Spoil
Reportedly, The U.S. Department of Health and Human Services has put Johnson & Johnson (JNJ) in charge of the Emergent BioSolutions facility in Baltimore that ruined 15 million doses of its COVID-19 vaccine. The incident has stopped British drugmaker AstraZeneca Plc from using the facility and w...
Apr 07, 2021
View Article
3M Launches New Silicone Adhesive
Reportedly, 3M (MMM) announced its latest addition to a new class of silicone adhesives that balances strength, flexibility, and comfort, the 2484 3M™ Single Coated Medical Film Tape with Hi-Tack Silicone Adhesive on Liner. The adhesive is breathable, comfortable, and enables up to a seven-day wea...
Apr 07, 2021
View Article
Amgen Announces Acquisition Of Rodeo Therapeutics Corporation
As per reports, Amgen Inc. (AMGN) has reached an agreement to acquire Rodeo Therapeutics Corporation, a Seattle-based privately-held biopharmaceutical company that develops small-molecule therapies focused to promote the repair and regeneration of multiple tissues. As per the terms of the deal, Amg...
Apr 07, 2021
View Article
INVO Bioscience, Inc. (Nasdaq: INVO) Reports Yearend Financial Highlights & Recent Operational Highlights Financial Highlights
On March 30, 2021 INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, announced its financial results for the year e...
Mar 31, 2021
View Article
Chinook Therapeutics’ Upcoming Data Presentations at ISN World Congress of Nephrology 2021 and 58th ERA-EDTA Congress
Chinook Therapeutics, Inc. (NASDAQ: KDNY) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. Chinook’s product candidates are being investigated in rare, severe chronic kidney disorders with opportunities for well-defined clinical pathways. Chino...
Mar 31, 2021
View Article
Atossa Therapeutics (ATOS) Financial Results & Key Developments For The Fiscal Year Ended December 31, 2020
Today, Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, announced financial results for the fiscal year ended ...
Mar 31, 2021
View Article
Merck’s Spinoff Unit Organon To Acquire Alydia Health – Medical Device Co. Focused on Preventing Maternal Mortality
As per reports, Merck & Co., Inc.(MRK) Inc. has entered into a definitive agreement with Alydia Health, following the spinoff of its women’s health under the new company, Organon. Organon, a global healthcare company will acquire Alydia Health, focusing on improving the overall health of women...
Mar 31, 2021
View Article
Walgreens Beats Q2 Estimates – Raises 2021 Profit Forecast
As per reports, Walgreen Boots Alliance (WBA) reported its second-quarter earnings this week beating estimates and reporting an 8.4% rise in quarterly profit due to higher sales at its pharmacy stores in the U.S. and the UK. The retailer reported a 4.5% increase in its same-store sales at its U.S. ...
Mar 31, 2021
View Article
VISTA ALERT: INVO Bioscience (NASDAQ: INVO) Releasing Results After Market Close Today! – Conference Call 4:30pm ET
INVO Bioscience, Inc.(NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, will report financial results for its fourth quarter and fis...
Mar 30, 2021
View Article
Immune Monitoring Technology Firm Aditxt Prepares Therapeutic Program For Psoriasis For First-In-Human Clinical Trials
Mountain View, California-based Aditx Therapeutics (NASDAQ: ADTX) is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The Company's immune monitoring technology is designed to provide a personalized comprehensive ...
Mar 29, 2021
View Article
INVIMA Confirms Johnson & Johnson’s One Shot Covid-19 Vaccine Shot Receives Approval For Emergency Use In Columbia
Reportedly, Colombia has approved the emergency use of Johnson & Johnson's (JNJ) one-shot COVID-19 vaccine, informed the director of food and drug regulator INVIMA. The government has entered an agreement to buy 9 million doses of J&J's one-shot vaccine. "In its capacity as regulator, INV...
Mar 26, 2021
View Article
Rebecca Herron, A Woodway Woman, Inspires Others With Her Breast Cancer Journey Through Photo Shoot
Rebecca Herron of Woodway, 52, shares her journey of her battle with breast cancer seeking to inspire many to stay strong and positive. After two months of diagnosis, Herron started her fight with the potentially deadly disease through chemotherapy. She chose to portray her journey with a series of ...
Mar 25, 2021
View Article
UnitedHealth Group Announces Q1 Earnings Release Date
Reportedly, the UnitedHealth Group (UNH) will announce its first-quarter 2021 financial results on Thursday, April 15, 2021, before the stock market opens. The company to host a teleconference at 8:45 a.m. ET to discuss and review the results with analysts and investors. The call will be available...
Mar 24, 2021
View Article
Atossa Therapeutics Adds $50M Via Registered Direct Offering On Monday!
Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19. On March 11, 2021 announced the FDA has issued a “Saf...
Mar 22, 2021
View Article
EMA Issues Warnings Against The Use Of Merck’s Anti-Parasite Drug For COVID-19
As per reports, the European Medicines Agency has issued warnings against the use of ivermectin, Merck & Co's (MRK) anti-parasite drug for the prevention or treatment of COVID-19 outside clinical trials. A similar warning was also issued from the U.S. Food and Drugs Administration stating, as p...
Mar 22, 2021
View Article
Johnson & Johnson COVID-19 Vaccine Approved For Use In Switzerland
Reportedly, Swiss drug regulator Swissmedic has approved Johnson & Johnson's (JNJ) COVID-19 vaccine for usage in the country, following the earlier two approved vaccines from Pfizer and BioNTech and from Moderna. Switzerland has so far not ordered J&J's one-shot vaccine, while deliveries hav...
Mar 22, 2021
View Article
Johnson & Johnson’s Multiple Sclerosis Treatment Drug Secures FDA Approval – Launching April 2021
Reportedly, FDA has approved Johnson & Johnson’s (JNJ) Ponvory, as a daily oral drug to treat relapsing forms of multiple sclerosis MS. The drug is expected to launch in early April 2021, entering a market currently dominated by big names like Novartis’ Kesimpta, Roche’s Ocrevus, and Gilen...
Mar 22, 2021
View Article
Johnson & Johnson COVID-19 Vaccine Gains Approval From Italy’s Medicines Agency For Usage
Reportedly, AIFA, Italy's medicines agency has approved the use of the single-dose COVID-19 vaccine produced by Johnson & Johnson following approval from the European drugs regulator last week. The J&J's vaccine approval marks fourth to be allowed for use in the European Union after vaccines...
Mar 16, 2021
View Article
PROGRESS REPORT: INVO Biosciences Signs JV Agreement To Open 1st U.S. INVOcell-Exclusive Clinic
The infertility population in the U.S. is large and significantly underserved. Currently, it is estimated that more than 90% of the patients who need advanced fertility treatment are unable access it. - Dr. Karen Hammond INVO Bioscience, Inc. (NASDAQ: INVO) is a medical device company focused on...
Mar 16, 2021
View Article
Merck Stocks Rise As Its Oral Antiviral Treatment Shows Promising Results
Reportedly, Merck & Co., Inc. (MRK) stocks soared after its Ridgeback Biotherapeutics-partnered Covid-19 treatment known as molnupiravir displayed promising results in an interim analysis of a Phase 2. Merck stock recently slipped this year after the company scrapped the development of two "i...
Mar 10, 2021
View Article
PROGRESS REPORT: INVO Bioscience & Ferring Pharma Agree For Increase Of INVO Company-Owned U.S. Clinics
INVO Bioscience, Inc.'s (NASDAQ: INVO) INVOcell® is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and In...
Mar 08, 2021
View Article
Amgen Buys Five Prime Deal For $1.9B Boosting Its Cancer Pipeline
As per reports, Amgen Inc. (AMGN) will buy Five Prime Therapeutics Inc. for $1.9 billion in cash that will add new cancer therapies to the pharmaceutical giant’s pipeline. Amgen will pay $38 a share for Five Prime, the transaction is expected to close by the end of the second quarter. South San F...
Mar 08, 2021
View Article
AstraZeneca-Amgen Asthma Drug Shows Promising Results
Reportedly, Amgen's (AMGN) and AstraZeneca's (AZN) experimental drugs have proven to reduce asthma attacks in patients with uncontrolled and severe forms of the respiratory condition in a large study. The medicine, tezepelumab, cut the rate of asthma attacks by 56% among patients when compared to p...
Mar 04, 2021
View Article
iPSC-Derived Cell Therapy Firm, Century Scores Casdin Capital Led $160M Series C Financing
Philadephia-based Century Therapeutics reports to be harnessing the power of adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first-generation cell therapies. Their genetically engineered, iPSC-derived iNK and iT cell products are said to be desi...
Mar 03, 2021
View Article
Walgreens Boots Alliance To Release Fiscal 2021 Q2 Earnings On March 31, 2021
As per reports, Walgreens Boots Alliance, Inc. will announce its fiscal 2021 second-quarter earnings results on Wednesday, March 31, 2021, at 7 a.m. Eastern time. The release will be followed by a one-hour conference call with the management beginning at 8:30 a.m. Eastern time. The conference call c...
Mar 03, 2021
View Article
Merck To Assist In Production Of J&J’s Single-Dose COVID-19 Vaccine, Snags Funds From BARDA To Expand Facilities
Reportedly, Merck & Co., Inc. (MRK) has entered into multiple agreements to expand and support the manufacturing capacity and supply of SARS-CoV-2/COVID-19 medicines and vaccines. BARDA, the Biomedical Advanced Research and Development Authority, a unit of the Office of the Assistant Secret...
Mar 03, 2021
View Article
TRIBE INVITATION: “Advancing A Unique Broad-based Vaccine Approach To Fighting COVID-19, Ebola & Beyond!”
You are cordially invited to join me at our sister organization's Tribe Public Webinar Presentation and Q&A Event which will be held today, Wednesday, March 3 (8:30 am PT/ 11:30 am ET). Tribe Public's (www.tribepublic.com) complimentary worldwide webinars are efficient 30-minute events that seek...
Mar 03, 2021
View Article
Mexico’s COFEPRIS Approves The Importation of INVO Bioscience’s INVOcell, An Effective & Affordable Alternative To IVF
COFEPRIS or the Federal Committee for Protection from Sanitary Risks (Comisión Federal para la Protección contra Riesgos Sanitarios) is the department within the Mexican Secretariat of Health that deals with the importation of medical devices and issues advertising permits for...
Mar 02, 2021
View Article
NKCell Firm Cytovia Therapeutics Announced The Opening of New Boston R&D Center of Excellence & cGMP Manufacturing Facility
Chimeric Antigen Receptors (CAR) are fusion proteins that combine an extracellular antigen recognition domain with an intracellular co-stimulatory signaling domain. Natural Killer (NK) cells are modified genetically to allow insertion of a CAR. CAR-NK cell therapy has demonstrated initial clinical r...
Mar 02, 2021
View Article
VP WATCHLIST PROGRESS REPORT: Chinook Therapeutics (KDNY), INVO Bioscience (INVO), PLUG Power (PLUG)
The VP Watchlist currently contains 10 coverage companies that we believe deserve consideration for short term and long term portfolio additions. Here are today's updates on 3 of the companies from the list. Chinook Therapeutics, Inc. (NASDAQ: KDNY) ($17.23, +4.17%) and Evotec SE today announc...
Mar 01, 2021
View Article
FDA Approves Johnson & Johnson Single-Dose Covid-19 Vaccine Shot For Use In The U.S
As per reports, the Food & Drug Administration has given clearance to Johnson & Johnson (JNJ) Covid-19 one-shot vaccine giving the U.S its third vaccine to prevent the pandemic. Health officials have been waiting for a one-dose option instead of two to help fasten the vaccination drive, as t...
Mar 01, 2021
View Article
PROGRESS REPORT: Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19
Today, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases, with a current focus on breast cancer and COVID-19, announced final results...
Feb 25, 2021
View Article
UnitedHealth Group Board Announces Cash Dividend, Payable On March 23
As per reports, the board of the UnitedHealth Group (UNH) has announced a cash dividend of $1.25 per share to all common stock shareholders as of March 15, 2021. The dividend is to be paid on March 23, 2021. Dow 30 component UnitedHealth Group Incorporated (UNH) operates as a diversified health and...
Feb 25, 2021
View Article
NK Cell Firm Fate Therapeutics Reports Q4 & Full Year Results While Confirming ‘2020 Was A Pivotal Year’
San Diego-based Fate Therapeutics (NASDAQ: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. The Company has established a leadership position in the clinical development and manufacture of universal...
Feb 24, 2021
View Article
Johnson & Johnson Submits Covid-19 Vaccine Data To World Health Organization For Emergency Use Listing
As per reports, Johnson & Johnson (JNJ) has submitted data to the World Health Organization (WHO) for emergency use listing of its single-dose COVID-19 vaccine, allowing wider access. The healthcare giant informed that an emergency use listing is mandatory for supplying vaccines to the COVAX va...
Feb 23, 2021
View Article
San Diego-Based Fate Therapeutics To Host Q4/Full Year 2020 Earnings & Corporate Update Conference Call Wednesday, February 24, 2021
San Diego-based Fate Therapeutics, Inc. (NASDAQ: FATE) has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno-oncology product can...
Feb 19, 2021
View Article
Iowa Withdraws From Microsoft’s COVID-19 Vaccine Scheduling Software Deal
As per reports, Iowa is backing out of a plan to use Microsoft Corp. (MSFT) software for registering and scheduling patients for the Covid-19 vaccinations. Iowa Governor Kim Reynolds announced the news at a conference, this week. He said state officials concluded it would be too hard to combine exis...
Feb 18, 2021
View Article
TALEN® Gene-Edited iPSC-Derived Natural Killer Cells To Be Developed By Cytovia Therapeutics & Cellectis (NASDAQ: CLLS) Partnership
Chimeric Antigen Receptors (CAR) are fusion proteins that combine an extracellular antigen recognition domain with an intracellular co-stimulatory signaling domain. Natural Killer (NK) cells are modified genetically to allow insertion of a CAR. CAR-NK cell therapy has demonstrated initial clinical r...
Feb 16, 2021
View Article
PROGRESS REPORT: NeuBase Therapeutics (NBSE) Reports Financial Results for Q1 Fiscal Year 2021
Pittsburgh-based NeuBase Therapeutics (NASDAQ: NBSE) is a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines which have been shown to be able to increase, decrease and change gene function, as appropriate, to resolve causal genetic defects in living sy...
Feb 12, 2021
View Article
A Letter From Atossa Therapeutics (NASDAQ: ATOS) President and CEO Dr. Steven C. Quay M.D., Ph.D.
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases, with a current focus on breast cancer and COVID-19. Atossa Therapeutics (NASDAQ: ATOS) P...
Feb 10, 2021
View Article
Amgen Releases Q4 Earnings – Lowers 2021 Outlook Below Estimates
U.S. biotech, Amgen (AMGN) announced a higher-than-expected profit for the fourth quarter reporting adjusted earnings per share of $3.81 beating the analyst estimate by 41 cents. Net profit for the quarter dropped 3% to $2.76 per share. Revenue increased 7% to $6.6 billion. Sales of rheumatoid arthr...
Feb 08, 2021
View Article
UnitedHealthcare Enters The Oklahoma Medicaid Market With SoonerSelect
Reportedly, the Oklahoma Health Care Authority has selected the UnitedHealthcare (UNH) Community Plan of Oklahoma to administer SoonerSelect, its statewide Medicaid program starting later this year. UnitedHealthcare will work with the state offering self-management care solutions and improving the ...
Feb 08, 2021
View Article
Johnson & Johnson COVID-19 Vaccine Awaits FDA Authorization
Reportedly, Johnson & Johnson (JNJ) has submitted its single-shot coronavirus vaccine for emergency use with the Food and Drug Administration for authorization. If authorized, the company plans to supply the U.S. with 100 million doses in the first half of 2021, also it expects to begin shipment...
Feb 07, 2021
View Article
FDA Grants Rare Pediatric Disease Designation to Precision Medicine Firm Chinook Therapeutics’ CHK-336 For Primary Hyperoxaluria (PH)
Hyperoxalurias, including PH, are diseases caused by excess oxalate, a potentially toxic metabolite typically filtered by the kidneys and excreted as a waste product in urine. Symptoms of PH include recurrent kidney stones, severe pain, blood in the urine and urinary tract infections; which when...
Feb 04, 2021
View Article
Salesforce To Launch Vaccine Cloud To Assist COVID-19 Vaccination Drive
As per reports, Salesforce Inc. (CRM) will launch Vaccine Cloud to assist healthcare providers and the government to globally record, manage, maintain records of COVID-19 vaccinations digitally. The vaccine Cloud will assist people to register and schedule for their vaccine shots, share their vaccin...
Feb 04, 2021
View Article
Breast Cancer & COVID-19 Focused Atossa Therapeutics Receives Another $21M & Presenting Feb.2 At Tribe Public
Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that it has received $21 million from the exercise of outs...
Jan 29, 2021
View Article
NeuBase Therapeutics’ Acquisition Of Gene Modulating Technology Believed To Extend Ability Of Existing Tech Platform To Directly Modulate The Human Genome
Today, Pittsburgh-based NeuBase Therapeutics, Inc. (Nasdaq: NBSE), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines to drug the genome, announced the execution of a binding agreement to acquire infrastructure, programs and intellectual property for...
Jan 28, 2021
View Article
Highlights From Johnson & Johnson’s Q4 Earnings Release
Johnson & Johnson (JNJ) reported their Q4 earnings and revenue numbers which exceeded market estimates, reporting EPS of $1.86 per share versus $1.82 expected and revenue of $22.48 billion versus $21.67 billion expected. The company’s pharmaceutical unit, also working on a coronavirus vacci...
Jan 27, 2021
View Article
3M Beats Q4 Estimates On Shoulders of Health-Care Division During The Covid-19 Pandemic
3M (MMM) reported better than expected Q4 earnings recently, driven by an increase in demand for its healthcare products during the Covid-19 pandemic. The company’s health-care unit recorded 12.3% in 2020 due to high consistent demand for its disposable respirators and safety products such as hand...
Jan 26, 2021
View Article
Atossa Therapeutics CEO Dr. Steven C. Quay & Anthony S. Fauci, MD, Director NIAID to Speak at Precision Medicine World Conference January 25-27, 2021 – “Development of New SARS-CoV-2 Therapeutics”
Seattle-based Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced today that Dr. Steven C. Quay, MD., Ph.D., P...
Jan 25, 2021
View Article
UnitedHealth Reports High Profits, Exceeds Expectations On Lower Medical Costs Amid Covid-19 Pandemic
UnitedHealth Group Incorporated (UNH) released better than expected quarterly earnings this week, reporting adjusted earnings of $2.52 per share while beating Wall Street estimates by 11 cents, as per reports. Health insurers incurred lower healthcare costs, for much of 2020 as people avoided docto...
Jan 25, 2021
View Article
You Are Cordially Invited To Tribe Public’s FREE Webinar Event “ALIGNed in the Fight Against Kidney Diseases” -Tuesday, January 26th (Meet Eric Dobmeier, CEO of Chinook Therapeutics (KDNY)
You are cordially invited to attend the next Tribe Public FREE Webinar Presentation and Q&A Event titled "ALIGNed in the Fight Against Kidney Diseases." The event will be co-hosted by yours truly, John F. Heerdink, Jr., managing member fo Tribe Public and Vista Partners and Eric Dobmeier, Pre...
Jan 25, 2021
View Article
INVO Bioscience Seeks To Expand Access To Infertility Care With INVOcell In The Fifth Most Populous Country In The World, Pakistan, With ~212 million People
Sarasota-based INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, recently announced it has entered an exclu...
Jan 23, 2021
View Article
Microsoft, Oracle, Cigna, Mayo Clinic , etc. Forming Coalition To Digitally Track Covid-19 Vaccinations
Reportedly, Tech giants Microsoft Corp (MSFT) & Oracle Corp, and healthcare companies Cigna Corp and the Mayo Clinic are part of an alliance working to help people get encrypted digital copies of their immunization records stored in a digital wallet of their choice under the project called Vacci...
Jan 17, 2021
View Article
Cytovia Therapeutics Partners with National Cancer Institute to Develop Novel Gene-Edited, iPSC-Derived GPC3 CAR NK Cells for the Treatment of Solid Tumors
Chimeric Antigen Receptors (CAR) are fusion proteins that combine an extracellular antigen recognition domain with an intracellular co-stimulatory signaling domain. Natural Killer (NK) cells are modified genetically to allow insertion of a CAR. CAR-NK cell therapy has demonstrated initial clinical r...
Jan 14, 2021
View Article
Amgen Announces Seven-Year Environmental Sustainability Plan
As per reports, Amgen (AMGN) has announced its new seven-year environmental sustainability plan 2027 with a commitment to achieve carbon neutrality along with a reduction in water use by 40% and waste disposal by 75%. Since 2007, Amgen has achieved a 33% reduction in carbon emissions, a 30% reducti...
Jan 13, 2021
View Article
Disneyland Creating A Super Point-Of-Dispensing (POD) For Mass COVID-19 Vaccination In Orange County
Reportedly, Walt Disney Co's (DIS) Disneyland which has been closed since March 2020 will become the first largest Super Point-of-Dispensing (POD) sites to provide COVID-19 vaccinations in Orange County, California. The facility is expected to host the operations later this week, informed government...
Jan 12, 2021
View Article
Walgreens Tops Earning Estimates, Assisted By Strong Pharmacy Sales
Walgreen Boots Alliance (WBA) reported its fiscal Q1 earnings, beating Wall Street estimates driven by strong pharmacy sales. Earning highlights for the first quarter ending November, 30: Adjusted EPS of $1.22 cents per share was reported, versus $1.03 expected. Revenue of $36.31 billion was ...
Jan 09, 2021
View Article
Johnson & Johnson Announces Q1 2021 Dividend Date
Reportedly, the Board of Johnson & Johnson (JNJ) has declared a cash dividend of $1.01 per share payable on March 9, 2021, to shareholders of common stock and of record at the close of business on February 23, 2021. Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused ...
Jan 08, 2021
View Article
Key Developments & Future Initiatives Position INVOcell® Within the Severely Underserved Fertility Market
Good morning! I hope that all of you are having a great start to your day here in the states or if I am reaching you across the world then hopefully your evening is treating you well too. I wanted to make sure that you were aware that INVO Bioscience, Inc. (NASDAQ: INVO) ($2.99/share, $28.59M ...
Jan 08, 2021
View Article
Atossa Therapeutics Announces Pricing of $25.2 Million Registered Direct Offering Priced At-The-Market
Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS) , a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced today that it has entered into a securitie...
Jan 07, 2021
View Article
United Health’s OptumInsight & Change Healthcare Joining Forces To Implement Modern Information & Technology-Enabled Health Care Platform
Reportedly, Optum, a diversified health services company and part of UnitedHealth Group (UNH), and Change Healthcare, a health care technology leader have agreed to come together to improve and upgrade healthcare services for everyone. Change Healthcare will join with OptumInsight to provide technol...
Jan 07, 2021
View Article
AmerisourceBergen Corp Agrees To Purchase Walgreens Boots Alliance Inc.’s Pharmaceutical Business
Reportedly, AmerisourceBergen Corp. (ABC) will purchase Walgreens Boots Alliance Inc.’s (WBA) pharmaceutical wholesale businesses for about $6.5 billion in cash and stock, extending its reach in Europe. The deal includes $6.275 billion in cash and 2 million in shares. Walgreens and AmerisourceBerg...
Jan 06, 2021
View Article
Columbia Enters Deal With Janssen For 9M COVID-19 Vaccine Doses
As per reports, Columbia has signed an agreement with Janssen, Johnson & Johnson's (JNJ) pharmaceutical division to acquire 9 million doses of coronavirus vaccines. Columbia with over 1.6 million cases of coronavirus and 43,000 deaths, had earlier secured deals with Pfizer and AstraZeneca Plc t...
Dec 31, 2020
View Article
AstraZeneca & Merck LYNPARZA®Receives Three New Advanced Cancer Approvals In Japan
As per reports, AstraZeneca and Merck’s (MRK) LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate, and pancreatic cancer. The approvals authorize LYNPARZA for use as maintenance treatment after first-line chemotherapy for the above cancers. Th...
Dec 31, 2020
View Article
Amgen’s Sotorasib Submitted For Marketing Authorization Application In Europe
Reportedly, Amgen has submitted Marketing Authorization Application to the European Medicines Agency (EMA) for sotorasib, an investigational KRASG12C inhibitor for patients previously treated non-small-cell lung cancer (NSCLC) with the KRAS G12C Mutation. The submission is backed by positive Phase ...
Dec 28, 2020
View Article
Merck Enters Supply Agreement With U.S. Government For Investigational Biological Therapeutic, MK-7110 For Severe & Critical COVID-19
Reportedly, Merck & Co., Inc. (MRK) has entered an agreement with the United States Government development, manufacture, and initial distribution of an investigational biological therapeutic, MK-7110 upon approval or Emergency Use Authorization from the U.S. Food and Drug Administration (FDA)....
Dec 25, 2020
View Article
Honeywell Dives Deeper Into Life Sciences Expansion With $1.3B Acquisition Of Sparta Systems
As per reports, Honeywell to acquire privately-held Sparta Systems, a leading provider of enterprise quality management software including a next-generation SaaS platform for the life sciences industry for $1.3 billion in an all-cash transaction from New Mountain Capital. The acquisition will streng...
Dec 23, 2020
View Article
Walgreens To Administer Pfizer’s COVID-19 Vaccine In Long-Term Care Facilities
Reportedly, Walgreen Boots Alliance (WBA) plans to administer Pfizer’s COVID-19 vaccine to approximately 3 million residents and staff in 35,000 long-term care facilities as part of the Centers for Disease Control and Prevention Program for long-term care program. The pharmacists are providing the...
Dec 19, 2020
View Article
AstraZeneca Agrees To Buy Rare Disease Firm Alexion For $39B Expanding Its Immunology Portfolio
As per reports, AstraZeneca (AZN) a leading Covid-19 vaccine developer and large multinational pharmaceutical firm has agreed to buy Boston-based biotechnology firm Alexion (ALXN) for $39 billion strengthening its position in immunology and rare diseases. Alexion shareholders will receive $60/share...
Dec 13, 2020
View Article
Merck ‘s KEYTRUDA® Gains Positive Committee for Medicinal Products for Human Use of the European Medicines Agency Approval
Merck & Co., Inc. (MRK) known as MSD outside the United States and Canada recently announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has released a positive opinion for the approval of KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for th...
Dec 13, 2020
View Article
Walgreens To Announce Fiscal 2021 First Quarter Earnings On Thursday, January 7, 2021
Reportedly, Walgreen Boots Alliance (WBA) is scheduled to announce its fiscal 2021 first-quarter earnings results on Jan. 7, 2021, Thursday at 7 a.m. ET. The release will be followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. For interested parties, the conference ...
Dec 11, 2020
View Article
UnitedHealth Partners With Lilly To Launch The Study Of Its COVID-19 Antibody Treatment
As per reports, UnitedHealth Group Incorporated (UNH) and Drugmaker Eli Lilly & Co and have come together to conduct a study of Lilly's COVID-19 antibody treatment bamlanivimab in patients who are at risk of becoming severely infected such as those over the age of 65 or the ones suffering from o...
Dec 10, 2020
View Article
Mexico May Order 22 Million Additional COVID Vaccine Doses From J&J
As per reports, Mexico could order an additional 22 million doses of coronavirus vaccine from Johnson & Johnson's Janssen unit, signed under a memorandum of understanding giving it the option of ordering additional doses, informed the Deputy Health Minister Hugo Lopez-Gatell. Recently, Mexico be...
Dec 09, 2020
View Article
8k Reveals That Atossa Therapeutics (ATOS) Has Entered Into An Agreement with Dana-Farber Cancer Institute, Inc.
An 8k was filed today at sec.gov by Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19 (website: www.atossatherapeuti...
Nov 30, 2020
View Article
An Interesting Argument Surfaces For Treating Coronavirus Patients Prior To Requiring Hospitalization
Recently, the Wall Street Journal published an interesting article expressing the argument that our healthcare system would be "less burdened" if coronavirus patients were treated prior to requiring hospitalization and suggesting that their are therapeutic options that patients can take themselves ...
Nov 30, 2020
View Article
Merck To Buy Privately-held, Clinical-stage Biopharmaceutical Company OncoImmune Adding To Suite Of Clinical Programs For SARS-CoV-2/COVID-19
As per reports, Merck & Co., Inc. (MRK) to acquire a privately-held, clinical-stage biopharmaceutical company, OncoImmune in a definitive agreement where Merck, will acquire all outstanding shares of OncoImmune for an upfront payment of $425 million in cash through a subsidiary. OncoImmune sha...
Nov 30, 2020
View Article
UnitedHealth Group To Hold Its Annual Investor Conference On December 1
Reportedly, UnitedHealth Group Incorporated (UNH) is scheduled to hold its annual Investor Conference virtually with analysts and institutional investors starting at 9:00 a.m. ET on Tuesday, December 1, 2020. The senior leaders will discuss the company’s progress in regards to the development of t...
Nov 30, 2020
View Article
Walgreen Boots Alliance Introduces 30-Minute Pickup
As per reports, Walgreen Boots Alliance (WBA) offers 30 minutes pick-up from placing an online order for health and wellness products from its stores under its loyalty program which has more than 100 million members in addition to at-home delivery and discounts on prescription drugs. Earlier this w...
Nov 24, 2020
View Article
Global Infertility Industry Focused Medical Device Firm INVO Bioscience Makes Strategic Move To Add Scientific Advisory Board
Sarasota-based INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO") is an innovative medical device company developing solutions for the global infertility industry. INVO's goal is to increase access to care and expand fertility treatment across the globe while seeking to lower the cost and increase the av...
Nov 19, 2020
View Article
Johnson & Johnson Broadens Relationship With Biomedical Advanced Research and Development Authority With Regards To Phase 3 Of COVID-19 Vaccine Candidate
Reportedly, Johnson & Johnson (JNJ) has expanded its partnership with the Biomedical Advanced Research and Development Authority (part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services) under its Janssen Pharmaceutic...
Nov 16, 2020
View Article
Amgen, AstraZeneca Experimental Asthma Drug Shows Promise
Reportedly, Drugmakers Amgen Inc. (AMGN) and AstraZeneca Plc (AZN) announced that a crucial trial found that their experimental medication tezepelumab largely reduced asthma attacks for people suffering from severe forms of the respiratory condition compared to a placebo. The patients were also rece...
Nov 13, 2020
View Article
INVO Bioscience Announces Pricing of Follow-on Public Offering & Listing on the NASDAQ Capital Market
Thursday after the markets closed, INVO Bioscience, Inc. (Nasdaq: INVO) developers of INVOcell®, the world's only in vivo Intravaginal Culture System, announced the pricing of an underwritten public offering of 3,625,000 shares of its common stock at a public offering price of $3.20 per share. Th...
Nov 13, 2020
View Article
As The Coronavirus Pandemic Surges Pfizer’s Vaccine Gives Hope, Eli Lilly’s Antibody Gets FDA Emergency Use Nod & Atossa’s Nasal Spray Trial Progresses
The coronavirus pandemic continues to surge across the world. On Tuesday, it was reported that 51.2M cases have been recorded where 33.5M people have recovered and 1.27M people have died worldwide. In the US, we now have recorded 10.2M cases and ~239k Americans have died from the coronavirus. ...
Nov 11, 2020
View Article
Merck Enters Acquisition Deal With VelosBio To Improve Oncology Pipeline
Reportedly, Merck & Co., Inc. (MRK) and VelosBio Inc have entered a definitive agreement under which Merck, will acquire all outstanding shares of VelosBio for $2.75B in cash through a subsidiary, subject to certain customary adjustments. VelosBio, a private owned clinical-stage biopharmaceut...
Nov 06, 2020
View Article
UnitedHealth Group Announces Cash Dividend
Reportedly, the board of UnitedHealth Group Incorporated (UNH) has announced a cash dividend of $1.25 per share payable on December 15, 2020, to all common stockholders as of the close of business on December 7, 2020. Dow 30 component UnitedHealth Group Incorporated (UNH) operates as a diversified ...
Nov 05, 2020
View Article
Merck Beats Q3 Expectations & Raises Outlook As Keytrada Sales Drive
As per reports, Merck & Co., Inc. (MRK) reported Q3 profits last month performing ahead of market estimates, as it expects the majority of the blow from the ongoing Covid-19 pandemic to now be behind it. Merck earned $1.74 per share, beating analysts’ average estimates of $1.44 per share. S...
Nov 05, 2020
View Article
Natural Killer (NK) Cell-based Immunotherapy Firm Kiadis Reaches Buyout Agreement With Sanofi (SNY)- Who’s Next?
Recently, natural killer (NK) cell-based immunotherapy has emerged as a promising therapeutic approach for solid tumors and hematological malignancies. NK cells are innate lymphocytes with an array of functional competences, including anti-cancer, anti-viral, and anti-graft-vs. -host disease potenti...
Nov 02, 2020
View Article
Pfizer Reports Declining Sales For Third-Quarter, Narrows Yearly Earnings Range
As per reports, Pfizer (PFE) released Q3 earnings recently, reporting sales of $12.13B and EPS of 72 cents per share. The analysts were expecting EPS of 69 cents per share on $12.3 billion in sales. The company narrowed its yearly earning guidance to $2.88-$2.93 a share on revenue of $48.8 billion ...
Nov 02, 2020
View Article
Dr. Quay Publishes Paper Documenting That SARS-CoV-2 Pandemic Began at General Hospital of Central Theater Command of People’s Liberation Army
A paper was published recently on Zenodo (DOI 10.5281/zenodo.4119263) by Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. (NASDAQ: ATOS), which illuminates new scientific observations and conclusions documenting that the SARS-CoV-2 pandemic began at...
Oct 28, 2020
View Article
PROGRESS REPORT: Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID-19
With the soaring numbers of worldwide coronavirus cases being reported daily with no viable vaccine realistically up for near term approval we need to find better solutions to treat patients that are infected. Recently, Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopha...
Oct 28, 2020
View Article
Amgen Reports Q4 Earnings- Lowers 2020 Earnings Guidance
U.S. biotechnology company, Amgen (AMGN) reported Q4 earnings this week, reporting a 2% drop in product sales due to competition from lower-cost generic drugs and biosimilars. Earnings Highlights: Sales for the quarter totaled $5.88 billion. Total revenue dropped 1% to $6.2 billion, ahead of ...
Oct 28, 2020
View Article
United Health Foundation Offers $2M Grant To Support Family First Health’s Federally Qualified Health Center
Reportedly, The United Health Foundation has partnered for a three-year $2M grant with Family First Health’s Federally Qualified Health Center at Hannah Penn K-8 school. The partnership is aimed to improve access to health care for children and families and serving vulnerable populations in the K...
Oct 27, 2020
View Article
Walgreens Includes Covid Testing Facility For Children Age 3 & Older
Reportedly, Walgreen Boots Alliance (WBA) has included testing sites for those aged 3 and older, previously testing was available to 18 years and above. Parents and Guardians can reach at Walgreens.com/COVID19Testing to schedule a test for the child along with electric consent and parents are also r...
Oct 26, 2020
View Article
Johnson & Johnson Announces Q3 Earnings, Raises Full-Year Guidance
As per reports, Johnson & Johnson (JNJ) reported Q3 earnings recently, beating Wall Street’s estimates. Earning Highlights: Adjusted earnings of $2.20 per share was reported, higher than the $1.98 per share estimate. The company generated $21.08 billion in revenue, better than $20.2 bil...
Oct 21, 2020
View Article
UnitedHealth Reports Q3 Earnings, Raises Annual Profit Forecast
Reportedly, the UnitedHealth Group Incorporated (UNH) announced its Q3 earnings this week beating estimates, the company raised its annual profit forecast pushed by growth in its Optum unit that deals in drug benefits. UnitedHealth alarmed demand for deferred services in May and June leading to hi...
Oct 20, 2020
View Article
NeuBase Therapeutics (Nasdaq: NBSE) Adds Peter Nielsen, Ph.D., Inventor of Peptide Nucleic Acid Technology, to SAB
Pittsburgh-based NeuBase Therapeutics (NASDAQ: NBSE) is a biotech firm that is accelerating the genetic revolution using a new class of synthetic medicines. NeuBase’s designer PATrOL™ therapies are centered around its proprietary drug scaffold to address genetic diseases at the source by combini...
Oct 13, 2020
View Article
Honeywell To Provide Individual PPE Packs For Panthers Fans For a Safer Stadium Experience
Reportedly, Honeywell (HON) has collaborated with NFL's Carolina Panthers, in an initiative to protect players, fans, and staff this season by providing a safer stadium experience amid the pandemic. Honeywell is providing an additional layer of safety to fans entering the stadium by providing them d...
Oct 08, 2020
View Article
J&J Enters Organizes Deal With Michigan’s Grand River Aseptic Manufacturing For Its COVID-19 Vaccine
Johnson & Johnson (JNJ) has entered a manufacturing deal with Michigan-based, Grand River Aseptic Manufacturing Inc for its SARS-CoV-2 vaccine candidate, which is being developed with partial funding from the U.S. government, as per reports. Recently, J&J launched a late-stage trial of its ...
Sep 29, 2020
View Article
Amgen’s Experimental Drug Shows Sign Of Improvement In Lung Cancer Patients With KRAS Gene Mutation
Reportedly, an experimental Amgen Inc (AMGN) drug meant for a specific genetic mutation reduced tumors in 32% of advanced lung cancer patients and 7% with those suffering from colon cancer in an early-stage trial. The drug sotorasib was given to lung cancer patients for 6.3 months and 4 months for c...
Sep 25, 2020
View Article
Amgen & Eli Lilly Enter Global Antibody Manufacturing Agreement For COVID-19 Antibody Therapies
As per reports, Eli Lilly & Company and Amgen have entered an agreement for a global antibody manufacturing to increase global supply capacity for Lilly's potential COVID-19 treatments. Lilly is currently researching a number of potential neutralizing antibodies for the prevention/treatment or b...
Sep 23, 2020
View Article
A Must Read: “Stay Safe: A Physician’s Guide to Survive Coronavirus” – A Resource That Will Help Protect Your Family Against the Coronavirus
Unfortunately, there are currently over 31.5 million confirmed coronavirus cases worldwide and over 967,000 related deaths! Recently, the director of the Centers for Disease Control and Prevention told lawmakers that he doesn't expect a potential COVID-19 vaccine to be available for most Americans...
Sep 23, 2020
View Article
Walgreens Introduces Personalized Pain Management Offering And Owned Brand Arthritis Pain Relief Gel
Walgreen Boots Alliance (WBA) announced the launch of diclofenac gel, an over-the-counter original prescription-strength arthritis pain relief in topical form for people suffering from chronic and acute pain. Specially trained Walgreens pharmacists, with support from the Global Healthy Living Founda...
Sep 17, 2020
View Article
PROGRESS REPORT: Atossa Therapeutics (Nasdaq: ATOS) Announces Positive Interim Safety Assessment in Clinical Study of AT-301 Nasal Spray Being Developed For Coronavirus Causing COVID
Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, plans to develop its nasal spray to potentially help prevent COVID...
Sep 17, 2020
View Article
J&J Janssen Unit Begins Mid-Stage COVID-19 Vaccine Trials In Spain
Reportedly, Johnson & Johnson's (JNJ) Janssen unit began mid-stage trials of its COVID-19 vaccine in Spain on 14th September 2020. 190 people are reported to take part in the country's trials, which will take place in three hospitals and will be concluded by Sept. 22. Phase II trials are being ...
Sep 17, 2020
View Article
UnitedHealthcare And Optum Come Forward With Assistance To Support People Affected By Ongoing Wildfires In California, Oregon, Washington, etc.
As per reports, UnitedHealthcare (UNH) and Optum have come forward to help people affected by the ongoing wildfires across parts of California, Oregon, Washington, and several other Western States offering support to health plan participants with health arrangements to access care and early prescrip...
Sep 17, 2020
View Article
Latin America To Come Forward With 1/3 Of J&J’s COVID-19 Vaccine Trial Volunteers
Reportedly, Johnson & Johnson (JNJ) is expecting 20,000 volunteers for late-stage human trials for its experimental coronavirus vaccine from Latin America, one of the worst affected regions by the pandemic making it an attractive testing sites for vaccine developers as it is an easier option to ...
Sep 17, 2020
View Article
Chile & Peru Added To The List Of Johnson & Johnson’s Latin America COVID-19 Vaccine Trials
As per reports, Johnson & Johnson (JNJ) will be adding Chile and Peru to the Latin nations where it plans to conduct Phase III trials for its vaccine against COVID-19. The trial involves 60,000 volunteers from Brazil, Chile, Colombia, and Peru, coordinated by J&J's pharmaceutical unit Jansse...
Aug 30, 2020
View Article
UnitedHealthcare To Serve Hoosier Care Connect Program Beneficiaries For State Of Indiana
As per reports, The Indiana Family and Social Services Administration has chosen UnitedHealth Group Incorporated (UNH) to administer its Hoosier Care Connect program. The program is designed to help blind and disabled members, eligible aged, and foster population. The four-year contract to begin on ...
Aug 29, 2020
View Article
Johnson & Johnson’s Diabetes Drug Relieved Of Boxed Amputation Risk Warning
As per reports, the U.S. Food and Drug Administration has removed the boxed warning about amputation risk for Johnson & Johnson's (JNJ) diabetes drug, Invokana. Amputations have been observed as the agency’s harshest warning. Approved in 2017, Invokana is advised to be used with diet and exerc...
Aug 26, 2020
View Article
Free Registration Now Open for NeuBase Therapeutic’s CEO, Dietrich A. Stephan, Ph.D., Tribe Public Presentation and Q&A Webinar Event on August 26, 2020
Tribe Public announced that Dietrich Stephan, Chief Executive Officer of NeuBase Therapeutics, Inc. (NASDAQ: NBSE), a biotechnology company developing next-generation antisense oligonucleotide (ASO) therapies using its scalable PATrOL™ platform to address genetic diseases, will present at Tribe Pu...
Aug 25, 2020
View Article
Johnson & Johnson Struck $6.5B Cash Buyout For Autoimmune Disease Developer Momenta
As per reports, Johnson & Johnson (JNJ) is set to buy Momenta Pharmaceuticals Inc. for about $6.5 billion to strengthen its portfolio of drugs for hard-to-treat autoimmune diseases. Treatments specializing in autoimmune conditions have gained importance and have fetched billions of dollars in ...
Aug 23, 2020
View Article
Johnson & Johnson Poised To Commence 60K Participant Phase 3 COVID-19 Vaccine Trial In September
As per reports, Johnson & Johnson (JNJ) is set to commence the large scale late-stage trial of its potential coronavirus vaccine next month. The trial is looking forward to enrolling up to 60,000 healthy people randomly selected from the age of 18 years and above across 180 locations in the U.S....
Aug 22, 2020
View Article
Britain Secures Relationship With J&J & Novavax For Potential COVID-19 Vaccine Supplies
As per reports, Britain has secured a deal for the potential COVID-19 vaccines from Johnson & Johnson (JNJ) and Novavax Inc. The latest addition brings Britain's total number of doses to 340 million, with options for millions more for its population of 66 million. "For now that is probably th...
Aug 21, 2020
View Article
Atossa Announces Advancement of COVID-19 Novel Nasal Spray Drug Treatment Candidate – “Focusing On Moving COVID-19 Clinical Studies As Quickly As Possible”
As of Monday night, worldwide coronavirus cases now total 22,049,426 with 777,439 deaths and 14,791,859 people have been reported to have recovered. In the US, we lead the world as we now have 5,612,027 reported cases, 173,716 deaths, and 2,973,587 have now recovered. With that said, the world co...
Aug 18, 2020
View Article
Pfizer, BioNTech Adds Japan To Coronavirus Vaccine Supply List For First Half of 2021
As per reports, Pfizer (PFE) and BioNTech SE to supply 120 million doses of their experimental coronavirus vaccine to Japan in the first half of 2021. Financial details of the agreement were not disclosed. Earlier, The United States also entered a similar deal with Pfizer and BioNtech for 100 millio...
Aug 06, 2020
View Article
Atossa Therapeutics Announces Interim Findings Following 18 Months Expanded Access Single-Patient Study of Atossa’s Endoxifen In Breast Cancer
Thursday, July 30th, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced interim findings following 18 months...
Jul 31, 2020
View Article
Pfizer And BioNTech Pushing Forward With Pivotal Global Study Of COVID-19 Vaccine Candidate
As per reports, U.S. drugmaker Pfizer (PFE) and German biotech BioNTech begin a pivotal global study to assess the performance of its COVID-19 vaccine which it calls BNT162b2. Successful completion of the study will enable the companies to submit the vaccine for regulatory approval by early October,...
Jul 30, 2020
View Article
Britain Enters Deals For Possible COVID-19 Vaccine Doses From Pfizer/BioNTech, Valneva
As per reports, Britain has entered deals to buy 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc (PFE) and BioNTech, and French group Valneva. Britain has signed in to procure 30 million doses of the early to mid-stage trials BioNTech/Pfizer vaccine and 60 million d...
Jul 23, 2020
View Article
Pfizer Enters $1.95B Deal To Provide U.S. With COVID-19 Vaccine Doses
Reportedly, Pfizer (PFE) has entered a $1.95 billion deal to provide 100 million doses of a COVID-19 vaccine to the U.S. government, with an additional right to purchase more 500 million doses. The company said that the Americans will be treated with the vaccine for free. The vaccine is in developme...
Jul 23, 2020
View Article
UnitedHealth Released Q2 Earnings, Warns Of Rising Costs But Sticks To Forecast
UnitedHealth Group Incorporated (UNH) reported earnings for Q2 ending June 30 and stuck to its full-year forecast, as per reports. The company warned of rising costs later this year as Americans catch up on less urgent surgeries put on hold by the coronavirus pandemic. The Insurer also expects fut...
Jul 23, 2020
View Article
INVO Bioscience Takes Key Commercialization Step With Registration of INVOcell in Turkey
“As the world’s only Intravaginal Culture System, INVOcell, a streamlined treatment solution, is uniquely positioned to address the challenges within the infertility industry.”- Steve Shum, CEO of INVO Bioscience (INVO) INVO Bioscience, Inc. ( INVO) (“INVO”) is an innovative medical devi...
Jul 16, 2020
View Article
Atossa Therapeutics Announced Successful In Vitro Testing Of Its COVID-19 Nasal Spray Formulation Treatment Candidate
According to a New York Times database, the U.S. COVID-19 pandemic has rapidly increased in 41 states over the past 2 weeks and reached 3.5M total infections as of Wednesday. Along with this growing concern and working to towards a treatment for COVID-19, Seattle-based Atossa Therapeutics, Inc. (...
Jul 16, 2020
View Article
Walgreens & VillageMD Partnering To Open Up To 700 Full-Service Doctor Offices Attached to Drug Stores in US
Reportedly, Walgreen Boots Alliance (WBA) is partnering with primary care provider VillageMD to offer doctor offices attached to its drugstores across the United States as a move to expand and offer healthcare services under one roof. The company is planning to open 500 to 700 physician-led primary ...
Jul 14, 2020
View Article
Atossa Therapeutics Advancing With Key Clinical & Regulatory Hires With Focus On COVID-19 & Breast Cancer Programs
Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced Wednesday that it has hired key personnel i...
Jul 09, 2020
View Article
Walgreens Restarts Immunization Services
As per reports, Walgreens (WBA) has restarted immunization services, taking care of all safety measures for pharmacy team members and patients. The changes comply with the updated U.S. Centers for Disease Control and Prevention (CDC) guidelines keeping in mind the flu season ahead, which may coi...
Jun 22, 2020
View Article
A Vista Partners Interview With Steve Shum CEO of INVO Bioscience Regarding Increasing Access To Care For Fertility Treatment
As compared to other countries, public payers in the US for the most part do not cover infertility services and, while a few state mandates for some coverage are in place, most private plans are exempted, leaving the majority of patients to pay out of pocket for their infertility care. With that min...
Jun 18, 2020
View Article
Eli Lilly Completes Successful Phase 3 Study On Breast Cancer Relapse
Reportedly, Eli Lilly (LLY), an American pharmaceutical company is expected to grab a significant share of Pfizer's (PFE) breast cancer treatment market after the completion of a successful Phase 3 study of Verzenio. The researchers at Eli Lilly tested Verzenio in combination with standard endocrin...
Jun 18, 2020
View Article
Fate Therapeutics Announces Completion of Public Offering of Common Stock At $28.31/share & Full Exercise of Underwriters’ Option to Purchase Additional Shares
Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. The Company has established a leadership position in the cl...
Jun 12, 2020
View Article
Atossa Therapeutics Announces Availability of Manuscript on Results from In vitro Testing of COVID-19 Drug, AT-H201
SEATTLE, June 11, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that the manus...
Jun 11, 2020
View Article
Will The Coronavirus Infect Every Human On The Planet? Atossa’s CEO Says…
In a recent article published at Best Life Online, Steven Quay M.D., Ph.D., the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and COVID-19 therapeutics, stated "corona...
Jun 04, 2020
View Article
European Health Regulators Bless J&J’s Ebola Vaccine
As per reports, Johnson & Johnson's (JNJ) two-dose experimental vaccine for Ebola in the European Union has received approval from the European health regulators. The vaccine is prepared to target the Ebola strain that causes the disease in most people, J&J submitted the approval application...
Jun 04, 2020
View Article
Atossa Therapeutics Teams With Nasal Spray Specialist Summit Biosciences To Develop Proprietary Drug Candidate AT-301 Intended to Prevent COVID-19 & Treat Early Cases
Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced on Thursday, May 28th that it has begun the...
May 29, 2020
View Article
Successful Results Announced From In Vitro Testing of AT-H201, Atossa’s Proprietary COVID-19 Drug Candidate
Earlier today, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announced the successful results from in vitro...
May 20, 2020
View Article
Johnson & Johnson’s Baby Powder Will Continue To Be Sold in U.K
Reportedly, healthcare giant Johnson & Johnson (JNJ) to continue selling its talc-based Johnson's Baby Powder in the UK and the rest of the world, after facing ban in the US and Canada. The component talc which is mined from the earth and is found close to that of asbestos, known to cause cance...
May 20, 2020
View Article
Seattle-based Biotech Firm Atossa Therapeutics (ATOS) Announces Q1 Progress
Seattle-based biotech firm Atossa Therapeutics (ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need announced its Q1 2020 Financial Results and confirmed the following progress: Launched a new dr...
May 14, 2020
View Article
J&J Beat Estimates, Lowers Full Year Guidance, & Raises Dividend
Johnson & Johnson (JNJ) recently released its quarterly earnings which beat market estimates. JNJ also made the decision to raise its dividend from $.95 cents a share to $1.01. The company forecasted 2020 adjusted earnings will reach the $7.50 to $7.90 per share level, much lower than its prior ...
May 13, 2020
View Article
Fertility Benefits Management Company Progyny, Inc. (PGNY) Realized A 72% Increase in Q1 2020 Revenue
Today, Progyny, Inc. (PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, announced its financial results for the 3-month period ended March 31, 2020, as compared to the three-month period ended March 31, 2019. PGNY co...
May 13, 2020
View Article
Pfizer Realizes Decline In Q1 Sales But Exceeds Expectations
Pfizer (PFE) reported first-quarter earnings on Tuesday, April 28, 2020, beating Wall Street Expectations. The drugmaker announced an adjusted EPS of 80 cents per share, 7 cents higher than Wall Street estimates. The company recorded total sales of $12 billion, an 8% decline in comparison to a year ...
May 06, 2020
View Article
UnitedHealth Group Beats Quarterly Profits
Dow 30 component, UnitedHealth Group Incorporated (UNH) released quarter earnings recently beating analyst expectations and upholding its 2020 outlook boosted by strength across its businesses. The company announced the medical loss ratio of 81.0%, beating analysts’ estimates of 81.57% for the qua...
May 05, 2020
View Article
COVID-19 HOPE Clinical Study Update: Atossa Therapeutics (ATOS) Contracts with NYC Health + Hospitals/Metropolitan
“Managing patient care and ventilator use has become a major challenge. We have an urgent need for a therapy to reduce reliance on ventilators and we are looking forward to playing a key role in what could be a much-needed solution for our sickest COVID patients.” commented Getaw Hassen, M.D.,...
Apr 27, 2020
View Article
UnitedHealth Group Led Initiative Providing Coventor, A Newly Invented “Light” Ventilator, During COVID-19 Pandemic
As per reports, UnitedHealth Group Incorporated (UNH) has teamed up with Boston Scientific, Medtronic, and the University of Minnesota for the distribution of 3k newly invented "light" ventilators to meet the limited stock of ventilators during the COVID-19 pandemic emergency. UnitedHealth Group is ...
Apr 24, 2020
View Article
Vios Fertility Institute Highlights INVO Bioscience’s INVOcell Infertility Treatment On The Morning Blend
April 19th-25th is National Infertility Awareness Week. Currently, it is estimated that only 1% to 2% of the estimated 150 million infertile couples worldwide are being treated, but help is on the way... This week, The Morning Blend aired an interview on WTMJ-4 Milwaukee where Dr. Ellen Hayes, a R...
Apr 23, 2020
View Article
The COVID-19 HOPE Trial Is Believed To Be The First Pharmaceutical Study Seeking To Address Getting Patients Off Mechanical Ventilators & Reducing High Death Rate
The number of worldwide coronavirus cases has grown to more than 2.4 million while the number of worldwide deaths have jumped to north of 170,000. Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), announced today that it has applied to the FDA for approval to commence a clinical stu...
Apr 20, 2020
View Article
3M Files Lawsuit Against Unauthorized Vendor Selling 3M-Branded N95’s At 500-600% Premiums
As per reports, 3M (MMM) has filed a lawsuit in federal court in Manhattan against New Jersey-based, Performance Supply LLC on Friday alleging that the company posed itself as an authorized vendor of 3M-branded N95 respirators and offered millions for sale to New York City officials at prices much h...
Apr 15, 2020
View Article
3M To Ramp Up Production Of Face Masks After Defense Production Act Orders
Reportedly, 3M (MMM) is continuing to increase the production of face masks after President Trump announced that he was invoking the Defense Production Act to get the company production rolling for more face masks. 3M to work closely with the Federal Emergency Management Agency to produce the masks....
Apr 07, 2020
View Article
FOX NEWS INTERVIEW TODAY: “Atossa Therapeutics'(ATOS) CEO Steven Quay MD, PhD Regarding New COVID-19 Hope Trial”
Steven Quay M.D., Ph.D. is the founder, Chairman & CEO of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions. He received his M.D. and Ph.D. from The ...
Apr 06, 2020
View Article
INVO Bioscience Appoints Christopher A. Myer as Vice President Of Business Development – Americas
INVO Bioscience, Inc. (INVO) is a medical device company focused on treating infertility with its FDA-cleared INVOcell® product. INVOcell is the first intravaginal culture device used for the incubation of eggs and sperm during fertilization and early embryo development using the women's body fo...
Apr 06, 2020
View Article
Fate Therapeutics (FATE) Shares Jump In Aftermarket Trading Post Announcing Worldwide Collaboration with Janssen
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today a global collaboration and option agreement with Janssen Biotech, Inc. (Janssen), one of the Jansse...
Apr 02, 2020
View Article
INVO Bioscience Reports A 199% Increase in Topline Revenues in 2019
INVO Bioscience, Inc. (INVO) is a medical device company focused on creating simplified, lower-cost treatments for patients diagnosed with infertility. Their solution, the INVO Procedure, is a new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers pat...
Mar 31, 2020
View Article
Walgreens Increases On-Demand Delivery Services Across Stores With Postmates Amid COVID-19 Pandemic
As per reports, Walgreen Boots Alliance (WBA) has partnered with Postmates to address the rising need for home delivery nationwide amid the coronavirus outbreak. Consumers can now get health and wellness items including some OTC products medications, household essentials from more than 7,000 Walg...
Mar 31, 2020
View Article
J&J Announces Lead COVID-19 Vaccine Candidate Committing More Than $1B To Co-fund Development
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson (JNJ) announced that it has selected a lead COVID-19 vaccine candidate whic...
Mar 30, 2020
View Article
Intel Is Providing Money & Equipment For COVID-19 Relief Programs In Oregon & Beyond
Reportedly, Intel Corporation (INTC) is working to provide money and equipment to health agencies and other COVID-19 relief programs. The company informed that $1 million out of $4 million announced this week will back groups in Oregon for essential services and equipment. The following community-ba...
Mar 30, 2020
View Article
NeuBase Expects To Announce Pharmacokinetic Data In Non-human Primates & In-vitro Pharmacodynamic Data For Its PATrOL™ Platform Next Week
Pittsburgh-based NeuBase (NASDAQ: NBSE) has developed a modular antisense peptide nucleic acid (PNA) platform with the capability to address rare genetic disease caused by mutant proteins with a single, cohesive approach. NeuBase believes that it has improved gene silencing therapies to include th...
Mar 26, 2020
View Article
Procter & Gamble’s Vicks Contributes $1M Funding To Assist Front Line Health Workers of COVID-19
The Procter & Gamble Company (PG)'s Vicks® family of cold and flu brands – NyQuil™, DayQuil™ and VapoRub™ are donating $1 million to Direct Relief, a humanitarian aid organization aiming to improve the health and lives of people affected by poverty or emergencies, including COVID-19. T...
Mar 24, 2020
View Article
UnitedHealth Group Announces Date For Q1 2020 Earnings & Call
As per reports, UnitedHealth Group Incorporated (UNH) will release its Q1 2020 financial results on Wednesday, April 15, 2020, before the market opens. The company to host a teleconference at 8:45 a.m. ET to be webcast on the Investors page of the company’s web site at (www.unitedhealthgroup.com)...
Mar 23, 2020
View Article
Walgreens Revises Store Operating Hours Beginning March 19
Walgreen Boots Alliance (WBA) announced revised operating hours for its stores and pharmacy beginning from Thursday, March 19 amid the growing COVID-19 pandemic. The revised operating hours to be implemented keeping in mind the safety of its store team members and ensuring to meet its customer's ne...
Mar 18, 2020
View Article
Pfizer To Co-Develop Potential COVID-19 Vaccine With BioNTech
As per reports, U.S. drugmaker Pfizer Inc and Germany's BioNTech SE have come together to develop a potential COVID-19 medicine using BioNTech's mRNA-based drug development platform. The drugmaker to start the collaboration immediately, the terms and conditions to be finalized over the next few week...
Mar 17, 2020
View Article
Infertility Treatment Innovator INVO Bioscience Makes Strategic Branding Move – Changes Trading Symbol to INVO
The Global Fertility Services market size is expected to reach $36 billion with a CAGR of 8.5% by 2023, according to a recent report by Market Research Future (MRFR) highlighted in Forbes. With that being the case, over the last handful of years, we are seeing growing investor interest and a growing...
Mar 16, 2020
View Article
Atossa Therapeutics Due To Meet FDA To Discuss The Clinical Development of Oral Endoxifen to Reduce Mammographic Breast Density (MBD)
MBD is an emerging public health issue affecting over 10 million women in the U.S. MBD is a recognized risk factor for future breast cancer and there is no approved therapy to reduce MBD. High-risk women are usually advised to have more frequent or sophisticated mammograms and to make lifestyle c...
Mar 13, 2020
View Article
INVO Bioscience Continues Global Buildout With Hire Of Yve Lyppens As Director Of Business Development Asia Pacific
According to the CDC's website, in general, infertility is defined as not being able to get pregnant (conceive) after one year (or longer) of unprotected sex. Because fertility in women is known to decline steadily with age, some providers evaluate and treat women aged 35 years or older after 6 mont...
Mar 11, 2020
View Article
UnitedHealthcare & Optum Stepping Forward To Offer Care & Support To Members Amid COVID-19
Dow 30 component UnitedHealth Group Incorporated (UNH) operates as a diversified health and well-being company in the United States. The company’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employer...
Mar 10, 2020
View Article
Thermo Fisher Scientific To Buy Global Provider of Molecular Diagnostics QIAGEN for ~$11.5B
Reportedly, Thermo Fisher Scientific Inc. (TMO), the world leader in serving science. is set to acquire Qiagen (QGEN), a Netherlands-based holding company and global provider of molecular diagnostics and sample preparation technologies. The deal received approval by the boards of directors, as well...
Mar 05, 2020
View Article
MIT’s Dr. Susan Hockfield To Join Pfizer’s Board Of Directors
Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. As per reports, Pfizer declared the election of Dr. Susan Hockfield to its Board of Directors. Dr. Hockfield will be added immediately & will also b...
Mar 04, 2020
View Article
Homewood’s America Institute of Reproductive Medicine Is Reducing IVF Costs With INVO Bioscience’s INVOcell Device
If you have never heard of a town called Homewood then you are probably not alone. Homewood is a town that is located adjacent to Birmingham, AL and has an unremarkable population of approximately 26,000 on a good day. So why am I interested? Simply put, Homewood is the home of the America Instit...
Mar 04, 2020
View Article
Has Pfizer Identified Compounds For Treatment Of Coronavirus?
Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. Reportedly, Drugmaker Pfizer has informed that it has identified certain antiviral compounds in development that has the potential to inhibit coronavir...
Mar 03, 2020
View Article
Atossa Therapeutics Achieves Important Milestone In Mammographic Breast Density & Gilead Puchases Forty-Seven, Inc. For $4.9B
MBD is an emerging public health issue affecting more than 10 million women in the United States. Studies conducted by others have shown that MBD increases the risk of developing breast cancer, and reducing MBD can reduce the incidence of breast cancer. Today Atossa Therapeutics, Inc. (Nasdaq: ...
Mar 02, 2020
View Article
Shares of Avadel Pharmaceuticals plc (AVDL) Are Surging In Concert With $65M Private Placement Led By Jefferies, Piper Sandler, and Stifel
Shares of Avadel Pharmaceuticals plc (AVDL) are surging today hitting an intraday high of $9.64/share ( a new-52-wk an all-time high) and currently is trading at $9.12/share, +28%. Their 52-wk range is $1.03 - $9.64. Avadel is a company focused on developing FT218, an investigational, once-nightly f...
Feb 21, 2020
View Article
Fate Therapeutics (FATE) Hits New All-Time High During Investor Conference Schedule
Shares of Fate Therapeutics, Inc. (FATE) hit an all-time new high today reaching $30.60/share which puts an approximate $2.3 Billion Market Cap. The 52-wk range is $12.59 - 30.60. Fate is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies f...
Feb 21, 2020
View Article
Is There An Intersect Between Breast Cancer & Heart Disease?
The growing awareness among Americans with respect to breast cancer and heart disease is quite evident, pink ribbons and red dresses have helped millions of men & women become aware of the risks, precautions, and prevention related to the above two most common illnesses. However, not many know ...
Feb 20, 2020
View Article
INVO Bioscience Progresses With Hiring of Inger Britt Carlson, Ph.D., Former Global Director of CooperSurgical Fertility & Genomics
INVO Bioscience (IVOB), under the guidance of newly appointed CEO Steve Shum (Q4, 2019), continues to make progress towards building a vibrant and growing organization in the fertility space. Today, INVO Bioscience, Inc. (IVOB), a publicly-traded medical device company focused on treating infertili...
Feb 13, 2020
View Article
China Pushes $10.26B Forward to Make Sure Public Not Hampered Financially In Dealing With Coronavirus Outbreak
According to Reuters today, "China's finance ministry said on Sunday all levels of government had allocated a total of 71.85 billion yuan ($10.26 billion) as of Saturday afternoon to fight coronavirus....
Feb 09, 2020
View Article
Nonfarm Payrolls Skyrocket 225k In January, Exceeds Wall Streets Estimates
The U.S. jobs market powered on to more gains, as nonfarm payrolls rose 225k for January exceeding Wall Street estimates. While the unemployment rate walked higher to 3.6% in concert with the labor force participation rate rising +.2 percentage points to 63.4%. The improvement is thought to be ...
Feb 07, 2020
View Article
INVO Bioscience Receives IRB Approval to Commence INVOcell Clinical Trial To Gain Expanded Labeling Including Live Birth After 5-Days of Continuous Vaginal Incubation
Sarasota-based INVO Bioscience, Inc. (IVOB) is a medical device company focused on treating infertility with its FDA-cleared INVOcell® product. the INVO® Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Their lead produc...
Feb 05, 2020
View Article
Interview with Atossa Therapeutics’ Kyle Guse On World Cancer Day “Transforming Breast Cancer Treatment”
Every February 4th is World Cancer Day, the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education and catalyzing personal, collective, and government action, they are working to reimagine a world where millions of pre...
Feb 04, 2020
View Article
Dow 30 Component Pfizer Reports Quarterly Earnings But Falls Short of Expectations
Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. Pfizer reported quarterly profits on Tuesday, falling short of market estimates for the first time in the last two years. Sale of its patent drug Lyrica...
Feb 01, 2020
View Article
Symphonix Health Insurance, A UnitedHealth Care Company Credited With Financial Strength Rating of A
Dow 30 component UnitedHealth Group Incorporated (UNH) operates as a diversified health and well-being company in the United States. The company’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employer...
Jan 30, 2020
View Article
INVO Bioscience To Attend The Arab Health Exhibition The Largest Gathering In The MENA Region
The Arab Health Exhibition is the largest and most comprehensive gathering for the healthcare industry in the MENA (the Middle East and North Africa) region. It first took place in Dubai, the United Arab Emirates in 1975 and is now recognized as the second-largest healthcare exhibition and congress ...
Jan 27, 2020
View Article
Breast Cancer Focused Atossa Therapeutics CEO Dr. Steven C. Quay Issued An Annual Letter to Shareholders Highlighting Key Accomplishments and Strategy for 2020
Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions. This week Atossa Therapeutics' President and CEO Dr. Steven C. Quay Issued an Annual Lette...
Jan 24, 2020
View Article
Johnson & Johnson Reports Earnings, Beats Wall Street Profit Estimates But Misses On Revenue
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson reported its fiscal Q4 profit results, beating Wall Street’s expectations...
Jan 24, 2020
View Article
Walgreens Gains First Enterprise-Wide URAC Specialty Pharmacy Accreditation
Walgreen Boots Alliance (WBA) is a pharmacy-led, health and wellbeing enterprise with a long history of trusted healthcare services, community pharmacy care, and pharmaceutical wholesaling dates. Reportedly, Walgreens has received the first enterprise-wide URAC accreditation in Specialty Pharmacy f...
Jan 24, 2020
View Article
“Day 4 JPM2020 Complete & Broad Markets Rise To New Record Levels” – Vista Partners Daily Market Recap For January 16, 2020
Day 4 of the 38th Annual J.P. Morgan Healthcare Conference in San Francisco is now complete. I logged in a few more meetings with companies in the biotech and healthcare sectors & also attended the Tribe Public Keynote Speaker luncheon event where Dietrich Stephan Ph.D., CEO of Pittsburgh-ba...
Jan 16, 2020
View Article
INVO Bioscience (IVOB) Signs First JV To Operate Dedicated INVOcell Fertility Clinics in India
The INVOcell system (picured below) is a novel fertility treatment that uses a woman's own body as a natural incubator for the incubation of eggs and sperm during fertilization and early embryo development. INVO Bioscience, Inc. (IVOB) believes this process is cost-effective and has shown comparab...
Jan 16, 2020
View Article
“Day 3 JPM2020 – Momenta & IsoRay Surge – Phase One Trade Deal Signed” – Vista Partners Daily Market Recap For January 15, 2020
Day 3 of the 38th Annual J.P. Morgan Healthcare Conference in San Francisco is complete and I have logged in another double-digit round of meetings with companies in the biotech and healthcare sectors. I met with interesting companies like CRISPR leader firm Intellia Therapeutics (NTLA) & Millen...
Jan 15, 2020
View Article
“Day 2 JPM2020 – Denali Therapeutics, Momenta Pharmaceuticals & Bellicum Pharmaceuticals Jump ” – Vista Partners Daily Market Recap For January 14, 2020
Day 2 of the 38th Annual J.P. Morgan Healthcare Conference in San Francisco is nearly complete. I met with another 12 companies in the biotech and healthcare sectors including interesting companies like Oncolytics Biotech (ONCY), Syros Pharmaceuticals, (SYRS), Prevail Therapeutics (PRVL) & man...
Jan 14, 2020
View Article
“JPM2020 The S&P 500, Nasdaq & Apple Soar To New Records” – Vista Partners Daily Market Recap For January 13, 2020
The 38th Annual J.P. Morgan Healthcare Conference kicked off today in San Francisco. It is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investme...
Jan 13, 2020
View Article
Towa Pharmaceutical Co. Ltd. To Strengthen Its Global Generic Medicine Business With The Acquisition Of Pensa Investments
As per reports, Kadoma, Osaka Japan-based company Towa Pharmaceutical Co. Ltd. that specializes in generic drugs announced it is acquiring 100% ownership of Pensa Investments, S.L. (Pensa), the generics division of the Spanish pharmaceutical company ESTEVE. The deal to be an all-cash deal with an up...
Dec 27, 2019
View Article
Shares of Atossa Rise After Contracting For Phase 2 MBD Study In Women & An Analyst BUY Recommendation
Breast cancer is the most common cancer in women in the US with more than 268,000 new cases in 2019 according to the American Cancer Society. Legislation has been recently enacted in over 35 states requiring that women be notified if they have Mammographic breast density (MBD) and those ...
Dec 20, 2019
View Article
Pfizer & Astellas Pharma’s XTANDI Gains Supplemental FDA-Approval For The Treatment Of Metastatic Castration-Sensitive Prostate Cancer
Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. Recently, Pfizer announced the results of the interim analysis of the Phase 3 BEACON CRC trial with a combination of BRAFTOVI® (encorafenib), MEKTOVI® ...
Dec 18, 2019
View Article
Merck Announced the Acquisition of Cancer-Drug Developer ArQule For $2.7B
Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue to be at the le...
Dec 14, 2019
View Article
J&J’s Janssen Pharmaceutical Companies To Provide 200k Ebola Vaccine Regimens to the Republic of Rwanda
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Reportedly, Johnson & Johnson’s Janssen Pharmaceutical Companies is set to provide 200k Ebo...
Dec 10, 2019
View Article
Breast Cancer Novel Therapeutics Firm Atossa Genetics Will Be Presenting at LD Micro Main Event Conference on Tuesday Dec 10 In LA
Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced that Kyle Guse, CFO, will be a featured presenter at the LD Micro Main Event on December 10, 2019, at 12:...
Dec 05, 2019
View Article
Seattle Genetics & Astellas Enter An Agreement With Merck To Assess Effectiveness Of Drug For Metastatic Urothelial Cancer
Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue to be at the le...
Dec 05, 2019
View Article
United Health Foundation & The Colorado Center For Nursing Excellence Seeking To Produce Better Behavioral Health Clinical Practice
Reportedly, The United Health Foundation is initiating a $1.5 million grant to the Colorado Center for the next three-years. This will go to support and recruit 39 currently-employed rural Advanced Practice Registered Nurse Behavioral Health Fellows. The move will further go to help the fellows to r...
Dec 03, 2019
View Article
Aslan Skyrockets (+36.13%), NeuBase Therapeutics Pops (+8%), Hecla Bumps (+2.43%) & Market/Manufacturing Drops – Vista Partners Daily Market Recap 12/2/19
The broad markets dropped this first trading day in December in a reaction to the ISM Manufacturing Index report for November which confirmed a 48.1% reading vs. a 48.3% reading for October still south of the Mendoza line for expansion and this did nothing to excite the market. The S&P 500 real...
Dec 02, 2019
View Article
The Latest on Gene Silencing Biotech Firm Arrowhead Pharmaceuticals Fiscal Year 2019 Results
Recently, Arrowhead Pharmaceuticals (ARWR), a company that develops medicines that treat intractable diseases by silencing genes that cause them, announced its earnings report for the quarter ending September 30, 2019. The company hosted a live webcast of the event, a replay of which will be availab...
Dec 01, 2019
View Article
Tech Data Leaps (+12.32%) On Apollo Bid & Broad Markets Take It On Chin! Vista Partners Daily Market Recap 11/29/19
Big Movers Shares of Tech Data (TECD) lept +12.32% today closing at $144.89/share. Private equity firm Apollo Global Management agreed to pay $145/share for TECD on Wednesday, up from its original bid of $130/share of Warren Buffett's Berkshire bid of $140/share from last week. TECD op...
Nov 29, 2019
View Article
Unexpected Key Data Points, AVX Corp (+18.97%), INVO Bioscience (+9.09%) & Broad Markets Rise! Vista Partners Daily Market Recap 11/27/19
Big Movers Shares of AVX Corporation (AVX) jumped +36.37% today. AVX is a leading manufacturer and supplier of advanced electronic components and interconnect, sensor, control, and antenna solutions that yesterday won the South Carolina Life Sciences Pinnacle Award for Organizational Contrib...
Nov 27, 2019
View Article
Arrowhead Pharma, Nutanix, Retail Sector & Broad Markets Rise! Vista Partners Daily Market Recap 11/26/19
Big Movers Arrowhead Pharmaceuticals, Inc. (ARWR), a company that develops medicines that treat intractable diseases by silencing the genes that cause them rose +18.79% today closing at $67.70/share. Yesterday after the close the company hosted the fiscal year 2019 conference call to review t...
Nov 26, 2019
View Article
Select Walgreens Stores To Launch UnitedHealthcare’s Member Medicare Services Centers
Reportedly, UnitedHealthcare and Walgreens are set to launch 14 UnitedHealthcare Medicare services centers within Walgreen stores in Las Vegas, Phoenix, Cleveland, Denver, and Memphis markets in January 2020. The initiative which is part of a multiyear agreement between the companies will allow Walg...
Nov 26, 2019
View Article
The Medicines Company (MDCO), IBB, & Russell 2000 Post Big Wins! Vista Partners Daily Market Recap 11/25/19
Big Movers Novartis (NVS) announced that it is buying The Medicines Company (MDCO) and its experimental treatment inclisiran uses a new approach to lower bad cholesterol in especially hard to treat patients for $9.7B. Shares of MDCO jumped +22.25% closing at $83.80/share. The Ishares Nasdaq ...
Nov 25, 2019
View Article
“Friday Market Drifts Up, Nordstrom & Buffett’s StoneCo Ltd. Surge!” Vista Partners Daily Market Recap 11/22/19
Big Movers Nordstrom (JWM) soared to $37.95/share up +10.58% today after beating Wall Street's expectations as they saw their digital sales drive Q3 performance leading them to revise their guidance upward. A leading provider of financial technology solutions that empower merchants to conduc...
Nov 22, 2019
View Article
“TD Ameritrade Flys On Chuck Schwab Interest” Vista Partners Daily Market Recap 11/21/19
Big Movers According to a plethora of sources, today Charles ("Chuck") Schwab (SCHW) is making a move to combine with rival brokerage firm TD Ameritrade (AMTD), a deal that could be worth more than $25B. It would also create a new behemoth company in the brokerage space with over $5T in combi...
Nov 21, 2019
View Article
New Type of IVF Treatment From Newcomer INVO Bioscience Is Headed To Reno
Worldwide, the fertility treatment market is severely underserved. Currently, only 1% to 2% of the estimated 150 million infertile couples worldwide are treated, with the primary prohibiting factor being cost and access to treatment. With this in mind, the business, art, & the science of gettin...
Nov 21, 2019
View Article
Will Novartis Acquire Parsippany-based The Medicines Company?
Reportedly, Novartis AG is in talks to acquire Parsippany, New Jersey-based The Medicines Company (MDCO) a developer of a promising cholesterol drug, as per sources. Other potential acquirers have also shown interest in the purchase of Medicines, tripling the value of its shares recently this year ...
Nov 21, 2019
View Article
“No Phase One In 2019? – Target & Neubase Therapeutics Jump!” Vista Partners Daily Market Recap 11/20/19
Big Movers Target Corporation (TGT) jumped +14.06% closing at $126.43/share after crushing earnings expectations and reporting a surge of +4.5% in same-store sales in Q3. Vista Partners recently highlighted a "one-to-watch-stock" in the weekly market recap called Neubase Therapeutics (NBSE),...
Nov 20, 2019
View Article
INVO Bioscience, Developers Of The World’s Only In Vivo FDA Cleared Intravaginal Culture System, Will Host A Live Investor Webcast at 11:00 AM ET (8:00 am PT) on Thursday, November 21, 2019
The business, art, & the science of getting pregnant in today's world is receiving greater focus from venture capitalists, private equity firms, mutual funds, and family offices. This interest is evidenced in the increasing number of startups innovating in the fertility space in recent years a...
Nov 19, 2019
Vie